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DNA adenine methyltransferase identification with sequencing (abbreviated DamID-
seq) is a technique that can measure protein-DNA interactions in the genome. Unlike
chromatin immunoprecipitation with sequencing (abbreviated ChIP-seq), this tech-
nique does not require validated antibodies, precipitation steps, or chemical cross-
linking, and can be used with minimal numbers of cells. Although the technique was
first developed in Drosophila nearly two decades ago, due to technical limitations only
a handful of experiments using mammalian cells have been published. The optimisa-
tion of mammalian DamID-seq in our lab has highlighted the need to survey potential
sources of bias, develop accurate analysis methods, and investigate the similarities
and differences with ChIP-seq for detecting protein-DNA interactions. Here, I de-
scribe several variables that influence the accuracy of DamID-seq experiments, present
the Daim software package (pronounced “Dime”) for the comprehensive analysis of
DamID-seq data, and assess the sensitivity and specificity of DamID-seq compared
with competing techniques. In particular, I show that differences in the experimental
procedure (polymerase usage and restriction digest) and features in the sequencing
data (fragment length and nucleotide content) generate systematic bias and technical
variation. I also demonstrate that DamID-seq data can be re-purposed to measure
Dam-accessible DNA in the genome, comparable with other chromatin accessibility
techniques (ATAC-seq, DNase-seq, and FAIRE-seq). To analyse DamID-seq data, I
vi
developed the Daim software package which incorporates methods for preprocess-
ing, normalisation, and identification of DNA binding and accessibility sites. Several
options for functional and sequence analysis of results are also included. The use of
Daim was demonstrated using data for transcription factors Oct4 and Sox2 in mouse
embryonic stem cells, embryonic fibroblast cells, and neural stem cells from a range
of cell numbers. Finally, I show that DNA binding and accessibility sites vary sub-
stantially between and within techniques, yet no clear reason for these differences has
been detected, prompting careful consideration of any biological conclusions. These
results show that Daim can be successfully used for the analysis, interpretation, and
visualisation of DamID-seq experiments, and that to achieve comprehensive results,
different techniques should be treated as complementary rather than competing.
vii
Lay Summary
Cells are the building blocks of life. They form the structure of all animals and plants,
from organs to tissues and everything within. There are different types of cells, each
of which play a specialised role in life, such as producing energy or fighting disease.
They contain a substance called DNA which provides a blueprint for building and
maintaining the cell. All of the DNA in a cell is referred to as the genome. Genes
are regions of the genome that are responsible for different characteristics, such as
cell shape and size. Different types of cells are created by proteins binding to the
genome and activating or deactivating specific genes. The key to understanding de-
velopmental biology is determining how and which genes are regulated by protein
binding. To detect where proteins bind, a technique called Dam identification (ab-
breviated DamID) was developed. The protein of interest is tied to a protein known
as Dam produced by bacteria. When the protein binds, Dam leaves a recognisable
mark on the DNA nearby the binding site. The DNA is then fragmented and only
the marked fragments are measured. To identify genome-wide binding sites, I have
written a computer program called Daim (pronounced “Dime”) which determines the
location of the protein-bound fragments in the genome, and measures how often the
DNA was marked. It then uses statistics to test the probability that this measurement
represents actual binding and not just random variation. This information can then be
used to check which genes are bound by the protein, providing a greater understand-
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1.1 Transcriptional regulation of gene expression
Recent initiatives such as the mouse cell atlas have demonstrated there are around
800 major cell types and potentially more than 1,000 subtypes in mammalian organ-
isms (Han et al., 2018). Each of these cell types exhibit divergent gene expression
profiles which drive the morphological and physiological characteristics underlying
their functionality. The central dogma of molecular biology is that genes encode for
functional products called proteins which perform specific roles within the cell such
as carrying out chemical reactions or transmitting signals. Gene expression profiles
therefore comprise large networks of genes and proteins which are co-regulated by
deterministic mechanisms to achieve the cellular diversity and functionality requisite
of mammalian complexity. The amazing repertoire on display is even more impressive
when one considers that all of these cells contain the same genetic information, only
it is read and parsed in a completely different manner depending on environmen-
tal and developmental cues. Gene expression itself can be controlled at the level of
transcription (DNA into mRNA) and translation (mRNA into protein) including other
downstream modifications (Cooper, 2000). Transcriptional regulation is the primary
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form of control in mammalian systems and is the combination of multiple protein-
protein and protein-DNA interactions, most notably transcription factor binding and
chromatin structure remodelling (Wilkinson, Nakauchi, and Göttgens, 2017).
1.1.1 Transcription factor binding
Transcription factors are DNA-binding proteins involved in controlling the rate at
which DNA is transcribed into mRNA via the enzyme RNA polymerase (Latchman,
1993). They bind to specific DNA sequences along the genome, often within promot-
ers and enhancers which modulate transcription of the corresponding gene. Bind-
ing specifically leads to recruitment of activator or repressor proteins which influence
DNA folding at the promoter making it easier or harder for RNA polymerase to bind
and form a pre-initiation complex leading to transcription (Haberle and Stark, 2018).
Genome sequence analyses have suggested there are roughly 1,300 to 1,500 transcrip-
tions factors encoded in the mammalian genome (Vaquerizas et al., 2009). These have
been grouped into families characterised by shared DNA-binding and regulatory do-
mains which underlie their sequence specificity and transcriptional influence, respec-
tively.
There are a number of ways in which transcription factors can be classified. One way is
by grouping them on the basis of their DNA binding domains which differ in their se-
quence and structure (Latchman, 1997). Examples of these include Homeobox, POU,
Paired Box, Zinc Finger, Basic Element, and Ets domains. Those which share the 60
amino acid domain called the homeodomain are aptly referred to as homeobox pro-
teins. The most studied of these are the hox genes, a cluster of eight genes which
code for transcription factors involved in patterning of the principal body axis dur-
ing embryonic development. They are particularly intriguing because they appear
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one after another in the order in which they are expressed which matches their func-
tion along the anterior-posterior body (Garcia-Fernàndez, 2005). The POU family of
transcription factors share a 150-160 amino acid domain first defined in Pit-1, Oct-1,
and Unc-86 proteins, hence the abbreviation. Collectively these members have been
shown to play an important role in development and functioning of the nervous sys-
tem (Latchman, 1999). Another class of transcription factors are those which contain
a zinc-finger domain, of which there are many different structures (coordinated by a
zinc ion) depending on what combination of cysteine and histidine amino acids are in-
corporated. Members of this family can bind to DNA, RNA, and even other proteins.
As such, they are involved in regulation of multiple processes, such as cell prolifer-
ation in skin, muscle differentiation, and even adipose generation (Cassandri et al.,
2017).
Instead of classifying transcription factors by their structural domains, an alternative
method is to classify them based upon four functional classes (Pope and Medzhitov,
2018): The first contains transcription factors which are expressed in all cell types and
are responsible for regulating ubiquitously expressed genes. The enzyme GAPDH is
required for glycolysis and its expression is continuously regulated by the transcrip-
tion factor HIF-1 (Said et al., 2009). The second consists of pre-existing proteins (al-
ready translated) that are activated when induced. The most well-studied of these is
the p53 tumour suppressor protein, which activates upon cellular stress and coordi-
nates a stress response program through transcriptional activation (Zilfou and Lowe,
2009). By contrast, the third comprises of proteins that first require translation when
induced. A prime example of this is the c-Myc oncogene which becomes expressed
in response to certain receptor transduction pathways such as MAPK/ERK and WNT
signalling (Dang, 2012).The last class of transcription factors are lineage-restricted and
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responsible for regulating and maintaining cell-type specific morphology and func-
tion. Notable examples include MyoD which regulates muscle differentiation (Bar-
Nur et al., 2018) and Sox2 which maintains neuronal progenitor identity (Kim et al.,
2011). Given the complexity of transcription factor families and the potential for mem-
bers to be reclassified based upon new evidence of novel function, classification by
functional class may be rather vague relative to classification by domain architecture,
which is generally more fixed. These different classifications are also liable to over-
lap in that a particular functional class of transcription factors may only be made up
of proteins with a particular functional domain. For example, approximately 49%
of transcription factor families in humans are tissue-specific, reflecting their specific
physiological functions. However, C2HS zinc-finger proteins for example are much
less tissue-specific, instead acting to repress transposable elements which occur in a
broad range of tissues and cell types (Lambert et al., 2018). Overall, the role of tran-
scription factors therefore is to make sure genes are expressed in the right cell at the
right time in response to developmental and environmental signalling cues.
1.1.2 Chromatin structure remodelling
Eukaryotic DNA is wrapped around histone proteins to form a hierarchically pack-
aged structure called chromatin. The basic unit of chromatin is the nucleosome. It
consists of a 146 bp segment of DNA wrapped around a core of eight histone proteins
(includes two copies of H2A, H2B, H3, and H4). Multiple nucleosomes are arranged
along a DNA molecule (separated by 38-53 bp segments of linker DNA) to form a 10
nm chromatin fibre, otherwise known as a nucleosomal array. Under a microscope
these fibres appear like “beads-on-a-string” and are often considered the ‘primary’
structure of chromatin (Luger, Dechassa, and Tremethick, 2012). Short-range interac-
tions between nucleosomes in the same fibre create folds which generate a thicker 30
nm chromatin fibre. This high-order structure is considered the ‘secondary’ structure
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of chromatin (Tremethick, 2007). The exact folding mechanism however is unclear,
with two prevailing theories still under debate: The solenoid model predicts that con-
secutive nucleosomes interact and fold the fibre into a one-start helix structure (Korn-
berg, 1974). The zigzag model suggests that alternative nucleosomes interact and fold
the fibre into a two-start helix structure (Woodcock, Frado, and Rattner, 1984). Whilst
both models have considerable supporting evidence, a recent review has suggested
that chromatin structure is more of a continuum of various states and that a model
combining both mechanisms is required (Luger, Dechassa, and Tremethick, 2012).
Long-range interactions between individual nucleosomes on different fibres provide
additional folding to form aggregates of fibres, also defined as the ‘tertiary’ structure
of chromatin. These aggregates then undergo successive rounds of coiling and looping
(driven by DNA-binding proteins such as cohesion and CTCF) to eventually form con-
densed chromatin complexes called chromosomes which pair up and fit inside the nu-
cleus of the cell (Merkenschlager and Nora, 2016). Both the ‘secondary’ and ‘tertiary’
structures are stabilised by architectural proteins (e.g. HP1, HMG1, and PARP1) and
influenced by histone variants (e.g. H2A.X, HSB1, and H3.3) and post-translational
modifications (e.g. acetylation, methylation, and phosphorylation) (Venkatesh and
Workman, 2015). Additionally, variations in the ‘primary’ structure reflecting dif-
ferent nucleosomal states can lead to large-scale rearrangements in the higher-order
structures. These rearrangements are required at particular times throughout the life-
time of the cell, for example in the metaphase stage of mitosis where constrained and
non-random structures are required. Finally, chromosomes within the nucleus are or-
ganised into particular territories which together constitute the ‘nuclear’ architecture
of the cell. Their organization however is not stable as during the cell cycle chromo-
somes are required to decondense and move to accommodate replication and transfer
of DNA to daughter cells. Generally, chromosomes during interphase and prophase
appear in similar locations within the nucleus compared to the metaphase, anaphase,
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and telophase stages of mitosis (Cremer and Cremer, 2010). When DNA is compacted,
it becomes very difficult for transcription factors and RNA polymerase to bind to the
promoter region of a gene to initiate transcription. Genes which are expressed are sub-
sequently found in more accessible regions of DNA than genes which are suppressed
(Tsompana and Buck, 2014). The structure of chromatin however is not static and can
be rearranged in order to provide access to particular genomic regions. The attraction
between DNA and histones can be weakened by modifying the N-terminal tails of hi-
stones using acetylation, phosphorylation, and methylation. Acetylation in particular
reduces the positive charge of the histones so the negatively charged DNA becomes
less tightly wrapped (Görisch et al., 2005). Specific histone proteins can also be re-
placed by variants (the most common being H2A.X, H2A.Z, and H3.3) which accu-
mulate permissive histone modifications and disrupt nucleosome stability (Henikoff
and Smith, 2015). Nucleosomes can additionally be evicted or pushed along the DNA
by specific ATP-dependent remodelling proteins thus providing access to the promot-
ers and enhancers of requisite genes (Flaus and Owen-Hughes, 2011). The structure of
chromatin therefore presents an additional layer of transcriptional regulation which
acts in tandem with transcription factor binding that requires its own level of control
from upstream signalling pathways.
1.2 Identification of genome-wide DNA accessibility sites
By mapping regions of the genome which are accessible, information regarding nu-
cleosome positioning and transcription factor occupancy can be generated. Together
this information can be integrated to reveal the location of regulatory elements in-
volved in gene expression which can be further studied. The first high-throughput
method to map chromatin accessibility was called DNase-seq and is based upon the
sensitivity of unbound DNA to cleavage by DNase I nuclease (Crawford et al., 2006).
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A library of hypersensitive fragments is generated and sequenced, then mapped back
to the genome to identify their original location relative to known genomic features.
Although this method has proved highly successful and is still continuously used
in research, a number of successive methods were developed to overcome limita-
tions in the original protocol. The method known as FAIRE-seq exploits the fact
that nucleosome-depleted regions of the genome are less susceptible to formalde-
hyde cross-linking, thus after phenol-chloroform extraction these regions are pref-
erentially segregated from nucleosome-bound DNA into the aqueous phase of the
solution (Giresi et al., 2007). Unlike DNase-seq, this method does not require perme-
abilization of the cells or isolation of the nuclei, meaning the experimental protocol is
often simpler and can be performed more quickly. Despite this advantage, it has since
been shown that FAIRE-seq performs worse than DNase-seq and is often less repro-
ducible (Song et al., 2011). Furthermore, both methods require a large number of cells
to achieve a sufficient DNA yield for high-throughput sequencing. The most recently
developed method called ATAC-seq was designed to overcome this limitation and is
based upon the ability of Tn5 transposase to preferentially insert into open chromatin
regions (Buenrostro et al., 2013). The hyperactive Tn5 transposase is first loaded with
sequencing adapters and then delivered into cells containing unfixed nuclei to simul-
taneously fragment and tag the genome with adapters for sequencing. This bypasses
the usual inefficient library preparation steps allowing fewer cells to be harvested and
more experiments to be performed in biological systems which are limited. Together
these methods constitute an array of different approaches to epigenomic profiling and
whilst all of them are still used in research, it is becoming clear that the accuracy
achieved by ATAC-seq combined with the resolution of single-cell technology is im-
portant to achieve a deeper understanding of regulatory elements (Buenrostro et al.,
2015).
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1.3 Identification of genome-wide DNA binding sites
The study of gene regulation relies on the ability to detect protein-DNA interactions,
such as RNA polymerase and transcription factor binding. By characterising which
genes are regulated by what proteins, more of the transcriptional network can be
pieced together to understand how the myriad of interactions bring about the ob-
served biological complexity (Wilkinson, Nakauchi, and Göttgens, 2017). This en-
deavour is particularly relevant to understanding cell fate control by transcription
factors (Iwafuchi-Doi and Zaret, 2016) and dysregulation of gene expression in can-
cer (Nebert, 2002). Over the last decade a variety of technologies have been used to
identify genome-wide DNA binding sites for transcription factors and other proteins.
What follows is an historical overview of their development and current limitations
which need to be addressed:
1.3.1 Chromatin immunoprecipitation (ChIP)
All of the technology discussed in this section originate from a technique first de-
scribed in 1984 by Gilmour and Lis named chromatin immunoprecipitation (Gilmour
and Lis, 1984). The authors determined the distribution of RNA polymerase in both
bacteria and Drosophila by covalently joining proteins to DNA using UV light irra-
diation, followed by precipitation of a protein antigen out of solution using an an-
tibody that specifically binds to the protein. The eluted DNA fragments in the pre-
cipitate were then purified and subjected to hybridization assays in order to identify
which DNA sequences were associated in vivo with the protein (Gilmour and Lis, 1984;
Gilmour and Lis, 1985). After the publication of this technique, many researchers be-
gan to adopt it for their own systems and shortly after in 1988 the relatively weak
UV fixation was switched to a much stronger formaldehyde fixation in order to pre-
vent loss of genuine but weak DNA-protein complexes during sample preparation
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(Solomon, Larsen, and Varshavsky, 1988). Furthermore, with the advent of microar-
ray technology the relatively low-throughput hybridization assays were replaced with
whole genome microarrays allowing researchers to measure binding at an unprece-
dented resolution. This new approach (ChIP-chip) was successfully demonstrated by
Ren and colleagues who measured the binding of Gal4 and Ste12 activator proteins
in yeast, showing genes whose expression is directly controlled by both proteins in
response to changes in carbon source and mating pheromone, respectively (Ren et al.,
2000).
1.3.2 Chromatin immunoprecipitation sequencing (ChIP-seq)
Although first described in 2007, the current most popular method to identify genome-
wide DNA binding sites is chromatin immunoprecipitation sequencing (ChIP-seq).
The concept behind ChIP-seq is to selectively enrich for regions of DNA bound to
the protein of interest by first targeting an antibody against an epitope on the protein.
The antibody binds to the epitope and the protein-DNA complexes are co-precipitated
out of the cellular solution using the antibody. The complexes can then be disassoci-
ated leaving just a collection of DNA fragments which are sequenced to identify the
genome-wide DNA binding sites (Johnson et al., 2007). In reality, the protocol behind
ChIP-seq is much more involved and each step requires consideration. The ChIP-seq
protocol starts by treating cells with formaldehyde to cross-link any protein-DNA in-
teractions. This ensures that bound proteins remain fixed to their DNA sequences dur-
ing chemical handling. The cells are then homogenised, and the chromatin is sheared
by sonication. This is used to achieve a greater binding site resolution by reducing the
size of the DNA region protruding out from the protein-DNA complex. The protein-
DNA complexes are then immunoprecipitated using a highly specific and sensitive
antibody. The antibody must target an exposed epitope on the protein or else it can-
not bind to the protein-DNA complex. The cross-linking is then reversed, and the
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DNA fragments are prepared for high-throughput sequencing (Johnson et al., 2007).
In order to identify genome-wide DNA binding sites from ChIP-seq data, the sequenc-
ing reads are first mapped to a reference genome using alignment software. Regions
of high read coverage in the ChIP sample compared to an input DNA sample (used
to correct for non-specific immunoprecipitation) are then located using peak calling
software (Pepke, Wold, and Mortazavi, 2009).
Whilst ChIP-seq has been used extensively over the last decade, it suffers from a num-
ber of inherent limitations: The quality of the ChIP-seq data is determined by the
specificity and sensitivity of the antibody. If a non-specific antibody is used a signif-
icant amount of unrelated protein-DNA complexes are immunoprecipitated and se-
quenced (Kidder, Hu, and Zhao, 2011). The library preparation method also contains
a number of inefficient enzymatic steps resulting in sample loss, therefore at least 107
cells are needed to generate enough immunoprecipitated DNA for sequencing (Gilfil-
lan et al., 2012). Whilst this number of cells can be achieved by expanding cell lines in
vitro, it is very difficult to collect enough cells in vivo from tissues and rare-cell pop-
ulations. Lastly, using formaldehyde to cross-link protein-DNA interactions includes
its own set of problems: Transient protein-DNA interactions are completely missed
(Schmiedeberg et al., 2009), prolonged fixation can recover non-specific interactions at
highly occupied regions (Baranello et al., 2016), cross-linking occurs between protein-
protein and protein-DNA interactions so direct and in-direct interactions cannot be
disassociated (Hoffman et al., 2015), and fixation can lead to irreversible changes in
the protein so the antibody can no longer recognise the epitope (Scalia et al., 2017).
1.3.3 New and improved ChIP-seq methods
Over the subsequent years a number of upgraded protocols have been developed to
overcome the limitations associated with immunoprecipitation, library construction,
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and formaldehyde fixation:
The search for low cell number alternatives began with the development of a nano-
ChIP-seq protocol in 2010 which was used to identify trimethylation of histone H3 at
lysine 4 (H3K4me3) in 104 mouse embryonic stem cells (ESC) (Adli, Zhu, and Bern-
stein, 2010). In this protocol, already immunoprecipitated DNA is first primed with
Sequenase enzyme using a custom primer containing a universal PCR sequence, a
BciVI restriction site, and a random 9-mer sequence. The primed DNA is then PCR
amplified using another custom primer containing the same universal PCR sequence
and BciVI restriction site. The resulting amplicons are lastly digested using the cor-
responding BciVI restriction enzyme to produce DNA products which can be directly
ligated to adapters for high-throughput sequencing. While these changes to the stan-
dard library preparation successfully reduced the number of cells required for ChIP-
seq, the protocol was only tested on histone modifications which are more abundant
and therefore generate a larger amount of starting material than transcription factors.
Three years later came the development of the carrier-assisted chromatin immunopre-
cipitation protocol (C-ChIP-seq) (Zwart et al., 2013). In this protocol, small numbers of
targets cells are first mixed with Drosophila cells before a conventional formaldehyde
ChIP-seq is performed. The foreign chromatin acts as a so-called carrier for the small
amount of target chromatin throughout the isolation procedure and consequently im-
proves enrichment from limited cell numbers. Although the exact mechanism remains
undetermined, it is thought that the carrier chromatin bulks up the solution which
helps to retain the target chromatin during chemical handling. Using this protocol,
the authors were able to identify binding of the transcription factor Estrogen receptor
alpha using 104 cells from biopsies of human breast tumours.
In 2014, a novel indexing-first chromatin IP protocol (iChIP-seq) was published which
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was used to identify histone modifications (H3K4me1 and H3K4me2) from a mini-
mum of 500 hematopoietic precursor cells (Lara-Astiaso et al., 2014). In this protocol,
the population of cells are first fixed and then sorted into sub-populations which are
sonicated. The chromatin is then immobilised on magnetic beads using an anti-H3 an-
tibody and indexed by ligating sequence-specific adapters. The barcoded chromatin is
then released from the beads and pooled before conventional formaldehyde ChIP-seq
is performed. While this protocol significantly reduced the number of cells required
for ChIP-seq of histone modifications, the minimum required for transcription factors
was still 104 cells.
Later in the year, a ChIP-seq protocol which used native chromatin and did not re-
quire fixation was also published (N-ChIP-seq) (Kasinathan et al., 2014). Instead of
formaldehyde cross-linking, the protocol relies on the intermolecular bonds between
nucleic acids and amino acids to sustain during the delicate chemical handling. The
protocol begins with isolating unfixed nuclei and shearing the chromatin using light
MNase digestion. The chromatin is then solubilised by careful needle extraction and
protein-DNA complexes are immunoprecipitated using antibody-conjugated magnetic
beads. Using this protocol, the authors successfully identified binding of multiple
transcription factors in Drosophila and Saccharomyces using 107 cells. Only a year later
however, an upgraded N-ChIP-seq protocol for ultra-low-input (ULI-NChIP) was pub-
lished and was used to identify histone modifications from a minimum of 103 embry-
onic stem cells (Brind’Amour et al., 2015). The authors had optimised multiple steps
from the original protocol associated with cell sorting, chromatin fragmentation, and
library preparation. Despite these improvements over formaldehyde fixation, there
is still a concern that highly dynamic DNA-binding proteins may redistribute during
library preparation (Skene and Henikoff, 2017).
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In 2015, a protocol for ChIP combined with Tn5 transposase tagmentation (ChIPmen-
tation) was used to identify histone modifications (H3K4me3 and H3K27me3) and
CTCF binding from 104 cells and 105 leukaemia cells, respectively (Schmidl et al.,
2015). In this protocol, the usual multi-stage library preparation (end-repair, purifi-
cation, A-tailing, adapter-ligation, and size selection) was replaced with a single stage
using Tn5 tagmentation of the DNA fragments. The Tn5 transposase is loaded in vitro
with sequencing adapters and in a single step can fragment and tag DNA with the
sequencing adapters. This makes the library preparation protocol faster, simpler, and
more efficient which reduces the number of cells required to generate a sufficient DNA
yield for high-throughput sequencing. While this in itself did not set new records for
the minimum number of cells required, this simple change could be combined with
other protocols to rely on less starting material.
The utility of Tn5 transposase tagmentation was later expanded by the development
of Transposase-Assisted Chromatin Immunoprecipitation (TAM-ChIP) by the Active
Motif company (Samuelsson et al., 2015). This technology allowed them to identify
histone modifications (H3K4me3 and H3K27me3) in primary human tissues, such as
formalin-fixed paraffin-embedded (FFPE) colon tumour cells. The protocol involves
fixing cells with formaldehyde, then sonication to produce short DNA fragments, fol-
lowed by incubation with an antibody directed against the DNA-binding protein. A
species-specific antibody chemically linked to Tn5 transposase containing barcoded Il-
lumina sequencing adapters is then added to bind the ChIP antibody. Upon activation
of the Tn5 transposase, nearby DNA surrounding the genomic region is tagmented
with sequencing adapters and then the antibody-bound DNA-protein complex is im-
munoprecipitated. The DNA is finally reverse cross-linked and purified for library
amplification then sequencing. Not only does this protocol reduce the number of cells
required, it also removes many of the downstream steps such as chromatin shearing.
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More importantly though, the barcoded sequencing adapters allow multiple targets to
be assayed within the sample biological sample, giving rise to a more detailed investi-
gation of multiple epigenetic modifications regardless of biological replicate variabil-
ity.
Later that year, Brind’Amour and colleagues published a protocol for microfluidics
ChIP-seq (Drop-CHIP) which they used to profile histone modifications (H3K4me2
and H3K4me3) in single mouse embryonic stem cells (ESC) and embryonic fibroblast
cells (MEF) (Rotem et al., 2015). The protocol combined many of the optimisations
from previous publications with a droplet-based microfluidics (DBM) system capa-
ble of processing single cell reactions. To avoid pull down of non-specific antibody
binding, chromatin from individual cells was indexed (similar to iChIP-seq) before
immunoprecipitation. Specifically, the DBM system was used to combine two sepa-
rate aqueous drops with an enzymatic solution: one drop containing the single cell
alongside a weak detergent and MNase enzyme, the other drop containing the unique
barcode sequencing adapters, and one small aliquot of enzymatic buffer with DNA
ligase. Indexed chromatin fragments from 100 cells were then pooled (similar to ULI-
NChIP-seq) and combined with carrier chromatin (similar to C-ChIP-seq) before per-
forming ChIP and using the enriched DNA for high-throughput sequencing. While
this was a ground-breaking advancement, the protocol is extremely complicated and
requires highly specialised equipment, likewise it has never been used to investigate
transcription factor binding because of the smaller amount of input DNA generated.
An important landmark in the search for low input ChIP-seq alternatives, was the
recent development of the CUT&RUN protocol (Skene and Henikoff, 2017). Unfixed
nuclei are immobilised on magnetic beads and treated successively with a target anti-
body and protein A-MNase enzyme. The antibody binds to the target protein followed
by MNase binding to the antibody. Calcium is then added to activate the MNase and
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cleave protein-DNA complexes which are released and diffuse out of the nucleus. The
mixture is then centrifuged to recover the supernatant – containing the protein-DNA
complexes – and the DNA is used to prepare libraries for high-throughput sequencing.
Importantly, this approach does not rely on cross-linking or immunoprecipitation, so
artefactual biases associated with formaldehyde fixation and the number of cells re-
quired to achieve a sufficient DNA yield are significantly reduced. The recommended
sequencing depth is also lower because the MNase only cleaves DNA around bind-
ing sites so the amount of non-specific DNA in the reaction is minimised. Excitingly,
the original CUT&RUN protocol was then later upgraded to facilitate ultra-low input
(abbreviated uliCUT&RUN) and achieve single-cell resolution (Hainer et al., 2018a).
The uliCUT&RUN protocol was used to profile CTCF, Nanog, and Sox2 binding from
individual mouse embryonic stem cells and blastocyst embryos.
In conclusion, the advancements made over the last decade have culminated in the
ability to profile histone modifications and transcription factors from single cells (us-
ing Drop-ChIP and uliCUT&RUN). This presents an unprecedented opportunity to
investigate protein-DNA interactions at a much higher resolution than previously ex-
amined, especially from in vivo tissues where the number of cells is limited. However,
all of these low cell number methods still rely on the existence of a specific and sensi-
tive antibody (often expensive and difficult to produce) which binds with high affinity
to the target protein (Aughey and Southall, 2016). Without an appropriate antibody
the advances in low-input protocols cannot be exploited and instead alternative meth-
ods which do not rely on antibodies are required. Additionally, both Drop-ChIP and
CUT&RUN require cell isolation for cell-specific profiling, compromising their ability
to measure in vivo binding (Skene and Henikoff, 2017).
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1.3.4 DNA adenine methyltransferase identification sequencing (DamID-
seq)
An alternative and increasingly popular method to identify genome-wide DNA bind-
ing sites is DNA adenine methyltransferase identification (DamID) (Van Steensel and
Henikoff, 2000). The protocol involves expressing a fusion protein containing the pro-
tein of interest (POI) which is tethered to Escherichia coli Dam methyltransferase. When
the POI binds to its target sites, Dam adds a methyl group to the N6 position of ade-
nine in nearby GATC sequences. The chromatin is then extracted and fragmented
using a DpnI restriction enzyme which cuts at methylated GATC sequences. Sequenc-
ing adapters are ligated to the restriction fragments and a DpnII restriction enzyme
is used to cut non-methylated GATC sequences. The adapter-ligated DNA is then
enriched using PCR amplification and sequenced using high-throughput sequencing
(Sun et al., 2003; Wu and Yao, 2013). Importantly, because Dam itself is a DNA-binding
protein a control sample containing just Dam is also sequenced and used to measure
the amount of non-specific background methylation. In order to identify DNA bind-
ing sites from DamID-seq data, the sequencing reads are mapped back to the reference
genome using alignment software and restriction fragments which are differentially
methylated between the Dam-fusion and Dam only samples are identified. Restric-
tion fragments which have been methylated significantly higher in the Dam-fusion
over the Dam only samples are regarded as containing a DNA binding site for the
protein of interest. The advantage of DamID is that it does not require cross-linking or
antibodies so no artefactual biases from formaldehyde treatment are expected, and no
immunoprecipitation step is required so fewer cells (< 104 cells) can be used as start-
ing material. However, an important consideration in the application of DamID is the
expression level of the Dam-fusion protein. High expression can lead to the entire
genome becoming methylated making it difficult to identify targeted binding. High
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concentrations of the Dam protein can also lead to toxicity of the cells and accumula-
tion of artefactual biases (Pindyurin et al., 2016). Consequently, the expression of the
Dam-fusion protein is kept low by exploiting the leakiness of uninduced promoters,
such as the hsp70 heat-shock promoter in Drosophila cells and the ecdysone promoter
in mammalian cells. An expression construct encoded for the Dam-fusion or Dam
only protein is placed directly upstream of a leaky promoter limiting expression to
levels almost undetectable by western blotting.
Whilst DamID offers a solution to the traditional problems associated with formalde-
hyde cross-linking and antibody availability, it does not come without certain compli-
cations: Given that Dam must be expressed at a sufficiently low level to avoid toxic-
ity, which is usually achieved by inserting an expression vector downstream of leaky
promoters, the model system must be tractable to genomic modification in order to
generate the transgenic cells required (Aughey, Cheetham, and Southall, 2019). With-
out these tools, it is difficult but not impossible to achieve the requisite expression
level via non-integrating lentiviral vectors, however cell-type specific profiling then
becomes limited. Next, in order to achieve a sufficient signal Dam must be expressed
for a number of hours ensuring all possible GATC sites have been profiled. The re-
sult of this long exposure time is that any binding observed could have occurred at
any point, which is the opposite of ChIP-seq data whereby a snapshot of binding is
detected at the point in which formaldehyde fixation is administered (Aughey and
Southall, 2016). Additionally, because DamID is reliant on the presence of GATC sites
to indicate binding the resolution achievable is reliant on the frequency of sites along
the genome. Certain regions with a defined sequence bias, such as repeats and pro-
moters, may therefore be under-represented for GATC sequences such that DamID
may not be able to identify binding. Finally, it must not be forgotten that physically
linking Dam to another DNA-binding protein may have an undetermined effect on
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the structure and function of the target protein. It is therefore crucial that control ex-
periments be carried out to ensure the fusion is viable: An electrophoretic mobility
shift assay (EMSA) can first be used to confirm the in vitro binding ability of the al-
tered target protein. If successful, downstream in vivo experiments can be performed
to ensure biological function is also retained. For example, an inactive version of Dam
can be linked to the target protein and expressed at usual levels in a knock-out system
to show that no deleterious effects or altered phenotypes are observed (Tosti et al.,
2018).
Although the original DamID protocol was developed nearly two decades ago for
specific use in Drosophila, it has since been adapted for a number of other organisms
including mouse (Tosti et al., 2018), human (Vogel et al., 2006), yeast (Steglich, Sazer,
and Ekwall, 2013), plants (Germann et al., 2006), and C. elegans (Schuster et al., 2010).
One interesting adaptation of DamID is the ability to detect interacting DNA-binding
proteins using a method called split DamID (SpDamID) (Hass et al., 2015). The Dam
protein is split in half and tethered to separate DNA-binding proteins which are spec-
ulated to form a protein-protein interaction. If the two proteins interact, the two in-
active halves of Dam are reconstituted to form an active protein and the location of
the dimeric protein-DNA interaction along the genome is marked. This method can
also be used to differentiate between monomeric and dimeric binding since two of the
same halves of Dam cannot reconstitute its methylation activity. Additionally, a tar-
geted DamID approach (TaDa) has been developed in Drosophila which can be used to
profile binding in a cell-specific manner (Southall et al., 2013). Using the GAL4/UAS
targeted gene expression system, different Drosophila strains were generated which
expressed the Dam-fusion protein only in specific cell-types. This allowed for the in
vivo profiling of RNA polymerase II binding in different neuronal cell types using
fewer than 104 cells without needing to isolate the cells. Furthermore, the Bas van
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Steensel group recently published a single-cell DamID-seq protocol, where the au-
thors reported the mapping of nuclear lamin B1 interactions (LmnB1) in single human
myeloid leukaemia cells (Kind et al., 2015). After 15 hours of Dam-LmnB1 expres-
sion, cells were FACS-sorted and captured in 96 well plates containing lysis buffer.
The chromatin was then digested with DpnI followed by adapter ligation and PCR
amplification as is standard. Importantly, all of the library preparation steps were per-
formed in the same well via sequential addition of reagents so there was no potential
for loss of starting material.
Despite these advances, DamID has only recently been combined with high-throughput
sequencing. The original DamID protocol by the Bas van Steensel lab and many subse-
quent studies used microarrays to identify DNA-binding. The resolution of microar-
rays however is considerably less than high-throughput sequencing and involves its
own set of biases which must be investigated (Hurd and Nelson, 2009). In addition,
very few published studies have up until now demonstrated transcription factor bind-
ing in mammalian cells using DamID-seq (Jesus Domingues et al., 2016). Recently,
our lab was the first to develop a protocol to perform mammalian DamID-seq with
transcription factors using a minimum of 103 cells. While this is an encouraging step
forward, there are a number of issues which need to be investigated before DamID-seq
can become more widely adopted. There has currently been no investigation into po-
tential systematic biases in the sequencing data produced by DamID-seq experiments.
This is concerning because many newly minted technologies exhibit artefacts which
are misinterpreted as genuine biology leading to inappropriate conclusions about the
results. Due to the lack of sequencing data, the accuracy and sensitivity of DamID-
seq has also not been assessed. This is primarily because the overwhelming number
of DamID studies were not measured by high-throughput sequencing, but rather mi-
croarray technology. The combination of DamID with sequencing is a relatively new
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adaptation (Lie-A-Ling et al., 2014) most of the subsequent studies were performed
in Drosophila rather than in a mammalian system, which is more applicable to our
research. A handful of studies have attempted to compare the results from DamID
and ChIP, such as GAF (Nègre et al., 2006) and HP1 (Yin et al., 2011) Drosophila cells,
however these comparisons were based on DamID-chip and ChIP-chip datasets, both
of which suffer from a lower resolution than sequencing. Nevertheless, the extent to
which both studies attempted to compare results was limited to simply calculating
correlation coefficients between microarray intensities (r=0.37 and r=0.77 for GAF and
HP1, respectively). Only one other study went further than this, showing that the cog-
nate motif was sufficiently enriched in the regions identified by the DamID method
(Bemmel et al., 2010). Additionally, most DamID datasets were produced because of
the inability to perform ChIP in their biological system and consequently have relied
on the comparisons made by previous studies to ensure confidence in their experi-
ments. Finally, at the time the work in this thesis was carried out there was actually
very little DamID-seq data available for transcription factors in mammalian cells, and
only one with accompanying ChIP-seq data (Jacinto, Benner, and Hetzer, 2015). In-
stead larger DNA-binding proteins such as RNA polymerase II and Lamin B1 have
been measured in more recent protocols such as TaDa (Southall et al., 2013) and single
cell DamID-seq (Kind et al., 2015). Through comparative analyses with ChIP-seq data,
it is important to examine whether DamID-seq can detect the same DNA binding sites
and measure how this reproducibility decreases with cell number. Additionally, ap-
propriate computational methods to analyse the sequencing data in a streamlined and
accurate manner are required.
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1.4 Aims
The aim of this work is to measure the accuracy and sensitivity of mammalian DamID-
seq experiments by investigating different experimental protocols, comparing to pre-
viously established assays, and developing rigorous analysis methods. I will first ex-
amine DamID-seq data for potential sources of bias caused by unwanted biological
and technical variation. To achieve this, I will determine whether the ability to mea-
sure methylation changes according to different sample preparation steps and deter-
ministic features such as GC content. I will then evaluate whether DamID-seq data
can be used to accurately measure chromatin binding from minimal numbers of cells.
To realise this, I will compare qDamID and DamID-seq methylation to identify an
appropriate normalisation and modelling strategy. Following which I will develop a
novel analysis method for calling binding sites from DamID-seq data and perform a
large-scale comparison using published ChIP-seq data. I will last determine whether
DamID-seq data can be used to accurately measure chromatin accessibility from min-
imal numbers of cells. To accomplish this, I will develop a novel analysis method
for calling accessibility sites from DamID-seq data and perform a large-scale compar-
ison with previously established assays using published ATAC-seq, DNase-seq, and
FAIRE-seq data. Overall, the results from these analyses will be used to guide the
development of a Bioconductor package for the analysis, interpretation, and visuali-





2.1 Availability of code and data
The computer code and supporting data for this thesis can be downloaded from a





The code developed to analyse DamID-seq data can also be downloaded from a pub-
lic GitHub repository (https://github.com/jma1991/Daim) and the sequencing data
from published experiments can be downloaded from the relevant public databases
(see attribution statement for each chapter and availability of sequencing data sec-
tions in this chapter). For clarity and reproducibility, command arguments have also
been documented in the relevant sections. The character $ at the beginning of each
line represents the command prompt and should not be typed.
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2.2 Analysis of DamID-seq experiments
2.2.1 Statement of attribution
The DamID-seq libraries were generated by Dr Luca Tosti - a previous PhD student in
Prof. Keisuke Kaji’s research group - and analysed by the author, James Ashmore.
2.2.2 Availability of sequencing data
The raw and processed sequencing data is available to download from the private FTP
server provided (see Section 2.1).
2.2.3 Processing of sequencing data
Quality control
The DamID-seq libraries were sequenced by either Edinburgh Genomics or the Bei-
jing Genomics Institute on an Illumina HiSeq 4000 machine. Approximately 20 mil-
lion 1x50 bp reads were generated from each library. Importantly, samples within
comparisons were sequenced together so no batch effects were generated. Read qual-
ity was evaluated from reports generated by FastQC (version 0.11.7) (Andrews, 2010)
and MultiQC (version 1.5) (Ewels et al., 2016). Reads were trimmed using Cutadapt
(version 1.16) (Martin, 2011) to remove low quality bases and adapter contaminant
sequences:




2. Illumina Nextera Adapters






Reads were aligned to the mm10 assembly of the mouse genome (Karolchik et al.,
2004) using BWA-MEM (Li, 2013). Duplicate reads were identified using the MarkDu-
plicates command from Picard Tools (Broad Institute, 2018) then sorted and indexed
using Samtools (Li et al., 2009). Reads were filtered using Bedtools (Quinlan, 2002)
and Samtools (Li et al., 2009) with multiple criteria: First, alignments to alternate, mi-
tochondrial, unplaced, and random chromosomes were removed. Next, non-unique,
secondary, duplicate, and supplementary alignments were removed. Last, alignments
to ENCODE (ENCODE Project Consortium, 2012) and Mitochondrial (Buenrostro et
al., 2013) blacklist regions were removed.
Genome coverage
To visualise coverage along the genome, read depth at each genome position was
generated in bedGraph format using the genomecov command from Bedtools (version
2.27.1) (Quinlan, 2002). The read depth values were then normalised for library size








where D is defined as the read depth at each genome position, S as the per million scal-
ing factor, and T as the total number of mapped reads. For faster display performance
and to save storage space, the plain-text bedGraph files were converted into indexed
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binary bigWig files (Kent et al., 2010) using the bedGraphToBigWig command from Kent
Utilities (version 4.0) (Kuhn, Haussler, and Kent, 2013). Genome browser images were
captured using the Integrative Genomics Viewer (version 2.4.9) (Robinson et al., 2011)
and pyGenomeTracks (version 2.0) (Ramírez et al., 2016).
2.2.4 Identification of DNA-binding sites
Experimental design
In Dam-fusion protein expressing cells, binding sites are marked by the addition of
a methyl group to the N6 position of adenine on nearby GATC sequences. The ge-
nomic DNA is then extracted, fragmented using methylated GATC specific restriction
enzyme DpnI, subjected to adapter ligation and PCR amplification, sequenced, and
aligned to a reference genome. When expressing a Dam-fusion protein, non-specific
background methylation caused by non-specific binding of Dam at open chromatin
loci is typically observed. To distinguish binding sites from background, the methyla-
tion profiles between Dam-fusion and control cells expressing just Dam are compared.
Binding sites are therefore identified by locating regions of the genome which have
been methylated more frequently in Dam-fusion than Dam protein expressing cells.
Fragment quantification
To measure methylation along the genome, the number of reads aligned to each hypo-
thetical restriction fragment were counted. An annotation file of restriction fragment
locations was generated by running a simulated digest on a map of DpnI and DpnII re-
striction sites in the reference genome. The restriction map was constructed by finding
all the occurrences of the pattern GATC in the genome sequence using the matchPattern
command from the Biostrings package (version 2.46.0) (Pagès et al., 2017). The number
of reads aligned to each restriction fragment was then counted using the featureCounts
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command from the Rsubread package (version 1.28.1) (Liao, Smyth, and Shi, 2013).
To obtain reliable counts, reads which were marked as duplicate, multi-mapping, or
aligned to more than one restriction fragment were discarded.
Sample normalisation
Normalisation is a standard and essential step in the preprocessing of sequence count
data. It is required to remove unwanted technical variation and transform the raw
counts into usable methylation measurements. If not corrected, technical variation can
often be mistaken for biological variation and lead to false discoveries (Hicks et al.,
2018). A considerable number of normalisation methods have been developed for se-
quence count data, but many of these assume that the samples have the same global
distribution (Aleksic, Carl, and Frye, 2014). To determine whether these methods were
appropriate for DamID-seq count data, a test for the assumptions of quantile normali-
sation was carried out using the quantro package (version 1.14.0) (Hicks and Irizarry,
2015). The test results indicated that the distribution of the Dam-fusion libraries were
significantly different to the Dam libraries, so instead the count data was normalised
with an appropriate weighted quantile method called smooth quantile normalisation
using the qsmooth package (version 0.0.1) (Hicks et al., 2018). In addition, sequence
count data typically exhibits a linear relationship with the length of the genomic fea-
ture being counted. In order to compare between features of different lengths, the
counts are typically divided by the feature length (Mortazavi et al., 2008). To deter-
mine whether DamID-seq count data follows this trend, the relationship between re-
striction fragment length and count abundance was modelled using the CQN package
(version 1.24.0) (Hansen, Irizarry, and Wu, 2012). The modelling showed a non-linear
relationship with restriction fragment length, which was corrected by applying CQN
computed offsets to the smooth quantile normalised count data.
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Differential methylation
To identify differentially methylated restriction fragments, the length-corrected smooth
quantile normalised count data was analysed using the limma package (version 3.34.9)
(Ritchie et al., 2015). Multidimensional scaling (abbreviated MDS) plots indicated that
the Dam-fusion samples exhibited significantly more within group variation than the
Dam samples. To account for this disparity, linear modelling was performed using
the arrayWeights (Ritchie et al., 2006) function to compute Dam-fusion and Dam group
weights.
Fragment clustering
Methylation by Dam has been shown to extend from any given DNA-binding site to a
distance of up to 5 kb (Van Steensel and Henikoff, 2000). Differentially methylated re-
striction fragments were therefore merged into clusters using the mergeWindows com-
mand from the csaw package (Lun and Smyth, 2016). For clustering, the maximum
distance between adjacent fragments was defined as 261 bp (the average size of frag-
ments in the mouse genome) and the maximum size of merged clusters was defined
as 5 kb (the maximum spread of Dam methylation). Clusters with a FDR < 0.1 and
log2FC > 0 were defined as statistically significant DNA-binding sites.
2.2.5 Identification of DNA-accessibility sites
Experimental design
To distinguish accessibility sites from non-specific methylation, the methylation pro-
file between Dam and the average methylation rate is compared. Accessibility sites
are therefore identified by locating regions of the genome which have been methy-
lated significantly more in Dam protein expressing cells than the average methylation
rate.
2.2. Analysis of DamID-seq experiments 29
Background modelling
In order to identify non-random enrichment of restriction fragments, methylation
measurements were compared to a neighbourhood background methylation rate. For
each fragment, the rate was defined as:
Rate = max(λ25k, λ50k, λ100kb) (2.2)
where λ25k, λ50k and λ100k are estimated from 25 kb, 50 kb, and 100 kb neighbour-
ing windows. Accessibility sites were then identified from differentially methylated
fragments using the procedure described previously (see Subsection 2.2.4).
2.2.6 Implementation of R package
The analysis, interpretation, and visualisation of DamID-seq experiments was per-
formed using the Daim package (https://github.com/jma1991/Daim). It includes
functions to process sequencing data, quantify fragment abundance, and detect DNA
binding-and-accessibility sites. Additionally, the package provides functions to per-
form downstream functional and sequence analyses. Daim is implemented in R and
takes advantage of the Bioconductor ecosystem (http://bioconductor.org). It is
freely available under a Massachusetts Institute of Technology (abbreviated MIT) li-
cense.
2.2.7 Comparison of DamID-seq analysis pipelines
There are currently four different published analysis pipelines for DamID-seq data, all
of which implement novel approaches but none of which have been benchmarked:
The first pipeline was released in 2015 by Li and colleagues and is described as a
non-parametric algorithm for peak calling (Li, Hempel, and Jiang, 2015). It begins by
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randomly sampling 90% of alignments from Dam and then counting how many Dam-
fusion and resampled Dam reads align within non-overlapping 100 bp windows along
the genome. To adjust for sequencing depth, read counts are normalised to reads per
million (RPM) and the signal in each window is represented as the log2 fold change
of the RPM values (Dam-fusion/Dam). The windows are then filtered by removing
those with a negative log2 fold change (Dam > Dam-fusion) which by definition do
not contain binding. The median log2 fold change of the remaining windows is then
calculated to estimate the average level of methylation across the genome. To define
significant windows, the previous steps are repeated (N = 200) and then the distribu-
tion of the median log2 fold changes (MFC) is calculated. Any windows which have a
log2 fold change greater than the 95% percentile of the MFC distribution are declared
significant. Adjacent windows are then merged together to define peak regions. As
a piece of software, the pipeline by Li and colleagues suffers from a number of prob-
lems: The pipeline is provided "as is" meaning all of the file paths are actually hard
coded to the authors computer and environment. You have to manually go through
the code and replace any instances of a hard path with the relevant path on your com-
puter. This is obviously fraught with issues, not only because it limits reproducibility
but also because it is sometimes not immediately obvious what type of file the hard-
coded paths refer to on the author’s computer. There are also many "magic numbers"
in the code (i.e. a hard-coded value which has no obvious description or justification)
which limits the overall readability and understanding of the software. For exam-
ple, chromosome sizes are hard-coded to the Drosophila genome and because there
is no automated way to update these values (besides a manual search and replace) it
becomes very difficult to adapt the algorithm to any other reference genome. Addi-
tionally, the peak regions identified by the algorithm do not contain any peak-level
statistics such as enrichment or significance values so no downstream filtering (e.g.
remove weakly bound regions) can be performed. Finally, no manual is provided to
2.2. Analysis of DamID-seq experiments 31
explain how to run the pipeline and there is no list of required packages, so it is par-
ticularly difficult to debug when an error has occurred. Given these multiple serious
issues, this pipeline should be disregarded in any future work looking to evaluate
DamID-seq analysis software.
The second pipeline was released later on in 2015 by Marshall and colleagues and is
described as an automated pipeline for processing DamID-seq datasets (Marshall and
Brand, 2015). It begins by counting how many Dam reads align within GATC restric-
tion fragments along the genome. The fragments are then filtered by removing any
with zero read counts and the remaining fragments are divided into deciles by total
read count. Those within the first three deciles and the highest 10% are also removed
because they produce inconsistent normalisation factors and contain genuine binding,
respectively. The distribution of the log2 fold change values (Dam-fusion/Dam) for
all remaining fragments is then calculated and the Dam-fusion counts are normalised
such that the point of maximum kernel density of the log2 fold change values equals
zero. Coverage tracks are finally generated containing either the normalised Dam-
fusion and Dam read counts or the log2 fold change values. The pipeline does not ac-
tually include a peak calling stage, instead an additional piece of software based upon
a separate publication can be downloaded and applied to the coverage tracks to iden-
tify binding sites (Wolfram et al., 2012). It is difficult to describe the exact methodology
of the peak caller because it was adapted from an algorithm used for DamID microar-
ray experiments, as such it has not been published or adequately described (see al-
gorithm section of the following website: https://github.com/owenjm/find_peaks).
According to the algorithm described by Wolfram and colleagues, the peak caller first
appears to merge consecutive restriction fragments and defines those greater than 900
bp in length which have a greater than 2-fold change as potential peak regions. A false
discovery rate (FDR) is then assigned to these regions using a Monte Carlo resampling
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method whereby the frequency of fold changes for a range of peak widths located in
the chromosome arms is calculated. This data is then used to model the exponential
decay of the FDR with respect to increasing fold change and peak width, therefore
enabling extrapolation of FDR values for higher and broader peaks. While the lack
of details regarding the peak calling software is concerning, the pipeline itself is well
documented and can be readily installed. The assumptions of the normalisation proce-
dure however are subject to critique (as discussed extensively at the end of Subsection
4.4.2). Briefly, the assumption that the majority of fragments should exhibit a log2 fold
change of zero and that the Dam-fusion read counts should be normalised to achieve
this assumption goes against the theory behind DamID which shows that most non-
target sites should be primarily methylated by Dam and therefore should have a log2
fold change less than zero. In order to establish whether the assumptions of this nor-
malisation procedure are practically appropriate, would require a large-scale analysis
of multiple DamID-seq datasets measuring a range of DNA-binding proteins which
exhibit different binding dynamics. In fact, the pipeline itself even has a separate set-
ting whereby if their assumption does not hold for the data it will instead perform a
standard read depth normalisation. Given this work has established that retaining the
significant differences in the methylation distributions between the Dam-fusion and
Dam proteins is important for peak calling accuracy, this pipeline no longer becomes
particularly novel.
The third pipeline was released in 2016 by Gutierrez-Triana and colleagues and is
based upon an improved protocol called iDamID-seq which inverts the DpnI and
DpnII digestion order and adds steps that involve a phosphatase and exonuclease
(Gutierrez-Triana et al., 2016). The pipeline begins by generating all possible GATC
restriction fragments in the specified genome, then removes any which are outside
the range of 200 to 2000 bp in length. Next, the number of Dam-fusion and Dam reads
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aligned within this subset of fragments is calculated and only fragments with a min-
imum number of reads relative to the fragment length are retained. This threshold
was computed as three times the total number of reads in all fragments divided by
their total length. Fragments that were not further apart than the smallest fragment
length were then joined together, and the number of reads aligned within these join
regions were calculated to produce a count matrix. Significant differences between the
Dam-fusion and Dam replicates are then computed using the DESeq2 package which
was originally developed for RNA-seq analysis (Love, Huber, and Anders, 2014). Un-
like the other pipelines, this one requires the reference genome to be available as
a BSgenome package, so it is not readily applicable to users with a non-reference
genome in FASTA format. Additionally, because fragments with high Dam-fusion
and Dam read counts are merged prior to differential methylation analysis the algo-
rithm cannot differentiate between sharp binding events (e.g. transcription factors)
whereby individual fragments in the merged region are differentially methylated in
both directions. Finally, because DESeq2 by default uses a two-tailed hypothesis test
to detect differential gene expression in both directions, it is more difficult to achieve
significance in one direction (i.e. testing only whether Dam-fusion > Dam). Specif-
ically, the two-tailed test splits the user-specified significance level and applies it to
both directions, thus each direction is only half as strong as a one-tailed test which
applies the significance in just one direction.
The fourth pipeline was released later on in 2016 by Maksimov and colleagues and
is specific to a particular DamID-seq protocol which only sequences DNA flanking
GATC sequences (Maksimov, Laktionov, and Belyakin, 2016). The pipeline first aligns
reads to the specified genome and then counts how many reads align immediately
upstream or downstream of a GATC sequence. Next, fragments showing greater than
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2-fold standard deviation (referred to as the dynSD between replicates) from the Dam-
fusion group average are removed. To identify significantly methylated fragments the
level of biological and technical variability in the data is assessed using a one-sided
Fisher’s exact test between Dam-fusion and Dam replicates (biological variability) and
within Dam-fusion replicates (technical variability). This information is then used to
assign a false discovery rate to the P values returned by the Fisher’s exact test for each
GATC fragment. Surprisingly, this pipeline does not actually create peak regions from
the significant fragments, instead only the fragment-level statistics are returned. This
means that a single DNA-binding event will be represented by multiple fragments in
the output file, making downstream analyses cumbersome. Whilst the user can take it
upon themselves to merge the fragments afterwards, all of the fragment-level statistics
would also have to be summarised using an appropriate calculation. This is particu-
larly difficult for P values where simply averaging the P value from independent tests
can result in loss of type I error control (Lun and Smyth, 2014). More worryingly, be-
cause the pipeline only counts reads which are adjacent to GATC sequences (which
is protocol-specific) it is not applicable to other protocols which sequence the entirety
of the GATC fragment allowing the read counts to be normalised with respective to
fragment length and GC content.
2.2.8 Development of analysis workflow
Processing of the raw sequencing data was automated using a custom pipeline built
with the Conda package manager (version 4.5.1) (Anaconda, 2018) and Snakemake
workflow engine (version 4.7.0) (Köster and Rahmann, 2012). The analyses described
in this section can be reproduced by downloading and running the relevant DamID-
seq workflow.
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2.3 Analysis of quantitative DamID (qDamID) experiments
2.3.1 Attribution statement
The qDamID template genomic DNA was prepared by Prof. Keisuke Kaji and the
qDamID experiments were performed by the author, James Ashmore.
2.3.2 Restriction fragment screen
In order to investigate how well DamID-seq data represented the actual in vivo DNA
methylation levels, I aimed to compare the DamID-seq data with qDamID data, a
qPCR-based method to detect methylation in cells expressing Dam (Van Steensel and
Henikoff, 2000). For this purpose, I first identified 192 restriction fragments which
cover the entire methylation levels and fold changes between Dam and Dam-Oct4
protein expressing ES cells. The advantages of sampling are that the laboratory cost is
lower and data collection is faster than measuring the entire population, which would
also be impractical in this experiment. The average abundance and fold change for
each restriction fragment was calculated from DamID-seq data described in Section
2.2: First, alignments from replicates were merged to produce a single sorted BAM
file using the merge command from Samtools (Li et al., 2009). The number of reads
aligned to each restriction fragment was then counted using the featureCounts com-
mand from Rsubread (Liao, Smyth, and Shi, 2013). Reads aligned to more than one
restriction fragment, multi-mapping reads, and reads marked as PCR duplicates were
not counted. Next, to minimize differences between samples for restriction fragments
with small counts and normalise with respect to library size, a regularized log (ab-
breviated rlog) transformation was applied using the rlog command from the DESeq2
package (Love, Huber, and Anders, 2014). After this, methylation differences between
samples were visualised with a Bland-Altman plot (also called an MA plot) gener-
ated using the smoothScatter function from R (R Core Team, 2017). On the graph, each
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restriction fragment is represented by a point, the x-axis measures the average abun-
dance over the mean of normalised counts (A-values), and the y-axis measures the
log2 fold change between samples (M-values). Finally, a 25 x 25 reference grid consist-
ing of 625 equally spaced points was drawn over the MA plot and the 10 restriction
fragments closest to each point as measured by the Euclidean distance were selected.
2.3.3 Primer design pipeline
To design accurate and efficient primer pairs for the 192 restriction fragments in a
high-throughput manner, an automated computational pipeline was developed. For
a given restriction fragment, primer pairs were designed flanking each restriction
site using Primer3 (Untergasser et al., 2012). The search parameters were configured
(Thornton and Basu, 2011) to increase the probability of finding a large number of
efficient primer pairs (see Appendix B). For each primer pair, amplimers were iden-
tified by performing an in-silico polymerase chain reaction (abbreviated PCR) against
the mm10 assembly of the mouse genome (Karolchik et al., 2004) using isPCR (Kuhn,
Haussler, and Kent, 2013). The alignment parameters were configured to increase the
probability of finding all potential amplimers (maxSize=4000, minSize=15, and min-
Good=15), and only primer pairs with zero off-target amplimers were retained. For
each reference point, only the restriction fragment with the lowest primer pair penalty
was selected.
2.3.4 Quantitative DamID protocol
The PCR templates for quantitative DamID (abbreviated qDamID) were generated by
extracting genomic DNA from Dam and Dam-Oct4 protein expressing ES cells us-
ing the DNeasy Blood & Tissue Kit manufactured by QIAGEN. Of the DNA that was
2.3. Analysis of quantitative DamID (qDamID) experiments 37
extracted, 4 µg of genomic DNA (gDNA) was diluted in 32 µl of purified water (ab-
breviated H2O). The solution was then divided into two tubes: one containing DpnII
buffer (2 µl) and H2O (2 µl) for undigested samples; and the other containing DpnII
buffer (2 µl) and DpnII enzyme (2 µl) for digested samples. Both tubes were then in-
cubated overnight at 37◦C and the DNA was diluted to 10 ng/µl by adding 180 µl of
H2O.
The qDamID experiments were performed in triplicate using 4.5 µl of PCR Master
Mix, 0.9 µl of digested or undigested DNA (10 ng/µl), and 1.8 µl each of the forward
and reverse primers. The qPCR reactions were performed in 384 well plates, in a 9 µl
reaction, using the LightCycler 480 SYBR Green I Master Mix and LightCycler 480 sys-
tem. Inefficient primer pairs or off-target amplimers were identified by extremely high
cycle threshold values or a bimodal peak in the melting temperature curve analysis,
respectively, and excluded from the analysis. For the full list of primers see Appendix
A.
2.3.5 Differential methylation analysis
To calculate restriction fragment abundance, the Ct values were normalised using con-
trol restriction fragments (zero reads in the DamID-seq data) and the difference in nor-
malised Ct values (abbreviated ∆Ct) between DpnII digested and undigested libraries
was calculated using the deltaCt command from the NormqPCR package (Perkins et
al., 2012) with the formula:
∆Ct = 2(CtUndigested−CtDigested) (2.3)
To calculate restriction fragment fold change, the ∆Ct values were normalised using
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controls - restriction fragments with zero fold change - and the difference in ∆Ct val-
ues (abbreviated ∆∆Ct) between Dam and Dam-Oct4 samples was calculated using
the deltadeltaCt command from the NormqPCR package (Perkins et al., 2012) with the
formula:
∆∆Ct = 2(∆CtDam−∆CtDam-Oct4) (2.4)
2.4 Analysis of ChIP-seq experiments
2.4.1 Statement of attribution
The previously published ChIP-seq experiments were performed by the relevant re-
search groups and re-analysed by the author, James Ashmore.
2.4.2 Availability of sequencing data
Raw sequencing data from published studies was downloaded from either the Ar-
rayExpress, ENA, ENCODE or SRA database. This included Oct4 ESC ChIP-seq li-
braries from PRJNA185339 (Aksoy et al., 2013), PRJNA127937 (Ang et al., 2011), PR-
JNA242533 (Buecker et al., 2014), PRJNA106455 (Chen et al., 2008), PRJNA356297
(Chronis et al., 2017), PRJNA185048 (Das et al., 2014), PRJNA284634 (Flynn et al.,
2016), PRJNA242892 (Galonska et al., 2015), ENCSR392DGA (Yue et al., 2014), PR-
JNA151337 (Hu et al., 2013), PRJNA269747 (Jacinto, Benner, and Hetzer, 2015), PR-
JNA153273 (Jang et al., 2012), PRJEB1833 (Karwacki-Neisius et al., 2013), PRJNA347885
(King and Klose, 2017), PRJNA252515 (Krishnakumar et al., 2016), PRJNA299026 (Liu
and Kraus, 2017), PRJNA358612 (Liu et al., 2017), PRJNA106023 (Marson et al., 2008),
PRJEB13059 (Miller et al., 2016), PRJDB4490 (Okashita et al., 2016), PRJNA336049
(Shen et al., 2017), PRJNA312531 (Shin et al., 2016), PRJNA291779 (Tu et al., 2016),
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PRJNA213131 (Wang et al., 2014), PRJNA189323 (Whyte et al., 2013), PRJNA272971
(Xu et al., 2015), PRJEB6095 (Yang et al., 2014); Sox2 ESC ChIP-seq libraries from
PRJNA356297 (Chronis et al., 2017), PRJNA242892 (Galonska et al., 2015), and PR-
JNA106023 (Marson et al., 2008); and Sox2 NSC ChIP-seq libraries from PRJNA152295
(Lodato et al., 2013), PRJEB5253 (Mateo et al., 2015), and PRJNA286988 (Mistri et al.,
2015).
2.4.3 Collection of sequencing data
A comprehensive list of Oct4 ESC ChIP-seq samples was obtained by querying pub-
lic sequence databases. The ArrayExpress (abbreviated AE) (Kolesnikov et al., 2015),
European Nucleotide Archive (abbreviated ENA) (Silvester et al., 2015), and Encyclo-
pedia of DNA Elements (abbreviated ENCODE) (Sloan et al., 2016) databases were
queried using a Representational State Transfer (abbreviated REST) application pro-
gramming interface (abbreviated API). The Gene Expression Omnibus (abbreviated
GEO) (Edgar, Domrachev, and Lash, 2002) and Sequence Read Archive (abbreviated
SRA) (Leinonen et al., 2011) databases were queried using the GEOmetadb (version
1.42.0) (Zhu et al., 2008) and SRAdb (version 1.42.2) (Zhu et al., 2013) packages, re-
spectively. To avoid missing samples, multiple terms for a single phrase were used
to query the metadata. The Ontology Lookup Service (abbreviated OLS) (Jupp et al.,
2015) was used to search for terms related to the query phrases POU5F1 and EM-
BRYONIC STEM CELL: the Ontology of Genes and Genomes (abbreviated OGG) (Liu,
Zhao, and He, 2016) database was queried with the phrase POU5F1, and the list of re-
turned terms included OCT-3, OCT-4, OCT3, OCT4, OTF-3, OTF3, and OTF4; and the
Cell Ontology (abbreviated CL) (Diehl, 2017) database was queried with the phrase
EMBRYONIC STEM CELL, and the list of returned terms included EMBRYONIC CELL,
ES CELL, ESC, and STEM CELL. For each search result, the project submission page
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and cited research article was manually checked to verify the target proteins, cell pop-
ulations, and experimental procedures were relevant. After manual curation, a total
of 31 Oct4 ESC ChIP-Seq samples were used for analysis.
2.4.4 Processing of sequencing data
Quality control
The raw sequenced reads were downloaded from the SRA database using a parallel
version of the fastq-dump command from the SRA Toolkit (version 2.8.2) (Kodama
et al., 2012) called parallel-fastq-dump (version 0.6.2) (Valieris, 2018). The quality of
the reads was evaluated from reports generated by FastQC (Andrews, 2010) and sum-
marised using MultiQC (Ewels et al., 2016) for easier comprehension. The reads were
then trimmed using Cutadapt (Martin, 2011) to remove low quality bases and adapter
contaminant sequences:
1. Illumina TruSeq Adapters
Universal AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
Index GATCGGAAGAGCACACGTCTGAACTCCAGTCAC[N]ATCTCGTATGCCGTCTTCTGCTTG
After adapter and quality trimming, new FastQC reports were generated to judge the
quality of the trimmed reads before proceeding to read alignment.
Read alignment
The trimmed reads were aligned to the mm10 assembly of the mouse genome (Karolchik
et al., 2004) using BWA-MEM (Li, 2013) with default settings. Duplicate reads were
identified with the MarkDuplicates command from Picard Tools (Broad Institute, 2018)
and alignments were sorted and indexed using Samtools (Li et al., 2009). To produce
a set of high quality alignments, the BAM files were filtered using Bedtools (Quinlan,
2.4. Analysis of ChIP-seq experiments 41
2002) and Samtools (Li et al., 2009) based on multiple criteria: Alignments to alternate,
mitochondrial, unplaced, and random chromosomes were removed; Non-unique, sec-
ondary, duplicate, and supplementary alignments were removed; and alignments to
ENCODE (ENCODE Project Consortium, 2012) blacklist regions were removed.
Genome coverage
To visualise read coverage along the genome, the read depth at each base pair was
calculated and reported in bedGraph format using the callpeak command from MACS2
(Zhang et al., 2008). The read depth values in the ChIP and input bedGraph files were
then compared to produce a log2 of the ratio or the subtracted difference using the
bdgcmp command from MACS2. For faster display performance and to save storage
space, the plain text bedGraph files were converted into an indexed binary bigWig file
(Kent et al., 2010) using the bedGraphToBigWig command (version 4.0) from the Kent
Tools software collection (Kuhn, Haussler, and Kent, 2013). Genome browser images
of read coverage and peak locations were captured using the Integrative Genomics
Viewer (version 2.3.98) (Robinson et al., 2011) and pyGenomeTracks (version 3.0.0)
(Ramírez et al., 2016).
2.4.5 Calculation of quality metrics
The quality of each ChIP-seq library was measured using a combination of metrics de-
veloped by the CISTROME platform (Liu et al., 2011) and ENCODE consortia (Landt
et al., 2012):
Sequence quality
The read number, average read length, and average Phred quality score was calcu-
lated for each library using FastQC (Andrews, 2010). Libraries with an average Phred
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quality score >= 25 were considered to have a good sequence quality.
Mapping quality
The number of mapped, unmapped, unique, duplicate, useable, blacklist, filtered,
and peak alignments were counted using Samtools (Li et al., 2009). Blacklist Number
of reads mapped onto the ENCODE blacklist regions (ENCODE Project Consortium
2012) for the mm10 assembly
Libraries with an average Phred quality score >= 25 were considered to have a good
sequence quality.
Library complexity
Library complexity was measured using the Non-Redundant Fraction (NRF) and PCR
Bottlenecking Coefficients 1 and 2 (PBC1 and PBC2). ChIP libraries with a NRF > 0.9,
PBC1 > 0.9, and PBC2 > 10 were considered to have an acceptable library complexity.
ChIP enrichment
Normalised strand cross-correlation coefficient (NSC), relative strand cross-correlation
coefficient (RSC), and average fragment length were calculated using ccQualityCon-
trol (version 1.11) (Marinov et al., 2014).
2.4.6 Identification of DNA-binding sites
Peak calling
In order to identify DNA-binding sites, enriched ChIP regions relative to the input
background were located using MACS2 (Zhang et al., 2008). Statistically significant
peaks were defined based on a false discovery rate (abbreviated FDR) significance level:
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narrow peaks of punctuate enrichment (Oct4, Sox2, H3, and H3.3) were called us-
ing a 0.05 FDR threshold; broad peaks of diffuse enrichment (H3K27me3, H3K36me3,
H3K79me2, H3K9me3) were called using a 0.1 FDR threshold; and gapped peaks of
compact enrichment (H3K27ac, H3K4me1, H3K4me2, H3K4me3, and H3K9ac) were
called using a 0.1 FDR threshold. For more reliable region identification and better
summit resolution, the signal profile was smoothed by extending read length to the
average fragment size, which was estimated by cross-correlation analysis using SPP
(Kharchenko, Tolstorukov, and Park, 2008) (see Listings 2.1 and 2.2).
$ macs2 callpeak --treatment <TREATMENT> --control <CONTROL> --format BAM --gsize mm
--keep-dup all --outdir <OUTDIR> --name <NAME> --bdg --SPMR --nomodel --shift 0
--extsize <EXTSIZE> -q 0.05
LISTING 2.1. Command arguments for narrow peak calling using MACS2
$ macs2 callpeak --treatment <TREATMENT> --format BED --gsize mm --keep-dup all --outdir
<OUTDIR> --name <NAME> --bdg --SPMR --nomodel --shift 0 --extsize <EXTSIZE> --broad
--broad-cutoff 0.1
LISTING 2.2. Command arguments for broad and gapped peak calling using MACS2
Peak reproducibility
The majority of published ChIP-seq experiments analysed in this work were not repli-
cated, so reproducible peaks within studies could not be identified using post-hoc
measurements such as the irreproducible discovery rate (abbreviated IDR). In order to
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treat libraries from different experiments equally, libraries from replicated ChIP-seq
experiments were merged to create a single library and peaks were called on the
merged library. Reproducible peaks across studies were generated by first building
a master list of non-overlapping regions from all inputs using BEDOPS (Neph et al.,
2012). Peaks that initially overlap were ranked by score, and the highest scoring peak
was then added to the master list. The original peaks from each study were then re-
placed by the "master" peak and only those found in multiple studies were used for
downstream analysis. The source code used to create the master list was adapted from
the BEDOPS tutorial: https://bedops.readthedocs.io/en/latest/content/usage-examples/
master-list.html
Peak comparisons
The presence of peaks across conditions (binary analysis) was calculated using the
intersect command from Bedtools (Quinlan, 2002) and visualised using proportional
euler diagrams generated using the eulerr package (Larsson, 2018). Given these dia-
grams suppose a one-to-one relationship between set elements - which is usually false
because a peak in one study can overlap two peaks in a different study - unique peaks
were defined as those which do not overlap any peak in another set of peaks, and
common peaks were defined as those which overlap any number of peaks in another
set of peaks which afterwards are merged to produce a set of non-overlapping regions.
To visualise peak occupancy between multiple experiments, a binary heatmap de-
picting common and unique peaks was generated. To start with, a binary matrix of
intersecting peaks was created using the multiinter command from Bedtools (Quin-
lan, 2002). Then, the distances between the rows and columns of the binary matrix
were calculated using the parDist command with the "binary" distance method from
parallelDist (Eckert, 2017). Next, the rows and columns of the distance matrix were
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clustered using the hclust command with the "complete" agglomeration method from
fastcluster (Müllner and Others, 2013). Finally, the clustered binary matrix was plotted
using pheatmap (Kolde, 2018).
2.4.7 Functional analysis of DNA-binding sites
Peak annotation
To categorise the global distribution of DNA-binding sites, called peaks were asso-
ciated with functionally relevant genomic regions using the annotatePeaks command
from Homer (Heinz et al., 2010). Genes were characterised using the UCSC Genes
annotation table for the mm10 assembly of the mouse genome (Karolchik et al., 2004).
Peaks were assigned to the nearest gene TSS (either upstream or downstream) and
genomic feature (either TSS, TTS, CDS, Exons, 5’ UTR, 3’ UTR, CpG Islands, Repeats,
Introns, or Intergenic) occupied by its centre. It is important to note that because non-
unique alignments were filtered from all of the sequencing data, coverage at regions
such as interspersed repeats, low complexity, and tandem repeat regions will be ar-
tifically reduced. This is particularly important to remember when interpreting the
chromatin state model results from ChromHMM in Chapter 2, and as such this issue
has also been documented in the relevant sections to serve as a reminder for the reader.
Target prediction
To determine how gene regulation is affected by DNA-binding, ChIP-seq and RNA-
seq data were integrated using BETA (Wang et al., 2013). Target genes and activat-
ing/repressive functions were predicted using differential gene expression data from
a knock-out Oct4 ESC ChIP-seq experiment (King and Klose, 2017).
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Gene ontology analysis
In order to interpret the functional profile of a set of peaks, gene ontology (abbreviated
GO) analysis was performed with the GREAT algorithm (McLean et al., 2010) using
the rGREAT package (Gu, 2017). Genomic regions were associated to genes using the
basal plus extension rule, and a background set of peaks from an Oct4 ESC ChiP-seq
knockout experiment (King and Klose, 2017) was provided as control regions.
2.4.8 Sequence analysis of DNA-binding sites
De novo motif discovery
Motif discovery and enrichment was performed on 500 base pair regions centred on
ChIP-seq peak summits using MEME-ChIP (version 4.12.0) (Ma, Noble, and Bailey,
2014). To reduce the influence of repeat sequences on de novo motif finding, peak
regions were masked with Repeat Masker (Tarailo-Graovac and Chen, 2009), Window
Masker (Morgulis et al., 2006), and Tandem Repeats Finder (Benson, 1999) annota-
tions for the mm10 assembly of mouse genome (Karolchik et al., 2004). To improve
the likelihood of identifying true motif occurrences, a background model and position
specific priors were generated from a knock-out ChIP-seq library (King and Klose,
2017) and ATAC-seq library (Chronis et al., 2017), respectively. Discovery was per-
formed on both DNA strands and motifs with an E value less than a 0.05 significance
level were defined as statistically significant.
Known motif search
Peak regions were scanned for occurrences of a given motif with position weight ma-
trices (abbreviated PWM) from the JASPAR 2018 core non-redundant motif database
(Khan et al., 2018) using the FIMO command (Grant, Bailey, and Noble, 2011) from the
MEME suite (Ma, Noble, and Bailey, 2014). Searches were performed on both DNA
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strands and matches with a P value less than a 0.0001 significance level (default for
FIMO) were defined as statistically significant. The PWM accession numbers used to
scan for the Oct4 and Sox2 motifs are MA0142.1 and MA0143.3, respectively.
Sequence conservation
To examine the sequence conservation over peak regions, the phastCons scores (Sie-
pel et al., 2005) for the mm10 assembly of the mouse genome (Karolchik et al., 2004)
were mapped onto overlapping peaks using the computeMatrix and plotProfile com-
mands from Deeptools (Ramírez et al., 2016). Conservation profiles were drawn 250
bp upstream and downsteam of the reference point (defined as the peak centre) us-
ing 10 bp bins. For bins without overlapping conservation scores, missing data was
replaced by zero values. The phastCons score track was downloaded through the Ge-
nomicScores package (Castelo, 2018), exported as a bedGraph file with the rtracklayer
package (Lawrence, Gentleman, and Carey, 2009), and converted to a bigWig file us-
ing the bedGraphToBigWig command from the Kent Tools software collection (Kuhn,
Haussler, and Kent, 2013)
2.4.9 Identification of chromatin states
State modelling
Chromatin models for ESC and MEF cell types were built using ChromHMM (ver-
sion 1.14) (Ernst and Kellis, 2017) with default settings. First, alignments from ATAC-
seq, ChIP-seq, and DamID-seq experiments were binarized using the BinarizeBed com-
mand. To better represent their enrichment patterns: ATAC-seq alignments were
shifted by -36 bp and extended to a size of 73 bp; ChIP-seq alignments were extended
to the average fragment size; and DamID-seq alignments were extended to the nearest
restriction site. Second, a single shared model with cell type specific annotations was
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derived using the LearnModel command. An 18 state model was decided upon (after
visually inspecting models with up to 30 states) as it provided an easily interpretable
yet multi-faceted segmentation of the chromatin landscape.
State profiling
Chromatin states were profiled by calculating an enrichment score for each state over
multiple genomic annotations using the OverlapEnrichment and NeighbourhoodEnrich-
ment commands. For overlap enrichment analysis, genomic annotations were gener-
ated from either the AnnotationHub package (Morgan, 2017) or the TxDb.Mmuscul
us.UCSC.mm10.knownGene annotation database (Team and Maintainer, 2016) using
the GenomicFeatures package (Lawrence et al., 2013). The genomic annotations used
in the analysis were: CDS, CpG, Exons, Gap, Genes, Intergenic, Introns, Microsatel-
lite, Promoters, RepeatMasker, SimpleRepeats, TES, TSS, Transcripts, 3’ UTR, 5’ UTR,
and WindowMasker. For neighbourhood enrichment analysis, the position of each re-
striction site in the mm10 assembly of the mouse genome (Karolchik et al., 2004) was
generated using the matchPattern command from the Biostrings package (Pagès et al.,
2017).
2.4.10 Development of analysis workflow
Processing of the raw sequencing data was automated using a custom pipeline built
with the Conda package manager (version 4.5.1) (Anaconda, 2018) and Snakemake
workflow engine (version 4.7.0) (Köster and Rahmann, 2012). The analyses described
in this section can be reproduced by downloading and running the relevant ChIP-seq
workflow.
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2.5 Analysis of ATAC-seq, DNase-seq, and FAIRE-seq experi-
ments
2.5.1 Statement of attribution
The previously published ATAC-seq, DNase-seq, and FAIRE-seq experiments were
performed by the relevant research groups and the raw sequencing data was re-analysed
by the author, James Ashmore.
2.5.2 Availability of sequencing data
The raw sequencing data is available from the SRA database. The BioProject acces-
sion numbers include ESC ATAC-seq from PRJNA356293 (Chronis et al., 2017), PR-
JNA279456 (Maza et al., 2015), and PRJNA369204 (Simon et al., 2017); MEF ATAC-
seq from PRJNA356293 (Chronis et al., 2017), PRJNA359484 (Li et al., 2017), and PR-
JNA279456 (Maza et al., 2015); ESC DNase-seq from PRJNA281090 (Domcke et al.,
2015), PRJNA233390 (Sherwood et al., 2014), and SRP015984 (Yue et al., 2014); MEF
DNase-seq from PRJNA269282 (Deng et al., 2015), PRJEB21708 (Herdman et al., 2017),
and SRP015984 (Yue et al., 2014); ESC FAIRE-seq from PRJNA242533 (Buecker et al.,
2014), PRJNA272126 (Dieuleveult et al., 2016), and PRJNA252824 (Murtha et al., 2015);
and MEF FAIRE-seq from PRJNA252824 (Murtha et al., 2015), PRJNA276442 (Schick
et al., 2015), and PRJNA188177 (Wapinski et al., 2013).
2.5.3 Processing of sequencing data
Quality control
The raw sequencing data was downloaded from the SRA database using the parallel-
fastq-dump command (version 0.6.2) (Valieris, 2018) command from the SRA Toolkit
(version 2.8.2) (Kodama et al., 2012). The read quality was evaluated from reports
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generated by FastQC (version 0.11.7) (Andrews, 2010) and MultiQC (version 1.4.0)
(Ewels et al., 2016). The reads were trimmed using Cutadapt (Martin, 2011) to remove
low quality bases and adapter contaminant sequences:
1. Illumina TruSeq Adapters
Universal AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
Index GATCGGAAGAGCACACGTCTGAACTCCAGTCAC[N]ATCTCGTATGCCGTCTTCTGCTTG





Before proceeding, new FastQC and MultiQC reports were generated to make sure all
low quality bases and adapter sequences were removed.
Read alignment
The trimmed reads were aligned to the mm10 assembly of the mouse genome (Karolchik
et al., 2004) using BWA-MEM (Li, 2013). Duplicate reads were identified using the
MarkDuplicates command from Picard Tools (Broad Institute, 2018) and alignments
were sorted and indexed using Samtools (Li et al., 2009). The alignment files were
filtered using Bedtools (Quinlan, 2002) and Samtools (Li et al., 2009) based on multi-
ple criteria: Alignments to alternate, mitochondrial, unplaced, and random chromo-
somes were removed; non-unique, secondary, duplicate, and supplementary align-
ments were removed; and alignments to ENCODE (ENCODE Project Consortium,
2012) and mitochondrial (Buenrostro et al., 2013) blacklist regions were removed. To
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better represent the centre of the transposon binding event in ATAC-seq experiments,
alignments to the plus and minus strands were shifted 4 bp and -5 bp, respectively.
Genome coverage
To visualise read coverage along the genome, the read depth at each base pair was
calculated and reported in bedGraph format using the callpeak command from MACS2
(Zhang et al., 2008). For faster display performance and to save storage space, the
plain text bedGraph files were converted into an indexed binary bigWig file (Kent et
al., 2010) using the bedGraphToBigWig command (version 4.0) from Kent Tools (Kuhn,
Haussler, and Kent, 2013). Genome browser images of read coverage were captured
using the Integrative Genomics Viewer (version 2.3.98) (Robinson et al., 2011) and
pyGenomeTracks (version 3.0.0) (Ramírez et al., 2016).
2.5.4 Identification of DNA-accessibility sites
Peak calling
In order to identify DNA-accessibility sites, enriched chromatin regions relative to the
background were located using MACS2 (version 2.1.1) (Zhang et al., 2008). Broad
peaks of diffuse enrichment (ATAC-seq, DNase-seq, FAIRE-seq, and ChIP-seq) were
called with a 0.1 FDR threshold. To better represent the centre of each accessibility
site, alignments were shifted by -36 bp and extended to a size of 73 bp corresponding
to the length of DNA wrapped around a single nucleosome (see Listing 2.3).














LISTING 2.3. Parameters for broad peak calling using MACS2
Peak reproducibility
The majority of published ATAC-seq, DNase-seq, and FAIRE-seq experiments anal-
ysed in this work were not replicated. In order to treat libraries from different exper-
iments equally, libraries from replicated experiments were merged to create a single
library and peaks were called on the merged library.
For experiments with biological replicates, alignments from all replicates were merged
to create a single bulk replicate, in agreement with un-replicated experiments. The
broadPeak file format was used to represent broad regions of enrichment typically
seen in accessibility experiments. Command line parameters used are listed below:
Peak comparisons
Reproducible regions were generated by comparing peaks from three different studies
using BEDOPS (version 2.4.3) (Neph et al. 2012) with a 1 bp overlap threshold. Firstly,
a master list of regions was generated by ranking overlapping peaks from each study
and choosing the peak with the highest score. The original peaks from each study
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were then replaced by the overlapping peaks in the master list and only those present
in all studies were used for downstream analyses. Code used to create the master list
was adapted from the website listed below:
https://bedops.readthedocs.io/en/latest/content/usage-examples/master-list.html
Differential accessibility
To identify differential DNA-accessibility sites, binding analysis was performed with
coverage data using DiffBind (version 2.6.5) (Ross-Innes et al., 2012). Sites with a FDR
< 0.1 and absolute log2FC > 1 were defined as statistically significant. For compar-
isons between technologies, bulk replicates from each study and reproducible peaks
between studies were used.
2.5.5 Visualisation of DNA-accessibility sites
Peak accessibility
To visualise DNA-accessibility at, heatmaps of read coverage over broadPeak regions
were produced using the computeMatrix and plotHeatmap commands from Deeptools
(Ramírez et al., 2016). Reads within 4 kb of the enhancer centre were counted into 10
bp bins, then the rows of the heatmap were sorted by average read coverage.
Enhancer accessibility
To visualise DNA-accessibility at enhancers, heatmaps of read coverage over H3K4me1
and H3K27ac chromatin states (see Subsection 2.4.9) were generated using the com-
puteMatrix and plotHeatmap commands from Deeptools (Ramírez et al., 2016). Reads
within 4 kb of the enhancer centre were counted into 10 bp bins, then the rows of the
heatmap were sorted by average read coverage. In addition, super-enhancers from
from a previously published experiment (Whyte et al., 2013) were visualised. The
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super-enhancer coordinates were re-mapped from the mm9 to mm10 assembly of the
mouse genome (Karolchik et al., 2004) using the liftOver command (version 4.0) from
Kent Utilities (Kuhn, Haussler, and Kent, 2013).
Promoter accessibility
To visualise DNA-accessibility at promoters, heatmaps of read coverage around tran-
scription start sites (abbreviated TSS) were generated using the computeMatrix and
plotHeatmap commands from Deeptools (Ramírez et al., 2016). An annotation file of
TSS locations was generated from the TxDb.Mmusculus.UCSC.mm10.knownGene an-
notation database (version 3.4.0) (Team and Maintainer, 2016) using the GenomicFea-
tures package (version 1.30.3) (Lawrence et al., 2013). Reads within 2 kb of a TSS were
counted into 10 bp bins, then the rows of the heatmap were sorted by normalised gene
expression (see Subsection 2.6.4).
2.5.6 Development of analysis workflow
Processing of the raw sequencing data was automated using a custom pipeline built
with the Conda package manager (version 4.5.1) (Anaconda, 2018) and Snakemake
workflow engine (version 4.7.0) (Köster and Rahmann, 2012). The analyses described
in this section can be reproduced by downloading and running the relevant ATAC-
seq, DNase-seq, and FAIRE-seq workflows.
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2.6 Analysis of RNA-seq experiments
2.6.1 Statement of attribution
The previously published RNA-seq experiments were performed by the relevant re-
search groups and the raw sequencing data was re-analysed by the author, James Ash-
more.
2.6.2 Availability of sequencing data
The raw sequencing data is available from the SRA database. The BioProject accession
numbers are PRJNA286869 (Milagre et al., 2017) and PRJNA347884 (King and Klose,
2017).
2.6.3 Processing of sequencing data
Quality control
The raw sequencing data was downloaded from the SRA database using the parallel-
fastq-dump command (version 0.6.2) (Valieris, 2018) from the SRA Toolkit (version
2.8.2) (Leinonen et al., 2011). The read quality was evaluated from reports generated
by FastQC (version 0.11.7) (Andrews, 2010) and MultiQC (version 1.5) (Ewels et al.,
2016). The reads were trimmed using Cutadapt (version 1.16) (Martin, 2011) to remove
low quality bases and adapter contaminant sequences:
1. Illumina TruSeq Adapters
Universal AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
Index GATCGGAAGAGCACACGTCTGAACTCCAGTCAC[N]ATCTCGTATGCCGTCTTCTGCTTG
Before proceeding, new FastQC and MultiQC reports were generated to make sure all
low quality bases and adapter sequences were removed.
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Transcript quantification
To quantify transcript abundance, trimmed reads were pseudo-aligned to the UCSC
mm10 assembly of the mouse transcriptome (Karolchik et al., 2004) using the quant
command from Kallisto (version 0.43.1) (Bray et al., 2016). Transcript sequences (n =
63,759) were generated from the TxDb.Mmusculus.UCSC.mm10.knownGene annota-
tion database (version 3.4.0) (Team and Maintainer, 2016) using the extractTranscript-
Seqs command from the GenomicFeatures package (version 1.30.3) (Lawrence et al.,
2013).
Gene summarisation
To generate gene-level count matrices, transcript abundance estimates were summarised
per gene using the tximport package (version 1.6.1) (Soneson, Love, and Robinson,
2015). Transcripts were mapped to genes (n = 24,116) by the GENEID and TXNAME
columns from the TxDb.Mmusculus.UCSC.mm10.knownGene annotation database
(version 3.4.0) (Team and Maintainer, 2016).
2.6.4 Identification of differentially expressed genes
Quality control
Gene-level count matrices were imported into R (version 3.4.3) (R Core Team, 2017)
and assembled into DESeqDataSet objects for processing using the DESeq2 package
(version 1.18.1) (Love, Huber, and Anders, 2014). Genes with very low counts (less
than 10) across all samples were filtered because there was no purpose in analysing
genes that were not expressed. In addition, fewer genes reduced the processing time
and severity of multiple testing correction. To compare expression levels among sam-
ples, gene counts were normalised using the median ratio method from the estimate-
SizeFactors function. Between and within sample group differences were evaluated
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from principal component analysis (abbreviated PCA) and Brand-Altman (abbrevi-
ated MA) plots generated using the plotPCA and plotMA functions.
Differential expression
Differentially expressed genes (abbreviated DEG) were identified using the standard
procedure implemented in the DESeq2 function: estimate size factors, estimate disper-
sions, fit generalised linear models (abbreviated GLM) based on the negative binomial
distribution, and compute Wald statistics. Genes with a FDR < 0.05 and absolute log2
FC > 1 were defined as statistically significant. To visualise the most meaningful DEG,
volcano plots and heatmaps were created using the ggplot2 (version 2.2.1) (Wickham,
2009) and pheatmap (version 1.0.8) (Kolde, 2018) packages.
Functional profiling
To characterise the molecular functions and pathways in which DEG are involved,
over-representation analyses for Gene Ontology (abbreviated GO) terms and Kyoto
Encyclopedia of Genes and Genomes (abbreviated KEGG) pathways were performed
using the GOseq package (version 1.3.0) (Young et al., 2010). Terms and pathways
with an over-represented P value < 0.005 were defined as statistically significant. To
visualise the most meaningful profiles, bar plots of the -log10 over-represented P val-
ues for the 10 most significant terms and pathways were generated using the ggplot2
package (version 2.2.1) (Wickham, 2009)
Multiomics integration
Downstream analyses integrating RNA-seq data with other functional genomics tech-
nologies (ATAC-seq, ChIP-seq, DamID-seq, DNase-seq, and FAIRE-seq) were carried
out using regularised log transformed gene counts generated using the rlog function.
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The transformation corrects for differences in library size and reduces the contribution
of lowly expressed genes by shrinking their variance.
2.6.5 Development of analysis workflow
Processing of the raw sequencing data was automated using a custom pipeline built
with the Conda package manager (version 4.5.1) (Anaconda, 2018) and Snakemake
workflow engine (version 4.7.0) (Köster and Rahmann, 2012). The analyses described




Bias detection and protocol
optimization in DamID-seq data
3.1 Introduction
The development of DamID-seq has provided researchers with an alternative method
to identify DNA binding sites in situations where conventional ChIP-seq has been
limited. It has been used for a variety of DNA-binding proteins, from transcriptional
regulators to chromatin and nuclear organisers (Aughey and Southall, 2016). While
the majority of these experiments were performed in Drosophila (Greil, Moorman, and
Van Steensel, 2006), considerable progress has been made in recent years adapting the
technology to mammals, principally to investigate rare cell populations (Tosti et al.,
2018). Whilst celebrated, these technological advancements have been applied rather
uncritically. Since the development of DamID nearly 20 years ago, there has been
relatively little consideration regarding the potential sources of bias in the DamID-
seq experimental procedure or the sequencing data generated. Currently, known bi-
ases in the experimental procedure include modulating the level of Dam expression to
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achieve a good signal to noise ratio (Greil, Moorman, and Van Steensel, 2006), methy-
lation of the Dam plasmid in transient transfection experiments (Pindyurin et al., 2016)
and the relatively low resolution of binding sites detected (Greil, Moorman, and Van
Steensel, 2006). However, to the best of our knowledge there has been no system-
atic review or publication of biases present in the sequencing data, unlike other high-
throughput technologies such as ChIP-seq (Furey, 2012; Meyer and Liu, 2014) and
RNA-seq (Conesa et al., 2016; Zheng, Chung, and Zhao, 2011). This presents concerns
for past results and future experiments, as technical artifacts may be misinterpreted as
biologically-relevant DNA binding. Historically, the application of newly-developed
technology has often exceeded our understanding of the data generated. Biases such
as chromatin fragmentation, nucleic acid isolation, PCR amplification, and read map-
ping in next-generation sequencing experiments are continually being documented
(Meyer and Liu, 2014). The accuracy and sensitivity of any given technology is greatly
influenced by multiple technical and biological factors. Without investigating their
impact on the data generated, technology with hidden potential may never be fully
realised, or worse technology which produces false-positives may become widely
adopted.
3.2 Aims
The aim of this chapter is to identify potential sources of bias in the DamID-seq ex-
perimental procedure and demonstrate how these biases affect the sequencing data
generated. This is necessary so that technical variation between the Dam and Dam-
fusion libraries is not misinterpreted as biologically-relevant DNA binding. Sources
of bias will be surveyed using DamID-seq data for transcription factors Oct4 and Sox2
in mouse embryonic stem cells (abbreviated ESC), embryonic fibroblast cells (abbre-
viated MEF), and neural stem cells (abbreviated NSC). To ensure cell number biases
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are not overlooked, biases will also be surveyed using Oct4 ESC DamID-seq data pre-
pared with 106, 104, 103, and 102 cells. Information about any potential sources of
bias can be used to guide future experimental design and inform the development of
rigorous analysis methods.
3.3 Attribution
The DamID-seq libraries were generated by Dr Luca Tosti, and the sequencing data
was analysed by the author, James Ashmore. All of the ChIP-seq libraries were taken
from public experiments and re-analysed.
3.4 Results
3.4.1 DamID-seq data yields broad regions of enrichment
In order to develop rigorous computational methods for analysing DamID-seq data,
it was first necessary to gain an understanding of the enrichment pattern generated
by DamID-seq experiments. This was evaluated by looking at the pileup of aligned
sequencing reads along the genome, particularly around regions likely to be enriched
(e.g. Transcription factor binding sites). Genome browser tracks showed that Oct4 and
Sox2 DamID-seq data exhibited much broader regions of enrichment around DNA
binding sites than ChIP-seq data (see Figure 3.1). Previous studies have demonstrated
that Dam can methylate DNA multiple kilobases away from the DNA binding site
(Van Steensel and Henikoff, 2000; Van Steensel, Delrow, and Henikoff, 2001). This
occurs because the tether in the fusion-protein allows Dam to diffuse locally around
the DNA binding site and methylate any DNA in close proximity. To estimate the
average reach of Dam, the distribution of DamID-seq reads around all DNA bind-
ing sites identified from ChIP-seq data was plotted (see Figure 3.2). The spread of
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the distributions showed that DamID-seq data display localised but much broader re-
gions of enrichment (~3 kb from the DNA binding site) than ChIP-seq data (~250bp
from the DNA binding site). One of the main features of ChIP-seq data used to in-
crease its resolution is the strand-specific structure of the reads aligned around the
DNA binding site (Pepke, Wold, and Mortazavi, 2009). In ChIP-seq experiments, im-
munoprecipitated DNA fragments are equally likely to be sequenced from both ends,
so the read density around a DNA binding site should show a bimodal enrichment
pattern (i.e. reads aligned to the forward strand should be enriched upstream of the
DNA binding site and vice versa) (Zhang et al., 2008). Peak calling algorithms ex-
ploit this shift to more accurately identify the location of the DNA binding site. This
strand-specific structure was immediately visible in the genome browser tracks of the
ChIP-seq data, but not the DamID-seq data (see Figure 3.3). To substantiate this ob-
servation, the distribution of strand-specific DamID-seq reads at DNA binding sites
identified from ChIP-seq data was plotted (see Figure 3.4). The completely overlap-
ping forward and reverse strand distributions in the DamID-seq data verified there
was no strand-specific structure which could be exploited to increase its resolution.
Instead it appears the resolution of DamID-seq experiments is limited by the reach
of Dam and the size of the restriction fragment in which the DNA binding site is lo-
cated (see Figure 3.5). In the mouse genome, the average restriction fragment length
is approximately 260 bp, meaning the average resolution for each DNA binding site
will be between 260 bp and 6 kb (combined upstream and downstream reach of Dam).
These results imply that DamID-seq will detect DNA binding sites at a much lower
resolution than ChIP-seq, which is limited to the size of chromatin fragments pro-
duced by sonication (typically between 200 and 500 bp). However, altered methods
such as ChIP-exo and X-ChIP-seq claim to acquire single base pair resolution using
exonucleases to degrade the DNA protruding either side of the DNA-protein complex
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(Skene and Henikoff, 2015). Lower resolution binding sites also hinder many down-
stream analyses such as de-novo motif enrichment and discovery by having to scan
much larger sequence regions (Ma, Noble, and Bailey, 2014).
FIGURE 3.1. Tracks of ChIP-seq and DamID-seq read coverage at DNA binding sites.
These tracks show ChIP-seq and DamID-seq read coverage at select Oct4 and Sox2 DNA bind-
ing sites in mouse embryonic stem cells (abbreviated ESC) and neural stem cells (abbreviated
NSC). The ChIP-seq tracks were generated by re-analysing data from public Oct4 ESC (Chronis
et al., 2017), Sox2 ESC (Marson et al., 2008), and Sox2 NSC (Lodato et al., 2013) experiments.
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FIGURE 3.2. Graphs of ChIP-seq and DamID-seq read coverage at DNA binding sites.
These graphs show ChIP-seq and DamID-seq read coverage at all Oct4 and Sox2 DNA bind-
ing sites in mouse embryonic stem cells (abbreviated ESC) and neural stem cells (abbreviated
NSC). The top panels are from three ChIP-seq experiments (Chronis et al., 2017; Marson et al.,
2008; Lodato et al., 2013) and the bottom panels are from three DamID-seq experiments (Tosti
et al., 2018). The DNA binding sites were identified by calling peaks from the Oct4 ESC (n =
37,925), Sox2 ESC (n = 15,690), and Sox2 NSC (n = 22,481) ChIP-seq data.
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FIGURE 3.3. Tracks of strand-specific ChIP-seq and DamID-seq read coverage at DNA bind-
ing sites.
These tracks show strand-specific ChIP-seq and DamID-seq read coverage at select Oct4 and
Sox2 DNA binding sites in mouse embryonic stem cells (abbreviated ESC) and neural stem
cells (abbreviated NSC). Reads aligned to the forward and reverse strands are coloured red
and blue, respectively. The panels also contain the location of the relevant transcription factor
binding motif (identified by FIMO) and the Dam binding motif (DpnII restriction site).
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FIGURE 3.4. Graphs of strand-specific ChIP-seq and DamID-seq read coverage at DNA
binding sites.
These graphs show strand-specific ChIP-seq and DaID-seq read coverage at all Oct4 and Sox2
DNA binding sites in mouse embryonic stem cells (abbreviated ESC) and neural stem cells
(abbreviated NSC). The top panels are from three ChIP-seq experiments (Chronis et al., 2017;
Marson et al., 2008; Lodato et al., 2013) and the bottom panels are from three DamID-seq
experiments (Tosti et al., 2018). There is a characteristic shift between reads aligned to the
forward and reverse strands at the DNA binding sites in the ChIP-seq experiments.
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FIGURE 3.5. Distribution of restriction fragment sizes in the mouse genome.
This graph shows the distribution of restriction fragment sizes generated from an in-silico
digest of the mouse genome by restriction enzyme DpnII (i.e. cutting all GATC sequences
between the adenine and thymine bases). The median restriction fragment length is 260 base
pairs.
3.4.2 Assessment of duplication rates in DamID-seq data
An important decision in the analysis of high-throughput sequencing data is whether
to remove duplicate sequencing reads. Duplicates are classed as reads which have the
same genomic sequence and consequently align to the same position in the reference
genome. There are multiple ways in which duplicates can arise, categorised either
by technical or natural duplication (Bansal, 2017). Technical duplicates are generated
by PCR amplification, which is necessary in most library preparations to enrich for
adapter-ligated DNA fragments for sequencing. This sometimes produces an altered
or unrepresentative library composition because polymerase efficiency is influenced
by the length and nucleotide content of the DNA fragment being amplified (Aird et al.,
2011). Natural duplicates on the other hand are generated when DNA fragments with
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a high copy number in the starting material are independently sequenced. In RNA-
seq experiments, highly expressed genes produce thousands of copies of the same
mRNA transcript which are then extracted, fragmented, and copied into cDNA for
sequencing. Shorter mRNA transcripts expressed at the same level as longer ones also
tend to generate more duplicates because the space of possible start and end positions
for mRNA fragmentation is saturated (Parekh et al., 2016).
To remove duplicates from sequencing data, computer software locates reads with
the same genomic sequence (Shen et al., 2016) or alignment position (Broad Institute,
2018) and filters all but the highest scoring read. The problem with this strategy is
that it cannot determine whether the reads were generated by technical or natural du-
plication (i.e. spurious technical copies or legitimate biological copies). Whilst there
are alternative library preparations which allow each individual DNA fragment to be
uniquely marked (e.g. universal molecular identifiers and cellular barcodes), these are
normally reserved for situations where a large number of PCR cycles is needed or the
library complexity is small enough to accommodate the maximum number of unique
barcodes which can be generated (Kivioja et al., 2011). The removal of duplicates af-
fects the quantification of the biology under investigation, and therefore influences the
results of the experiment. The general consensus for RNA-seq data is that duplicates
should not be removed because the probability of natural duplication is inherently
high given the level of transcription (Conesa et al., 2016). In comparison with ChIP-
seq data, duplicates are routinely removed because the maximum copy number of
DNA from a single cell is two (a single chromosome pair), and DNA fragmentation is
unbounded so the probability of sequencing the exact same fragment is low (Carroll
et al., 2014). For DamID-seq data, it is unclear what the rate of technical to natural
duplication is because the maximum copy number of a restriction fragment from a
single cell is two, but the possible number of DNA fragmentation sites is bounded by
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the length of the restriction fragment.
In order to assess the behaviour of duplicates in DamID-seq experiments, a logistic
regression model (i.e. duplicates predicted from methylation) was fitted to Oct4 and
Sox2 DamID-seq data (see Figure 3.6). The models showed no relationship between
the percentage of duplicate reads and the level of methylation. Instead the percentage
of duplicates varied between 0% and 100% for a fixed level of methylation (e.g. 102
reads/kb). Only at exceedingly high methylation levels did the percentage of dupli-
cate reads increase linearly (e.g. 104 reads/kb). This same pattern was also observed
in the low cell number Oct4 DamID-seq data, but as the number of cells decreased
a much larger proportion of restriction fragments exhibited duplicates (see 3.7). In
this situation, the increased duplication rate can be explained by the higher number
of PCR cycles employed in the library preparation which suggests they are technical
rather than natural duplicates. For comparison, RNA-seq data which displays a high
rate of natural duplication exhibits a linear relationship between expression and du-
plication. The DamID-seq data did not exhibit this relationship, which indicated very
few natural duplicates in the DamID-seq data, and that duplicate removal should be
performed. To evaluate the affect of duplicate removal, the distribution of DamID-seq
reads around DNA binding sites identified from ChIP-seq data with and without du-
plicates removed was plotted (see 3.8). In the Sox2 ESC and Sox2 NSC DamID-seq
data the removal of duplicates either increased or did not affect the read coverage at
DNA binding sites. The increase in coverage can be explained by the removal of reads
not associated with the DNA binding sites, therefore decreasing the overall library size
and consequently when normalised to reads per million causing an increase in cover-
age at the DNA binding sites. Surprisingly, coverage at DNA binding sites was also
not affected in the low cell number DamID-seq data (see 3.9). Together these results
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indicated that the number of natural duplicates in DamID-seq data is low and con-
sequently PCR duplicates can be safely removed without affecting coverage at DNA
binding sites.
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FIGURE 3.6. Graphs of duplication rates from Oct4 and Sox2 DamID-seq experiments.
These graphs show the duplication rates from Oct4 and Sox2 DamID-seq experiments in
mouse embryonic stem cells (abbreviated ESC), fibroblast cells (abbreviated MEF) and neu-
ral stem cells (abbreviated NSC). The X-axis measures the number of reads per kilobase pair
aligned to each restriction fragment, and the Y-axis measures the percentage of reads aligned
to each restriction fragment which are marked as PCR duplicates. There is no strong rela-
tionship between methylation and duplication, meaning the number of natural duplicates is
low.
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FIGURE 3.7. Graphs of duplication rates from low cell number Oct4 DamID-seq experi-
ments.
These graphs show the duplication rates from Oct4 DamID-seq experiments in 106, 104, 103,
and 102 mouse embryonic stem cells. Each point represents one restriction fragment in the
mouse genome. The X-axis shows the number of reads per kilobase pair aligned to each
restriction fragment, and the Y-axis shows the percentage of reads aligned to each restric-
tion fragment which are marked as PCR duplicates. There is no strong relationship between
methylation and duplication, meaning the number of natural duplicates is low.
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FIGURE 3.8. Graphs of DamID-seq read coverage with and without PCR duplicates re-
moved at DNA binding sites.
These graphs show DamID-seq read coverage with and without PCR duplicates removed at
Oct4 and Sox2 DNA binding sites in mouse embryonic stem cells (abbreviated ESC) and neural
stem cells (abbreviated NSC). The DNA binding sites were identified by calling peaks from the
Oct4 ESC (n = 37,925), Sox2 ESC (n = 15,690), and Sox2 NSC (n = 22,481) ChIP-seq data.
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FIGURE 3.9. Graphs of low cell number Oct4 DamID-seq read coverage with and without
PCR duplicates removed.
These graphs show DamID-seq read coverage with and without PCR duplicates removed at
Oct4 DNA binding sites in 106, 104, 103, and 102 mouse embryonic stem cells (abbreviated
ESC). The DNA binding sites were identified by calling peaks from the Oct4 ESC (n = 37,925),
Sox2 ESC (n = 15,690), and Sox2 NSC (n = 22,481) ChIP-seq data.
3.4.3 Dam binding is not biased by nucleotide composition
The DNA adenine methyltransferase (abbreviated Dam) used in DamID-seq experi-
ments is taken from Escherichia coli bacteria. Methylation of adenine is widespread
across many bacteria, but is largely absent in eukaryotes (Aughey and Southall, 2016).
When expressed in an entirely new system, it is possible that the binding specificity of
Dam is altered or preferentially binds restriction sites with a specific local nucleotide
composition. This invariably would alter which DNA binding sites were identified,
because restriction sites with an unfavourable local nucleotide composition would be
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less methylated or not methylated at all compared to other more favourable restric-
tion sites. This type of bias can be seen in sequencing data generated by the Illu-
mina Nextera DNA preparation kit, whereby the Tn5 transposase preferentially in-
serts itself into chromatin at a particular sequence (Ason and Reznikoff, 2004). To
the best of our knowledge, only two previous studies have sought evidence for Dam
exhibiting compositional DNA preference in binding. Horton and colleagues gen-
erated a crystal structure of Dam in complex with non-cognate DNA, lacking any
GATC sequences. Their structures exhibited an apparent 5 bp DNA binding sequence,
which was also found flanking GATC sites in some Dam-regulated promoters in the
Drosophila genome (Horton et al., 2015). While this is unexpected, it is not clear
whether Dam would bind to such an element in vivo away from the concentrated
solution used in this study to achieve a crystal structure of high resolution. Addi-
tionally, Bergerat and colleagues observed that at very low temperature (0◦C) and in
the presence of S-Adenosyl methionine (Ado-Met) Dam can bind to non-specific DNA
with low affinity (Bergerat and Guschlbauer, 1990). Again, this altered specificity for
binding is only observed in vitro and it is unknown whether Dam would exhibit such
behaviour at a physiological temperature and condition. Importantly, neither of these
experiments have been carried out on a genome-wide scale where the ability to mea-
sure methylation at every individual GATC site is possible, and can be accurately
quantified.
To determine if Dam preferentially binds restriction sites with a specific local nu-
cleotide composition, the DNA compositional bias around methylated and unmethy-
lated restriction sites in multiple DamID-seq data sets was plotted (see Figure 3.10). In
all libraries a uniform sequence composition around both methylated and un-methylation
restriction sites was observed. The difference between the guanine-cytosine (GC) and
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adenine-thymine (AT) compositions was caused by the GC (42%) and AT (58%) con-
tent of the mouse genome (Ruvinsky and Marshall Graves, 2005). To visualise more
subtle patterns in the data, the plots were scaled to remove the influence of the GATC
site on the nucleotide frequency (see Figure 3.11). When scaled, the plots showed
a small decrease in A/T nucleotides flanking the GATC motif in methylated versus
unmethylated restriction fragments (methylated = 0.35 and unmethylated = 0.38).
However, it is not clear whether such a small decrease ( 3%) is biologically significant
reflecting an innate bias in Dam binding, or whether some technical factor such as PCR
amplification bias, differential fragmentation efficiency of DNA templates, or simply
changing the cut-off threshold for defining methylated versus unmethylated restric-
tion fragments would change this observation. Either way, such a small decrease is
unlikely to alter the genome-wide methylation levels to any extent that downstream
peak calling would be affected. To ensure there was no sequence-specificity at differ-
ent levels of methylation, the DNA compositional bias around restriction sites sepa-
rated into quartiles by methylation level was also plotted (see Figure 3.12). Again, all
libraries displayed a uniform sequence composition regardless of the level of methy-
lation. These results indicated that Dam does not preferentially bind restriction sites
in a sequence-specific manner and that no correction of the data with respect to local




































FIGURE 3.10. Graphs of nucleotide frequency around methylated and unmethylated re-
striction sites.
Graphs of nucleotide frequency around methylated and un-methylated restriction sites from
DamID-seq data for embryonic stem cells (ESC), embryonic fibroblast cells (MEF), and neural
stem cells (NSC). Restriction sites neighbouring a restriction fragment with greater than 10
reads were classed as methylated, and vice versa. Distance zero was defined as the position of
adenine in the restriction site GATC sequence.







































FIGURE 3.11. Graphs of nucleotide frequency around methylated and unmethylated re-
striction sites.
Graphs of nucleotide frequency around methylated and un-methylated restriction sites from
DamID-seq data for embryonic stem cells (ESC), embryonic fibroblast cells (MEF), and neural
stem cells (NSC). Restriction sites neighbouring a restriction fragment with greater than 10
reads were classed as methylated, and vice versa. Distance zero was defined as the position
of adenine in the restriction site GATC sequence. The graphs caled to remove the influence of
the GATC site on the nucleotide frequency. The vertical dashed lines represent the position of

















































FIGURE 3.12. Nucleotide frequency around restriction sites divided into quartiles by
methylation.
Graphs of nucleotide frequency around methylated restriction sites from DamID-seq data for
embryonic stem cells (ESC), embryonic fibroblast cells (MEF), and neural stem cells (NSC).
Restriction sites neighbouring a restriction fragment with greater than 10 reads were classed
as methylated. Restriction sites were then divided into quartiles my methylation. Distance
zero was defined as the position of adenine in the restriction site GATC sequence.
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3.4.4 DpnII digestion is required for enrichment of factor-bound chromatin
In the original DamID-seq experimental protocol, adapted-ligated DNA was digested
with restriction enzyme DpnII to avoid amplifying fragments containing unmethy-
lated restriction sites (Greil, Moorman, and Van Steensel, 2006). However, recent pub-
lications aiming to improve upon this protocol have removed the digestion step en-
tirely, citing reasons of redundancy and simplicity (Hass et al., 2015; Kind et al., 2015;
Pindyurin et al., 2016). They argue that in a typical library there should be very few
adapter-ligated fragments which contain unmethylated restriction sites, and that their
limited presence should not impact the sequencing data generated.
To determine the effect of DpnII digestion, read coverage of restriction fragments
in Oct4 DamID-seq data prepared with and without DpnII digestion (abbreviated
+DpnII/-DpnII) was measured. Genome browser tracks showed that read coverage
at multiple of Oct4 binding sites was drastically reduced without DpnII digestion (see
Figure 3.13). More precisely, read coverage at all Oct4 binding sites was approximately
four-fold lower in the -DpnII libraries, and the ratio of Dam-Oct4 over Dam was al-
most two-fold lower (see Figure 3.14). The reduction in coverage at DNA binding
sites makes it more challenging to identify statistically significant binding, because
the level of methylation is closer to the level of random noise in the sequencing data,
such as non-specific background methylation. In a typical ChIP-seq experiment, the
input DNA library is expected to display a uniform distribution of reads along the
genome. There should be no preferential enrichment at particular genomic features.
By comparison, the antibody-treated library is expected to display a biased distribu-
tion of reads along the genome. There should be preferential enrichment at the bind-
ing sites of the target protein (Diaz, Nellore, and Song, 2012). A similar pattern should
be observed in the DamID-seq data, with the Dam-fusion library localised to binding
sites, and the Dam library distributed more widely across the genome. If the reads in
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both the treatment and control libraries are spread equally across the genome, it be-
comes harder to differentiate signal from background. Without DpnII digestion, both
the Dam and Dam-Oct4 reads were more widely distributed along the genome, and
the difference between the Dam and Dam-Oct4 distributions was narrower (see Fig-
ure 3.15). These observations suggested that DpnII digestion is required for adequate
read coverage at DNA binding sites, and that without DpnII digestion it is harder to
differentiate between the foreground and background methylation.
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FIGURE 3.13. Tracks of +DpnII/-DpnII Oct4 DamID-seq read coverage at Oct4 binding
sites.
Tracks of Oct4 DamID-seq data generated with and without DpnII digestion (abbreviated
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FIGURE 3.14. Graph of +DpnII/-DpnII Oct4 DamID-seq read coverage at Oct4 binding
sites.
Graph of Oct4 DamID-seq read coverage at all Oct4 binding sites in mouse embryonic stem
cells (abbreviated ESC) with and without DpnII digestion. The Oct4 binding sites were identi-
fied by calling peaks from the Oct4 ESC (n = 37,925) ChIP-seq data. Distance zero was defined
as the position of the summit in the ChIP-seq peaks.
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FIGURE 3.15. Graph of the distribution of reads from +DpnII/-DpnII Oct4 DamID-seq data
Graph showing the proportion of DamID-seq reads aligned in 1 kb bins along the entire
genome. The curve shows the bottom x fraction of bins have y fraction of the total sequencing.
Libraries prepared with DpnII digestion have more localised and stronger enrichment than
those without DpnII digestion.
3.4.5 Polymerase efficiency impacts restriction fragment amplification
In the original DamID-seq experimental procedure, adapter-ligated DNA was am-
plified using the polymerase chain reaction (abbreviated PCR) with an Advantage II
polymerase from Takara Clontech (Van Steensel and Henikoff, 2000). Since then, man-
ufacturers have engineered more processive and sensitive polymerases yet the major-
ity of published DamID-seq experiments have not upgraded. The PCR amplification
process is worth exploring because it has been shown that different polymerases gen-
erate libraries with varying complexity and coverage, which impacts the accuracy and
sensitivity of the DNA-seq experiment (Brandariz-Fontes et al., 2015). To determine
the affect of PCR amplification on DamID-seq experiments, read coverage of Oct4
ESC DamID-seq libraries prepared from the same DNA sample but amplified with
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two different polymerases (the original Advantage II polymerase from Takara Clon-
tech and the more recent KAPA HiFi from Kapa Biosystems) were compared. Genome
browser tracks showed that sequencing libraries generated with the Kapa polymerase
contained enriched regions which were entirely absent in those generated with the
Clontech polymerase (see Figure 3.16). More specifically, the number of sequenced
bases along the genome (i.e. genome coverage) was consistently higher in the Kapa
than Clontech libraries over a range of sequencing depths (see Figure 3.17). Addi-
tionally, libraries prepared with the Kapa polymerase were revealed to have higher
read and restriction fragment complexity than those prepared with the Clontech poly-
merase (see Figures 3.18 and 3.19). These results indicated that libraries prepared with
the Kapa polymerase successfully amplified a higher number of restriction fragments,
which potentially would also contain DNA binding sites for the protein being assayed.
Generally, different polymerases greatly affected the PCR amplification process, and
that to achieve higher quality DamID-seq libraries, future experiments should be per-
formed with a more accurate polymerase (e.g. KAPA HiFi from Kapa Biosystems).
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FIGURE 3.16. Tracks of Oct4 DamID-seq data amplified using Clontech and Kapa poly-
merases.
Tracks of DamID-seq read coverage prepared from the same DNA library but amplified with
either the Advantage II polymerase from Takara Clontech or the KAPA HiFi polymerase from
Kapa Biosystems. In all tracks, the Kapa libraries display enriched regions which are missing
from the Clontech libraries.
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FIGURE 3.17. Coverage of DamID-seq data generated by Clontech and Kapa polymerases.
Graphs displaying the number of distinct bases sequencing in the mouse genome over a range
of library sizes for Oct4 ESC DamID-seq libraries prepared from the same DNA library but
amplified with either the Advantage II polymerase from Takara Clontech or the KAPA HiFi
polymerase from Kapa Biosystems. In both the Dam and Dam-Oct4 sequencing data, the Kapa

























FIGURE 3.18. Read complexity of DamID-seq data generated by Clontech and Kapa poly-
merases.
Graph of read complexity for Oct4 ESC DamID-seq libraries prepared from the same DNA
sample but amplified with either the Advantage II polymerase from Takara Clontech or the
KAPA HiFi polymerase from Kapa Biosystems. In both the Dam and Dam-Oct4 sequencing
data, the Kapa libraries are more complex compared to the Clontech libraries.





























FIGURE 3.19. Restriction fragment complexity of DamID-seq data generated by Clontech
and Kapa polymerases.
Graph of restriction fragment complexity for Oct4 ESC DamID-seq libraries prepared from
the same DNA sample but amplified with either the Advantage II polymerase from Takara
Clontech or the KAPA HiFi polymerase from Kapa Biosystems. In both the Dam and Dam-
Oct4 sequencing data, the Kapa libraries are more complex compared to the Clontech libraries.
3.4.6 Restriction fragment size affects the level of methylation
Read coverage in next-generation sequencing experiments is meant to provide an ac-
curate and quantitative measurement of the biology under investigation. For example,
coverage can be used to quantify enrichment of factor-bound chromatin (ChIP-seq),
expression of mRNA transcripts (RNA-seq), or interaction of associated chromatin
(Hi-C). For DamID-seq experiments, read coverage is used to quantify the methyla-
tion of factor-bound chromatin. Previous work has shown that read coverage can be
biased by technical factors such as transcript length in RNA-seq experiments (Osh-
lack and Wakefield, 2009) or restriction fragment length in Hi-C experiments (Yaffe
and Tanay, 2011). In RNA-seq data, longer transcripts tend to have greater cover-
age than shorter ones, even if they have the same level of expression. In Hi-C data
however, longer restriction fragments tend to have less coverage than shorter ones,
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even if they have the same physical contact. This variation in coverage between fea-
tures of different lengths presents two problems: it confounds comparisons between
features because coverage is influenced by factors unrelated to abundance, and bio-
logical replicates can be biased differently which reduces reproducibility. To identify
DNA binding sites from DamID-seq data, each restriction fragment is tested for differ-
ential methylation between the Dam and Dam-fusion libraries. In theory, differential
methylation should not be affected by fragment length because proteins bind along
the genome without regard for the location of restriction sites, and therefore the level
of methylation should not be influenced.
To determine if there is a relationship between restriction fragment length and differ-
ential methylation, Oct4 and Sox2 DamID-seq read counts were binned according to
restriction fragment length and the percentage of differentially methylated fragments
was plotted (see Figure 3.20). The data showed that as fragment length increased
the ability to detect differential methylation decreased. This same pattern was also
observed in the low cell number Oct4 DamID-seq data (see Figure 3.21). To inves-
tigate the exact relationship between read coverage and restriction fragment length,
a quantile regression model (i.e. coverage predicted from length) was fitted to data
from multiple DamID-seq experiments (see Figure 3.22). All of the models displayed
strong sample-specific non-linear relationships between coverage and length, which
were different between fusion proteins and cell types. Similar sample-specific non-
linear relationships were also observed for the low cell number DamID-seq data (see
Figure 3.23), and despite measuring the same underlying biology (i.e. Oct4 binding in
ESCs) there was no common relationship between libraries from different cell num-
bers. There was however a notable convergence in coverage within all of the libraries
for restriction fragments between 103 and 104 base pairs in length. However, coverage
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of restriction fragments smaller or greater than this range were either continuously in-
creasing or decreasing. This suggest that regardless of their size, restriction fragments
in this 103 to 104 range were methylated equally and preferentially over those outside
this range. This is concerning because comparisons between DNA binding sites will
be influenced by the size of the restriction fragment where they are located. In ad-
dition, the data also showed that the non-linear relationships were distinct between
the Dam and Dam-fusion proteins. This is also concerning because in order to cor-
rectly test for differential methylation we assume that the same restriction fragment
can be methylated with equal opportunity across the Dam and Dam-fusion libraries.
If this assumption does not hold, restriction fragments could be incorrectly identi-
fied as being differentially methylated because of Dam and Dam-fusion length biases
rather than differences in DNA binding between the Dam and Dam-fusion proteins.
Together these results highlight a significant need for analysis methods which test dif-
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FIGURE 3.20. Graphs of differential methylation by fragment length in Oct4 and Sox2
DamID-seq data.
Graphs showing the percentage of differentially methylated fragments binned according to
restriction fragment length in Oct4 and Sox2 DamID-seq data. Differential methylation was
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FIGURE 3.21. Graphs of differential methylation by fragment length in low cell number
Oct4 DamID-seq data.
Graphs showing the percentage of differentially methylated fragments binned according to
restriction fragment length in low cell number Oct4 DamID-seq data. Differential methylation
was tested using limma (FDR < 0.1).
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FIGURE 3.22. Graphs of the fragment length effect on methylation in Oct4 and Sox2
DamID-seq data.
Graphs of the estimated fragment length effect on methylation in Oct4 and Sox2 DamID-seq
data from mouse embryonic stem cells (abbreviated ESC), embryonic fibroblast cells (abbrevi-
ated MEF), and neural stem cells (abbreviated NSC). The X-axis measures the restriction frag-
ment length in kilobases and the Y-axis measures the fit from the quantile regression model.
Specifically, for each sample a systematic bias function using natural cubic splines can be es-
timated. For each value on the x-axis, the y-axis plots the fitted value generated from each of
the sample-specific bias functions. The sample-specific affect of the covariate on read counts
can be visualised by plotting the estimates from the bias functions. Each line represents the
trend from a biological sample.
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FIGURE 3.23. Graphs of the fragment length effect on methylation in low cell number Oct4
DamID-seq data.
Graphs of the estimated fragment length effect on methylation in low cell number DamID-seq
data from mouse embryonic stem cells (abbreviated ESC). The X-axis measures the restric-
tion fragment length in kilobases and the Y-axis measures the fit from the quantile regression
model. Specifically, for each sample a systematic bias function using natural cubic splines can
be estimated. For each value on the x-axis, the y-axis plots the fitted value generated from
each of the sample-specific bias functions. The sample-specific affect of the covariate on read
counts can be visualised by plotting the estimates from the bias functions.
3.4.7 Restriction fragment GC content affects methylation levels
Similar to feature length, read coverage can also be affected by sequence composition
such as guanine-cytosine (GC) content (Hansen, Irizarry, and Wu, 2012). In RNA-
seq data, mRNA transcripts expressed at the same level can be measured differently
because of their GC content and this can substantially bias differential expression anal-
ysis (Risso et al., 2011). In addition, Hi-C data can also be strongly affected by GC con-
tent near the ligated restriction fragment ends (Yaffe and Tanay, 2011). For DamID-seq
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data, differential methylation should not be affected by restriction fragment GC con-
tent because proteins bind along the genome without regard for the GC content of the
restriction fragment, and therefore the level of methylation should not be influenced.
To determine if there is a relationship between restriction fragment GC content and
differential methylation, DamID-seq read counts were binned according to restriction
fragment GC content and the percentage of differentially methylated fragments was
plotted (see Figure 3.24). The data showed that as GC content increased the ability to
detect differential methylation increased. This same pattern was also observed in the
low cell number DamID-seq data (see Figure 3.25). To investigate the exact relation-
ship between read coverage and restriction fragment GC content, a regression model
(i.e. coverage predicted from GC content) was fitted to data from multiple DamID-
seq experiments (see Figure 3.26). All of the models displayed strong sample-specific
non-linear relationships between coverage and GC content, which were also different
between fusion proteins and cell types. Similar sample-specific non-linear relation-
ships were also observed for the low cell number DamID-seq data (see Figure 3.23),
and despite measuring the same underlying biology (i.e. Oct4 binding in ESCs) there
was no common relationship between libraries from different cell numbers. Similar
to the restriction fragment length bias identified previously, the affect of GC content
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FIGURE 3.24. Graphs of differential methylation by fragment GC content in Oct4 and Sox2
DamID-seq data.
Graphs showing the percentage of differentially methylated fragments binned according to
restriction fragment GC content in Oct4 and Sox2 DamID-seq data. Differential methylation
was tested using limma (FDR < 0.1).
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FIGURE 3.25. Graphs of differential methylation by fragment GC content in low cell num-
ber Oct4 DamID-seq data.
Graphs showing the percentage of differentially methylated fragments binned according to
restriction fragment GC content in low cell number Oct4 DamID-seq data. Differential methy-
lation was tested using limma (FDR < 0.1).
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FIGURE 3.26. Graphs of the fragment GC content effect on methylation in Oct4 and Sox2
DamID-seq data.
Graphs of the estimated fragment GC content effect on methylation in Oct4 and Sox2 DamID-
seq data from mouse embryonic stem cells (abbreviated ESC), embryonic fibroblast cells (ab-
breviated MEF), and neural stem cells (abbreviated NSC). The X-axis measures the restric-
tion fragment GC content and the Y-axis measures the fit from the quantile regression model.
Specifically, for each sample a systematic bias function using natural cubic splines can be es-
timated. For each value on the x-axis, the y-axis plots the fitted value generated from each of
the sample-specific bias functions. The sample-specific affect of the covariate on read counts
can be visualised by plotting the estimates from the bias functions.
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FIGURE 3.27. Graphs of the fragment GC content effect on methylation in low cell number
Oct4 DamID-seq data.
Graphs of the estimated fragment GC content effect on methylation in low cell number Oct4
DamID-seq data from mouse embryonic stem cells (abbreviated ESC). The X-axis measures the
restriction fragment GC content and the Y-axis measures the fit from the quantile regression
model. Specifically, for each sample a systematic bias function using natural cubic splines can
be estimated. For each value on the x-axis, the y-axis plots the fitted value generated from
each of the sample-specific bias functions. The sample-specific affect of the covariate on read
counts can be visualised by plotting the estimates from the bias functions.
3.4.8 Regional GC content does not affect methylation levels
Finally, it was important to check whether a relationship between restriction fragment
length and GC content could also be observed. The restriction fragment GC content
may reflect the regional GC content in the genome, which then influences the fre-
quency of GATC sites and therefore the length and methylation level of restriction
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fragments. To determine if read coverage is affected by the relationship between re-
striction fragment length and GC content, DamID-seq read counts were first length-
normalised then binned according to restriction fragment GC content and the percent-
age of differentially methylated fragments was plotted (see Figures 3.28 and 3.29). If
there is a relationship between restriction fragment length and GC content, a reduc-
tion in GC bias would be observed after normalising read counts for length. The plots
however showed that a similar GC content bias was still observable after normalising
for fragment length in both the multiple cell type and low cell number DamID-seq
data (compare Figure 3.28 to 3.24 and Figure 3.29 to 3.25). To investigate the exact
relationship between length-normalised read coverage and GC content, a regression
model (i.e. length-normalised coverage predicted from GC content) was fitted to the
DamID-seq data (see Figures 3.30 and 3.31). All of the models again displayed strong
sample-specific non-linear relationships between length-normalised coverage and GC
content (compare Figure 3.30 to 3.26 and Figure 3.31 to 3.27). It is important to note
that although a strong bias was observed in all the datasets, the regression models
appeared to be slightly different to the ones previously calculated. This was expected
given that when the original GC content bias models were calculated, the effect of
restriction fragment length was held constant in the model in order to visualise just
the effect of GC content on read coverage. Ultimately, none of the length-normalised
bias plots showed a reduction in GC content bias suggesting that there is no strong
relationship between regional GC content and methylation level.
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FIGURE 3.28. Graphs of differential methylation by fragment GC content in length-
normalised Oct4 and Sox2 DamID-seq data.
Graphs showing the percentage of differentially methylated fragments binned according to
restriction fragment GC content in length-normalised Oct4 and Sox2 DamID-seq data. Dif-
ferential methylation was tested using limma (FDR < 0.1). Read counts were normalised for
restriction fragment length using conditional quantile normalization from the cqn package
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FIGURE 3.29. Graphs of differential methylation by fragment GC content in low cell num-
ber length-normalised Oct4 DamID-seq data.
Graphs showing the percentage of differentially methylated fragments binned according to
restriction fragment GC content in low cell number length-normalised Oct4 DamID-seq data.
Differential methylation was tested using limma (FDR < 0.1). Read counts were normalised
for restriction fragment length using conditional quantile normalization from the cqn package
(Hansen, Irizarry, and Wu, 2012).
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FIGURE 3.30. Graphs of the fragment GC content effect on methylation in length-
normalised Oct4 and Sox2 DamID-seq data.
Graphs of the estimated fragment GC content effect on length-normalised methylation in Oct4
and Sox2 DamID-seq data from mouse embryonic stem cells (abbreviated ESC), embryonic
fibroblast cells (abbreviated MEF), and neural stem cells (abbreviated NSC). Read counts were
normalised for restriction fragment length using conditional quantile normalization from the
cqn package (Hansen, Irizarry, and Wu, 2012). The X-axis measures the restriction fragment
GC content and the Y-axis measures the fit from the quantile regression model. Specifically, for
each sample a systematic bias function using natural cubic splines can be estimated. For each
value on the x-axis, the y-axis plots the fitted value generated from each of the sample-specific
bias functions. The sample-specific affect of the covariate on read counts can be visualised by
plotting the estimates from the bias functions.
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FIGURE 3.31. Graphs of the fragment GC content effect on methylation in low cell number
length-normalised Oct4 DamID-seq data.
Graphs of the estimated fragment GC content effect on length-normalised methylation in low
cell number Oct4 DamID-seq data from mouse embryonic stem cells (abbreviated ESC). Read
counts were normalised for restriction fragment length using conditional quantile normaliza-
tion from the cqn package (Hansen, Irizarry, and Wu, 2012). The X-axis measures the restric-
tion fragment GC content and the Y-axis measures the fit from the quantile regression model.
Specifically, for each sample a systematic bias function using natural cubic splines can be es-
timated. For each value on the x-axis, the y-axis plots the fitted value generated from each of
the sample-specific bias functions. The sample-specific affect of the covariate on read counts
can be visualised by plotting the estimates from the bias functions.
3.4.9 Dam preferentially binds euchromatin and regulatory regions
One disadvantage of ChIP-seq in comparison to DamID-seq, is that it requires a highly
specific antibody to bind with high affinity to the target protein. Such antibodies can
be difficult or expensive to produce, thus limiting most applications of ChIP-seq to
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proteins with already validated antibodies. Even then, antibodies for the same pro-
tein from multiple manufacturers display different binding characteristics and the ex-
perimental procedure must be specifically adapted. In theory, DamID can be applied
to any protein for which it is possible to engineer a Dam-fusion expression construct,
providing the tether does not interfere with the protein’s function. However, just like
ChIP-seq antibodies, Dam may exhibit its own binding characteristics which restrict
its usefulness to already validated proteins. For example, DNA binding sites in par-
ticular chromatin states may be easily accessible by the target protein, but not by the
Dam protein. If Dam is unable to methylate restriction sites within these chromatin
states, the technology would be unsuitable for a great number of proteins.
To determine the binding characteristics of Dam, a chromatin state model for ESCs
and MEFs was built using histone modification, chromatin accessibility, and Dam se-
quencing data (see Figures 3.32 and 3.33). The model showed Dam was enriched in
multiple states (E3, E4, E14, E15, E16, E17, and E18) associated with chromatin acces-
sibility (ATAC) and multiple histone modifications (H3K4me1, H3K4me2, H3K27ac,
H3K9ac, H3K4me3, and H3K36me3). These typically mark elements that are responsi-
ble for regulating gene expression: H3K4me1 at active and primed enhancers (Local et
al., 2018), H3K4me2 at transcription factor binding regions (Wang, Li, and Hu, 2014),
H3K27ac at active enhancers (Creyghton et al., 2010), H3K9ac at active promoters
(Barski et al., 2007), H3K4me3 at transcribed genes (Liu et al., 2016), and H3K36me3
at nucleosomes (Sims and Reinberg, 2009). Next, the enrichment of each chromatin
state overlapping different genomic features was calculated (see Figure 3.34). Out
of the seven chromatin states which displayed Dam binding, three of these (E3, E15,
and E16) were highly enriched over intergenic regions and the other three (E14, E17,
and E18) were moderately enriched over gene and promoter regions. Interestingly,
3.4. Results 105
only one chromatin state E3 was uniquely bound by Dam, and was enriched over in-
tergenic, repeat and microsatellite regions. This is surprising, given that non-unique
alignments were filtered out of the sequencing data for all downstream analyses. In
theory this would have greatly reduced coverage at regions with a low complexity
and large repeat sequences such as those mentioned previously. It is therefore possi-
ble that the enrichment observed for state E3 over these repeat regions may actually be
underestimated. To establish whether Dam is prevented from methylating restriction
sites in certain chromatin states, the enrichment of each chromatin state around all
restriction sites in the genome was calculated (see Figure 3.35). All chromatin states
except for E3, E4, and E15 were highly enriched, but these were generally unique
to Dam so enrichment at the site itself (where DpnI and DpnII cleave) was expected
to be reduced. Promoter regions tend to be highly occupied given multiple DNA-
binding proteins work together to regulation gene expression. To check if Dam can be
obstructed from methylating restriction sites in promoter regions, the enrichment of
each chromatin state around all transcription start sites in the genome was calculated
(see Figure 3.36). Only chromatin states E17 and E18 (which exhibit a high likelihood
of observing Dam) were enriched suggesting that Dam is able to methylate restriction
sites within promoter regions. Interestingly, chromatin state E4 (which also exhibits a
high likelihood of observing Dam) was enriched around all transcription end sites in
the genome (see Figure 3.37). Together these results indicate that Dam predominantly
binds accessible chromatin, including enhancers and promoters within intergenic and
transcribed regions.























FIGURE 3.32. Tracks of chromatin state annotations produced by ChromHMM.
Tracks of ESC and MEF chromatin state annotations produced by ChromHMM using chro-
matin accessibility, histone modification, and Dam sequencing data. Descriptions of each




































































FIGURE 3.33. Heatmap of chromatin state emissions produced by ChromHMM.
Heatmap of ESC and MEF chromatin state emissions produced by ChromHMM using chro-
matin accessibility, histone modification, and Dam sequencing data. Each row corresponds
to a different chromatin state, and each column corresponds to a different epigenomic mark.
A darker colour corresponds to a greater probability of observing the epigenomic mark in
the chromatin state. All of the sequencing data was re-analysed from public ATAC-seq and
ChIP-seq experiments (Chronis et al., 2017).









































































































































FIGURE 3.34. Heatmap of chromatin state enrichment over genomic features.
Heatmap of ESC and MEF chromatin state enrichment over genomic feature annotations. A
darker colour corresponds to a greater enrichment, and there is a column-specific colour scale















































































































FIGURE 3.35. Heatmap of chromatin state enrichment around GATC sequences.
Heatmap of ESC and MEF chromatin state enrichment 2 kb around GATC sequences. A darker
colour corresponds to a greater enrichment, and there is a column-specific colour scale for the
entire heatmap.













































































































FIGURE 3.36. Heatmap of chromatin state enrichment around TSS sites.
Heatmap of ESC and MEF chromatin state enrichment 2 kb around transcription start sites
(abbreviated TSS). A darker colour corresponds to a greater enrichment, and there is a column-
















































































































FIGURE 3.37. Heatmap of chromatin state enrichment around TES sites.
Heatmap of ESC and MEF chromatin state enrichment 2 kb around transcription end sites
(abbreviated TES). A darker colour corresponds to a greater enrichment, and there is a column-
specific colour scale for the entire heatmap.
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3.4.10 Impact of m6A methylation in mouse embryonic stem cells
In DamID-seq experiments, binding sites are marked by the addition of a methyl
group to the N6 position of adenine (abbreviated m6A) in nearby GATC sequences
using an Escherichia coli DNA adenine methyltransferase. It is therefore required that
cells from the experimental organism lack both an endogenous m6A methyltrans-
ferase and de-methyltransferase. In recent years, m6A methylation has been observed
at very low levels in multiple eukaryotes: Drosophila melanogaster (Zhang et al., 2015),
Caenorhabditis elegans (Greer et al., 2015), Homo sapiens (Xiao et al., 2018), and Mus
musculus (Wu et al., 2016). These reports cast doubt on the utility of DamID-seq in
eukaryotes because DNA may be marked by Dam and the endogenous methyltrans-
ferase, leading to false positive DNA binding sites being identified. In addition, true
positive DNA binding sites may not be identified because methylation is lost by the
as yet unidentified mechanisms that remove endogenous m6A methyltransferase.
To assess the impact of endogenous m6A methylation on DamID-seq data, the m6A
methylome from mouse embryonic stem cells was surveyed (see Figure 3.38). The N6-
methyladenines were identified by single molecule real time sequencing combined
with chromatin immunoprecipitation (SMRT-ChIP) from a published study (Wu et al.,
2016). Compared to all adenines in the mouse genome (~739.08 M), only a small pro-
portion (0.046%) of m6A adenines were located within GATC sequences. Endogenous
m6A methylation at non GATC sequences cannot interfere with the DamID-seq exper-
iment because the restriction enzyme DpnI used to fragment the DNA only recognises
methylated GATC sequences. To check whether the small proportion of endogenous
m6A adenines within GATC sequences affected the levels of methylation measured by
DamID-seq, read coverage from Oct4 DamID-seq data was plotted over Oct4 ChIP-seq
and m6A SMRT-ChIP peak regions (see Figure 3.39). The plots showed that Dam-
Oct4 coverage was consistently higher than Dam at Oct4 binding sites, regardless of
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whether the binding site was in an m6A methylated region. In addition, Dam-Oct4
coverage was very low at regions which did not contain Oct4 binding but were in an
m6A methylated region. In fact, the m6A levels observed here are likely to be even
lower due to non-specific background in DNA immunoprecipitation followed by se-
quencing (DIP-seq) assays, originating primarily due to the intrinsic affinity of IgG for
short unmodified DNA repeats (Lentini et al., 2018). In this specific case, it appears
that the low level of endogenous m6A methylation does not affect the DamID-seq
data. However, more DamID-seq and m6A methylome data from a range of cell types








FIGURE 3.38. Proportion of N6-methyladenines within GATC sequences.
The Euler diagram represents the overlap between three sets of adenines in mouse embry-
onic stem cells: all adenines in the genome (abbreviated A), N6-methyladenines (abbreviated
m6A), and adenines in a GATC sequence (abbreviated GATC). The N6-methyladenines were
identified by single molecule real time sequencing combined with chromatin immunoprecip-
itation (Wu et al., 2016). The diagram highlights the small proportion of N6-methyladenines
within GATC sequences compared to all adenines in the genome.
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FIGURE 3.39. Graphs of Oct4 ESC DamID-seq read coverage at Oct4 and m6A peaks.
Graphs of Oct4 ESC DamID-seq read coverage at Oct4 ChIP-seq (n = 37,925) and m6A (n =
37,581) SMRT-CHIP peaks (Chronis et al., 2017; Wu et al., 2016).
3.5 Discussion
The results from this chapter showed that the accuracy of DamID-seq experiments can
be influenced by differences in the experimental procedure (e.g. polymerase choice
and DpnII digestion) and systematic biases in the sequencing data (e.g. restriction
fragment length and GC content). In addition, it was demonstrated that Dam binds
principally to euchromatin (i.e. loosely packaged DNA) which suggests the sequenc-
ing data could be repurposed to identify DNA accessibility sites. Equally important,
these results have also demonstrated that Dam binding is not influenced by the local
nucleotide composition of restriction sites and that endogenous m6A methylation can
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not be detected in the ESC sequencing data analysed. In summary, these results pro-
vide a comprehensive overview of the factors which influence the quality of DamID-
seq data and highlight the need for rigorous analysis methods to account for the dif-




Identification of transcription factor
binding from DamID-seq data
4.1 Introduction
Gene expression can be regulated by controlling the rate at which DNA is transcribed
into mRNA via the enzyme RNA polymerase. Before transcription occurs, RNA poly-
merase must first bind to the promoter sequence of a gene alongside other necessary
proteins. Transcription factors promote or block the recruitment of RNA polymerase
by binding to cis-regulatory elements which influence the structure of DNA at the pro-
moter making it easier or harder for RNA polymerase to initiate transcription (Latch-
man, 1993). There are approximately 1,500 transcription factors encoded in the mam-
malian genome, all of which define when and where genes are expressed throughout
the development of an organism (Zhou et al., 2017). It is therefore crucial that such
important proteins are studied, and their individual contributions catalogued.
Currently, the most popular method to identify genome-wide DNA binding sites for
transcription factors and other protein is ChIP-seq (Furey, 2012). It has been used ex-
tensively over the last decade to understand the role of transcription factors in gene
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expression, especially during differentiation and reprogramming (Takahashi and Ya-
manaka, 2016). However, conventional ChIP-seq protocols require a clinical grade an-
tibody and a minimum of 107 cells to produce a sufficient DNA yield (Gilfillan et al.,
2012). This limits the application of ChIP-seq to already validated antibodies (expen-
sive and temperamental) and cells grown in vitro under culture (under-represent in
vivo complexity). Although recent advances such as CUT&RUN (Skene and Henikoff,
2017) and high intensity UV ChIP-seq (Steube et al., 2017) have managed to reduce
the number of cells significantly, both of these techniques still require a highly specific
antibody.
The limitations of ChIP-seq can be avoided altogether using DamID-seq because no
antibodies or inefficient enzymes are required to enrich for factor-bound chromatin
and genetic engineering can be used to measure in vivo binding with tissue-specific
promoter driven Dam expression (Marshall et al., 2016). Although DamID-seq has
been used extensively in Drosophila and other model systems, only recently have pro-
tocols for mammalian cells combined with high-throughput sequencing been pub-
lished (Tosti et al., 2018). As a consequence, there has been no inspection of the ac-
curacy and sensitivity of the sequencing data, including proper methods to analyse
differential methylation. This eventually could lead to artefactual results and inap-
propriate conclusions being made which pollute our ideas about transcription factor
binding. Therein lies the impetus to perform a comprehensive assessment of DamID-




The aims of this chapter are to evaluate different normalisation strategies for DamID-
seq data, develop an accurate and sensitive peak calling method for transcription fac-
tor binding, and investigate systematic differences between ChIP-seq and DamID-seq
assays. To accomplish these aims, normalisation strategies were compared with cor-
responding qDamID data from roughly two hundred restriction fragments, a soft-
ware package for the comprehensive analysis of DamID-seq data was developed, and
DamID-seq data of multiple transcription factors (Oct4 and Sox2) from multiple cell
types (ESC and NSC) with multiple cell numbers (106, 104, 103) was compared with a
large collection of corresponding ChIP-seq data from public experiments.
4.3 Attribution
The DamID-seq libraries were generated by Dr Luca Tosti - a previous PhD student in
Prof Keisuke Kaji’s research group - and the sequencing data was analysed by the au-
thor, James Ashmore. The ChIP-seq libraries were generated by the relevant research
groups and the public sequencing data was re-analysed. The qDamID experiments
were performed by the author, under supervision from Prof Keisuke Kaji.
4.4 Results
4.4.1 Analysis of published Oct4 ESC ChIP-seq experiments
In order to determine the accuracy and sensitivity of DamID-seq data, a comprehen-
sive set of transcription factor binding sites for comparative analysis was first re-
quired. There is an exponential wealth of ChIP-seq data in public databases which
can be downloaded and re-analysed for this objective, and additionally the variability
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between experiments can be investigated. A comprehensive search for Oct4 ESC ChIP-
seq data from multiple databases (including ArrayExpress, ENA, ENCODE, GEO, and
SRA) was performed and then manually checked to ensure wild type experimental
conditions were followed. Wild type was defined as any combination of antibody
and cell line without deleterious experimental treatment or genetic modification. Ap-
proximately 32 ChIP-seq experiments met these criteria (see Table 4.1) and the raw
sequencing data was analysed using the same computational pipeline to ensure tech-
nical consistency (see Figure 4.1).
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Reference Condition Cell Strain Antibody Media
Aksoy I (2013) TgSox2-V5 KH2 C57BL/6 x 129/Sv sc-8628 Serum
Ang YS (2011) WT CCE 129S/SvEv-Gpi1 sc-8628 Serum
Buecker C (2014) WT R1 129X1/SvJ x 129S1/Sv sc-8628 2i
Chen X (2008) WT E14TG2a 129P2/Ola sc-8628 Serum
Chronis C (2017) WT v6.5 C57BL/6 x 129S4/SvJae AF1759 Serum
Das PP (2014) GFP shRNA J1 129S4/SvJae sc-8628 Serum
Flynn RA (2016) Non-targeting ASO v6.5 C57BL/6 x 129S4/SvJae sc-8629 Serum
Galonska C 1 (2015) WT KH2 C57BL/6 x 129/Sv sc-8628 2i
Galonska C 2 (2015) WT KH2 C57BL/6 x 129/Sv sc-8628 Serum
Hardison R (2014) WT E14TG2a 129P2/Ola ab19857 Serum
Hu G (2013) Luc shRNA CMTI-1 129S6/SvEvTac ab19857 Serum
Jacinto FV (2015) Scrambled shRNA E14TG2a 129P2/Ola sc-5279 Serum
Jang H (2012) TgOct4-Flag (-Dox) ZHBTc4 129P2/Ola F3165 Serum
Karwacki-Neisius V 1 (2013) WT E14TG2a 129P2/Ola sc-8628 2i
Karwacki-Neisius V 2 (2013) Oct4 (+/-) OKO160 129P2/Ola sc-8628 2i
King HW 1 (2017) TgOct4 (+Dox) ZHBTc4 129P2/Ola C30A3C1 Serum
King HW 2 (2017) TgOct4 (-Dox) ZHBTc4 129P2/Ola C30A3C1 Serum
Krishnakumar R (2016) miR-290/302 v6.5 C57BL/6 x 129S4/SvJae sc-9081 2i
Liu Y 1 (2017) Asynchronous (-H3Ser10p) v6.5 C57BL/6 x 129S4/SvJae sc-8628 Serum
Liu Y 2 (2017) Mitotic (+H3Ser10p) v6.5 C57BL/6 x 129S4/SvJae sc-8628 Serum
Liu Z (2017) WT 129/Sv 129/Sv sc-8628 Serum
Marson A (2008) WT v6.5 C57BL/6 x 129S4/SvJae sc-8628 Serum
Miller A (2016) Mbd3 (+/-) E14TG2a 129P2/Ola sc-8628 2i
Okashita N (2016) WT E14TG2a 129P2/Ola sc-8629 Serum
Shen Z (2017) WT C57BL/6 C57BL/6 sc-8629 2i
Shin J 1 (2016) G1 (-Noc) E14TG2a 129P2/Ola sc-5279 Serum
Shin J 2 (2016) G2/M (+Noc) E14TG2a 129P2/Ola sc-5279 Serum
Tu S (2016) WT KH2 C57BL/6 x 129/Sv sc-5279 2i
Wang L (2014) Non-targeting ASO J1 129S4/SvJae sc-8628 Serum
Whyte WA (2013) WT v6.5 C57BL/6 x 129S4/SvJae sc-8628 Serum
Xu T (2015) WT E14TG2a 129P2/Ola ab19857 Serum
Yang SH (2014) Rex1-GFP E14TG2a 129P2/Ola sc-8628 2i
TABLE 4.1. Collection of published Oct4 ESC ChIP-seq experiments.
This table contains the metadata for 32 published Oct4 ESC ChIP-seq experiments. They were
found by automating queries to the ArrayExpress, ENA, ENCODE, GEO, and SRA biological
sequence databases. Each experiment is referenced using the first author’s last name and year
of publication (see Chapter 2 for a full list of accession numbers).













FIGURE 4.1. Genomic snapshot of published Oct4 ESC ChIP-seq experiments at a repre-
sentative locus (chr4:133,500,000-134,500,000).
The genome browser tracks display the input-subtracted read coverage from published Oct4
ESC ChIP-seq experiments at a representative locus (chr4:133,500,000-134,500,000). Each track
is scaled independently to mitigate large differences in the signal-to-noise ratio from different
experiments. The green and red bars indicate reproducible and variable regions of enrichment,
respectively.
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The quality of the sequencing data was checked using a variety of metrics proposed by
the ENCODE and CISTROME consortia based upon sequence quality, mapping qual-
ity, library complexity, and enrichment of immunoprecipitated chromatin (see Figure
4.2). None of the experiments passed all of the quality control metrics and many un-
derperformed according to library complexity. The library size was still sufficient ac-
cording to previous guidelines for transcription factor binding in mammalian cells,
and enrichment of immunoprecipitated chromatin was generally successful across
most of the experiments. Despite their quality, meaningful biological information has
already been extracted from these experiments so not much consideration was given
to interpreting these results at this stage of the investigation.
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FIGURE 4.2. Quality metrics for published Oct4 ESC ChIP-seq experiments.
The quality of each ChIP-seq experiment was evaluated using quality metrics proposed by the
ENCODE consortia and the CISTROME project. The green and red circles indicate whether
or not an experiment passed the recommended guidelines for transcription-factor ChIP-seq
experiments (Landt et al., 2012). The sequence quality metrics include the average read length
(Length), the total number of reads (Reads), and the average read quality (Quality). The map-
ping quality metrics include the number of mapped reads (Mapped), the number of uniquely
mapped reads (Unique), and the number of uniquely mapped reads after PCR duplicate re-
moval (Usable). The library complexity metrics include the non-redundant fraction (NRF), the
PCR bottleneck coefficient 1 (PBC1), and the PCR bottleneck coefficient 2 (PBC2). The ChIP
enrichment metrics include the normalised-strand cross-correlation (NSC), the relative strand
cross-correlation (RSC), and the fraction of reads in peaks (FRiP).
The similarity between experiments was measured by calculating Spearman’s rank
correlation coefficient on the number of aligned reads within 500 bp windows along
the genome. The correlation coefficients ranged between -0.20 and 0.67 but on aver-
age experiments were only 0.22 correlated (see Figure 4.3). This was concerning as it
implied that the ChIP-seq experiments were not particularly reproducible, however
this result could change substantially based on the size of the window because larger
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windows average out fluctuations whilst smaller ones achieve greater scrutiny. Tran-
scription factor binding sites were detected by comparing the pileup of sequencing
reads along the genome between the immunoprecipitated library and the naked DNA
library in a process otherwise known as peak calling. The number of peaks ranged be-
tween 0 and 95,678 but on average 19,636 were called (see Figure 4.4). The discrepancy
between the number of peak calls was concerning given the experiments were all sup-
posed to be measuring the same biological phenomenon. To identify technical aspects
which may be responsible, regression models were used to evaluate the relationship
between the quality metrics and the number of peak calls (see Figure 4.5). None of the
regression models showed a strong linear relationship, even the number of mapped
reads - a commonly relied upon measure of appraisal for sequencing experiments was
not predicative of the number of peaks called.
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FIGURE 4.3. Spearman correlation of published Oct4 ESC ChIP-seq experiments.
Spearman’s rank correlation coefficient was used to measure the similarity in read coverage
between experiments. The coefficients ranged between -0.20 and 0.67 but on average experi-
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FIGURE 4.4. Number of peaks from published Oct4 ESC ChIP-seq experiments.
Transcription factor binding sites were detected from published Oct4 ESC ChIP-seq experi-
ments by peak calling using MACS2 (FDR < 0.05). The number of peaks ranged between 0
and 95,678 indicating a large variability between experiments.
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Sequence quality Mapping quality Library complexity ChIP enrichment
FIGURE 4.5. Relationship between quality metrics and number of peaks from published
Oct4 ESC ChIP-seq experiments.
The panel of graphs display the relationship between a single quality metric and the number
of peaks called from published Oct4 ESC ChIP-seq experiments. The coloured lines represent
a linear regression model used to evaluate the relationship between the two variables. The
sequence quality metrics include the average read length (Length), the total number of reads
(Reads), and the average read quality (Quality). The mapping quality metrics include the
number of mapped reads (Mapped), the number of uniquely mapped reads (Unique), and
the number of uniquely mapped reads after PCR duplicate removal (Usable). The library
complexity metrics include the non-redundant fraction (NRF), the PCR bottleneck coefficient
1 (PBC1), and the PCR bottleneck coefficient 2 (PBC2). The ChIP enrichment metrics include
the normalised-strand cross-correlation (NSC), the relative strand cross-correlation (RSC), and
the fraction of reads in peaks (FRiP).
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The similarity between experiments was then measured by calculating Jaccard’s sim-
ilarity coefficient based on the size of the intersection and union of peak calls along
the genome. The correlation coefficients ranged between 0 and 0.50 but on average
experiments were only 0.11 correlated (see Figure 4.6). Under the relatively naïve as-
sumption that peaks between experiments should be highly correlated given they are
supposed to be measuring similar binding sites along the genome, this result was sur-
prising. Perhaps a more appropriate null hypothesis for this comparison would be
that the correlation between studies is the same as the correlation between replicates
within a study. However, technical variation between experiments makes the null hy-
pothesis unlikely, therefore the 0.1 correlation reported was relatively unsurprising
given that on average replicates within the same study were only 0.27 correlated. It is
also difficult to assess whether this correlation is surprising given, to the best of our
knowledge, there are few similar comparisons in the literature. The closest examples
either measure reproducibility between replicates within multiple studies (Devailly et
al., 2015) measure correlation across hundreds of datasets in order to pull out general
information regarding the properties of ChIP-seq data (Landt et al., 2012; Liu et al.,
2011). Additionally, engagement of the DNA-binding protein with the genome is an-
other factor which may influence the expected correlation between experiments. For
example, it has been shown that engagement of Oct4 with the genome is dynamic
and context-dependent (i.e. “naïve” versus “ground state” versus “primed” stem cell
states) in early differentiation (Simandi et al., 2016). Overall, this dynamism could
contribute to highly variable binding sites and a low correlation between the ChIP-
seq experiments. The experiments were also significantly clustered (AU ≥ 95) using
multiscale bootstrap resampling into three groups, which was indicative of some un-
observed variable (see Figure 4.7).
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FIGURE 4.6. Jaccard correlation of published Oct4 ESC ChIP-seq experiments.
Jaccard’s correlation coefficient was used to measure the similarity in peak calls between ex-
periments. The correlation coefficients ranged between 0 and 0.50 but on average experiments


















































































































































































































































































































FIGURE 4.7. Bootstrap analysis of Jaccard correlation clustering.
Hierarchical clustering of 32 ChIP-seq experiments using Jaccard’s correlation coefficient. Val-
ues at branches are the approximately unbiased (AU) p-values (left), bootstrap probability
(BP) values (right), and cluster labels (bottom). Clusters with AU ≥ 95 are indicated by the red
rectangles.
It was possible that independent experimental procedures may have contributed to
the clustering pattern, so the similarity between peak calls was cross-referenced against
different experimental variables: First, the media used to culture the cells (serum or 2i)
was inspected because these have been shown to induce distinct expression profiles
known as naïve and ground state pluripotency (Kolodziejczyk et al., 2015). There was
no obvious clustering of the experiments based upon this variable which was surpris-
ing given the experimental evidence which shows naïve and ground state pluripotent
cells have different characteristics (see Figure 4.8).
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FIGURE 4.8. Cell culture media of published Oct4 ESC ChIP-seq experiments.
The cell culture media used in each published Oct4 ESC ChIP-seq experiment is displayed
alongside the heatmap of the Jaccard correlation coefficients.
Second, the cell line used to generate the population was examined because it has
been reported that different lines exhibit varying levels of pluripotency markers (Ginis
et al., 2004). However, no apparent clustering of the experiments based upon this
variable was observed (see Figure 4.9).
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FIGURE 4.9. Cell lines of published Oct4 ESC ChIP-seq experiments.
The cell lines used in each published Oct4 ESC ChIP-seq experiment is displayed alongside
the heatmap of the Jaccard correlation coefficients.
Third, the mouse strain used to generate the cell lines was tested because it has been
demonstrated that different strains require slightly different procedures for the es-
tablish of pluripotency (Kawase et al., 1994). Again, no apparent clustering of the
experiments based upon this variable was observed (see Figure 4.10).
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FIGURE 4.10. Mouse strains of published Oct4 ESC ChIP-seq experiments.
The mouse strains used in each published Oct4 ESC ChIP-seq experiment is displayed along-
side the heatmap of the Jaccard correlation coefficients.
Lastly, the antibody used to immunoprecipitate the chromatin was checked because
it is well known that different antibodies have different binding characteristics that
can bias which binding sites are detected (Jager and Vaegter, 2016). Just as before,
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FIGURE 4.11. ChIP antibodies of published Oct4 ESC ChIP-seq experiments.
The ChIP antibodies used in each published Oct4 ESC ChIP-seq experiment is displayed along-
side the heatmap of the Jaccard correlation coefficients.
The inability to identify a causative variable for the clustering pattern was surprising
and demonstrated that experiments should be carefully cross-validated, particularly
if a novel cell line or antibody is employed. To investigate the differences at a higher
resolution, binding sites which were bound or unbound across all experiments were
visualised (see Figure 4.12). The occupancy map demonstrated that a large number
of sites were either unique or only bound in a small handful of experiments. These
sites would have greatly reduced the correlation coefficients previously calculated and
indicate a high level of variability. Interestingly, a small group of sites near the top and
136 Chapter 4. Identification of transcription factor binding from DamID-seq data
bottom of the map appeared to be bound in just over half of the experiments. These
sites also exhibited high read coverage (see Figure 4.13) and were enriched for the
Oct4 binding motif (see Figure 4.14).
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FIGURE 4.12. Peak occupancy from published Oct4 ESC ChIP-seq experiments.
Sites which are bound or unbound in each ChIP-seq experiment are coloured black and grey,
respectively. Each row of the heatmap represents a peak region within the genome called from
at least one of the analysed ChIP-seq experiments. Each column of the heatmap represents a
single experiment whose ChIP-seq data was analysed. The heatmap shows which peaks were
called across multiple experiments, revealing that a large number of sites are bound in only a
handful of experiments.
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FIGURE 4.13. Peak occupancy and read coverage from published Oct4 ESC ChIP-seq exper-
iments.
Sites which are bound or unbound in each ChIP-seq experiment are coloured by the input-
subtracted read coverage. The heatmap shows that conserved sites exhibit high read coverage,
which indicates strong binding.
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FIGURE 4.14. Peak occupancy and motif enrichment from published Oct4 ESC ChIP-seq
experiments.
Sites which are bound or unbound in each ChIP-seq experiment are coloured by the likelihood
of Oct4 motif enrichment. The heatmap shows that conserved sites exhibit higher Oct4 motif
enrichment than un-conserved sites.
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For the comparison with DamID-seq it was necessary to filter the data to obtain a com-
prehensive yet reliable set of Oct4 binding sites. An unsupervised filtering of the data
was performed by selecting only peaks in greater than a chosen number of experi-
ments. This number was determined by measuring how many peaks were in greater
than 1 to 32 experiments then identifying at which number the rate of change started
to plateau (see Figure 4.15). Although there was no obvious elbow, a distinct rate of
change was visible from five to seven experiments. The optimal number of experi-
ments chosen therefore was six (median value) , leaving approximately 34,891 peaks
for downstream comparison with DamID-seq data (see Figure 4.16). Surprisingly, less
than 5,000 peaks were present in more than 16 experiments which suggested either
that at least half of experiments were of particularly low quality - which was hard to
assess given that all of the usual quality metrics were not informative - or that there
is a substantial amount of inherent variability in the ChIP-seq experimental proce-
dure. It could also be argued that given 79% of sites are not reproducible across the
experiments, then much of the signal underlying these sites may simply be random
noise. However, this is unlikely given that sites are identified by calling significant
peaks against an input sample representing the chromatin background (i.e. random
noise). Regardless, the genes which were associated with the conserved set of peaks
(by nearest TSS to the centre of the peak region) were appropriately enriched for mul-
tiple biological processes and pathways related to pluripotency and the embryonic
stem cell niche (see Figure 4.17).
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FIGURE 4.15. Filtering of peaks from published Oct4 ESC ChIP-seq experiments.
A comprehensive yet reliable set of Oct4 ESC ChIP-seq peaks was selected by first counting
how many peaks were in more than N experiments. The number of peaks in more than 1 to 32
experiments was then plotted and the value of N which occurred before the number of peaks
began to plateau was used.
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FIGURE 4.16. Filtered peak occupancy from published Oct4 ESC ChIP-seq experiments.
Sites which are bound or unbound in each ChIP-seq experiment after filtering for reproducible
peaks are coloured green and grey, respectively. Around 79% of sites were filtered, leaving just
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FIGURE 4.17. Gene ontology and molecular pathway analysis on conserved Oct4 ESC ChIP-
seq peaks.
Gene ontology and molecular pathway analysis was used to profile the binding sites of the
conserved Oct4 ESC ChIP-seq peaks. The peaks were enriched for categories related to
pluripotency and the stem cell niche, which were indicative of the known function of Oct4
in embryonic stem cells.
After filtering, the similarity between experiments was measured again by calculat-
ing Spearman’s rank correlation coefficient on the number of aligned reads within the
34,891 peak regions along the genome. As expected, the range of correlation coeffi-
cients increased up to 0.80, however on average they were still only 0.26 correlated
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(see Figure 4.18). Similar to past observations, the experiments clustered into groups
but neither of these could be explained by cross-referencing with either quality metrics
or experimental variables. Considering that many experiments were on average only
0.21 correlated and that one cluster of experiments negatively correlated with the other
cluster, this suggests that a particular fraction of Oct4 binding sites exhibit great vari-
ability between experiments possibly because they are bound transiently. The tran-
sience of transcription factor binding is well known, given single-molecule tracking
and photobleaching studies have repeatedly shown that the time a factor spends re-
siding at its binding site lasts for only a few seconds (Swift and Coruzzi, 2017). For
example, Chen and colleagues show through live-cell single-molecule imaging experi-
ments that Oct4 and Sox2 spend 98% of their search time sampling non-specific sites in
the nucleus of ES cells before acquiring a cognate binding site (Chen et al., 2014). Tak-
ing into account the molecular concentration of both factors, they further show that
a single Oct4-Sox2 site is sampled roughly every 24 seconds and the residence time
is usually between 12 and 16 seconds. These dynamics are consistent with the slid-
ing and sampling model for transcription factors which has previously been reported,
whereby factors alternate between diffusing and non-specifically sliding along naked
DNA in search for a cognate binding site (Hammar et al., 2012). This model may
explain the variability in ChIP-seq experiments given cross-linking produces a snap-
shot of binding at the moment of fixation, capturing some fraction of specific binding
and non-specific sliding. Filtering sites by some measure of binding strength, such
as fraction of reads in peaks, is also unlikely to select specific binding as residence
time appears to be unrelated to the strength of binding (Swift and Coruzzi, 2017).
To uncover the reason behind the two clusters of ChIP-seq experiments, additional
information such as chromatin accessibility and conformation plus gene expression
from the same studies (which unfortunately is unavailable in almost all cases) would
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have to be integrated to better define these high variability binding sites as either gen-
uine regulatory elements with biological influence or simply non-specific yet strongly
bound interactions.
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Spearman                                
FIGURE 4.18. Spearman correlation heatmap of Oct4 ESC ChIP-seq experiments.
Spearman’s rank correlation coefficient was used to measure the similarity in read coverage
inside peak regions between experiments. The coefficients ranged between -0.30 and 0.80 but
on average experiments were only 0.26 correlated.
Overall, these results were surprising for a number of reasons: none of the commonly
used quality metrics were able to explain the disparity in the number of peak calls; the
correlation between experiments was consistently low even though they were sup-
posed to be measuring the same biological phenomenon, and many of the peaks called
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were unique to only a handful of experiments which also could not be explained by
any experimental variables reported. Despite these concerns, a comprehensive yet re-
producible set of 34,891 binding sites were identified which exhibited high read cov-
erage, Oct4 motif enrichment, and were implicated in relevant biological process and
molecular pathways. This set of peaks was used to measure the accuracy and sensitiv-
ity of transcription factor binding site identification using Oct4 ESC DamID-seq data
from a range of cell numbers.
4.4.2 Identification of binding sites from DamID-seq data
Having generated a comprehensive yet reliable set of Oct4 binding sites from ChIP-
seq data, a method to identify binding sites from DamID-seq data was then developed.
The analysis of most quantitative sequencing experiments involves aligning reads to
the genome, counting reads within genomic features, and comparing the means be-
tween conditions. The read counts usually undergo pre-processing to remove tech-
nical biases and make the comparison between conditions more accurate and fairer.
For example, if the number of reads sequenced in one condition is twice as much as
the other condition, the read counts from the former would on average be double
those from the latter. Comparing the means would therefore be inaccurate because
technical variation is misinterpreted as biological variation. In this case, simply di-
viding by the total number of reads can remove this discrepancy. There are however
many other sources of technical variation which need to be considered, and a range of
normalisation strategies for between and within sample comparisons have been de-
veloped for sequence count data (Aleksic, Carl, and Frye, 2014). Read counts can be
normalised with respect to library size (counts per million), to the length of the feature
(reads per kilobase per million and transcripts per million), and to library composition
(Trimmed mean of M-values, relative log expression, and upper quartile) (Li et al.,
2015). Each of these normalisations assume a statistical property about the data which
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must be carefully checked to ensure the transformed counts accurately reflect the bi-
ology. Unfortunately, when novel technologies are developed it is sometimes unclear
what assumptions are appropriate and instead additional evidence to help decide can
be generated.
In order to evaluate appropriate normalisation strategies for DamID-seq data, a refer-
ence standard was generated using corresponding qDamID data of roughly two hun-
dred restriction fragments (see Figure 4.19). To generate Dam/Dam-Oct4 fold change
values, qDamID experiments were performed on both Dam and Dam-Oct4 express-
ing cells with and without DpnII digestion. For each restriction fragment, the level of
methylation in the Dam and Dam-Oct4 expressing cells was calculated by measuring
the difference in cycle threshold values between the DpnII digested and undigested
samples. The Dam/Dam-Oct4 fold changes values for each restriction fragment were
then calculated based on the ratio of the DpnII values previously calculated. The
restriction fragments were chosen based on DamID-seq data to generate the largest
range of fold-change values at multiple levels of methylation. The qDamID fold-
change values were then compared to Oct4 ESC DamID-seq fold-change values gen-
erated after applying different normalisations to the restriction fragment read counts
(see Figure 4.20). Surprisingly, the correlation plots showed very little difference be-
tween different normalisations and in some cases, for example transcripts per million
(TPM) and the geometric mean implemented in DESeq2 (DE), the indicated correla-
tion coefficient did not accurately represent the relationship observed. For example,
the pattern observed in the DE panel shows almost no relationship even though the
calculated correlation coefficient is similar to the other panels, which tend to show a
more linear relationship as expected. This outcome can occur due to single outliers in
the data, as effectively shown by Anscombe’s quartet - a dataset comprising of four
different sets all of which have the same descriptivie statistics but ultimately show
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very different patterns when plotted. One explanation for these results is that DamID-
seq data may not require a specialised normalisation, and instead simply scaling by
library size is sufficient to measure differential methylation. A more convincing ex-
planation is that the number of restriction fragments assayed (i.e. 192 out of a possible
6,684,545 in the mouse genome) was too few to demonstrate any effect size between
different normalisations. Overall, the results from the qDamID data were difficult to
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FIGURE 4.19. Mean-difference plot of restriction fragments assayed by qDamID.
Plot shows the average methylation and fold change for each restriction fragment from Oct4
ESC DamID-seq data. The red crosses indicate the location of 192 restriction fragments assayed
for the qDamID experiment. Restriction fragments were chosen to achieve the largest range of
fold change values across multiple levels of methylation.













































































FIGURE 4.20. Correlation between qDamID and DamID-seq fold change values using dif-
ferent normalisations.
Graphs show the correlation between fold change values for 192 restriction fragments mea-
sured using qDamID and DamID-seq after applying different normalisations to the read
counts. The normalisations evaluated are raw read count (RC), counts per million (CPM),
reads per kilobase per million (RPKM), transcripts per million (TPM), trimmed mean of M-
values (TMM), DESeq2 (DE), relative log expression (RLE), upper quartile (UQ), and quantile
(Q). The relationship between fold change values was calculated using Pearson’s correlation
coefficient, which is indicated in the bottom right hand corner of each graph. A two-sided
t-test was used to measure the signifiance of the relationship. The P value tests the null hy-
pothesis that there is no correlation between DamID-seq and qDamID fold change values. The
two-tailed P value answers the question, if the null hypothesis were true, what is the chance
that 192 randomly picked restriction fragments would have an r value greater or less than the
one reported.
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Many normalisations assume that only a minority of features are significantly differ-
ent between the conditions being compared. These types of normalisation are referred
to as global adjustment methods because they assume that any global variability be-
tween conditions is due to technical variation and should be removed. However, if
a substantial number of features are different then these normalisations would be in-
appropriate and have been shown to remove genuine differences between the condi-
tions (Hicks and Irizarry, 2015). To check whether global adjustment methods were
appropriate for DamID-seq data, the distribution of read counts between Dam and
Dam-Oct4 samples were compared (see Figure 4.21). The density plots showed that
the Dam and Dam-Oct4 samples were globally quite different, particularly at lower
cell numbers. The Dam-Oct4 libraries also tended to generate a longer tail at higher
read counts which was indicative of genuine binding. This pattern was also observed
using a different transcription factor and cell line with Sox2 NSC DamID-seq experi-
ments (see Figure 4.22).
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Oct4 ESC DamID-seq (Counts per million)
FIGURE 4.21. Distribution of read counts from Oct4 ESC DamID-seq data.
The panel of graphs show the distribution of restriction fragment read counts for Dam and
Dam-Oct4 samples from DamID-seq experiments using a range of cell numbers. The read
counts were normalised using log2 counts per million. The distributions show global differ-
ences between the Dam and Dam-Oct4 samples which indicate that global adjustment meth-
ods are inappropriate for normalisation.
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Sox2 NSC DamID-seq (Counts per million)
FIGURE 4.22. Distribution of read counts from Sox2 NSC DamID-seq data.
The panel of graphs show the distribution of restriction fragment read counts for Dam and
Dam-Oct4 samples from multiple DamID-seq experiments using a range of cell numbers. The
read counts were normalised using log2 counts per million. The distributions show global
differences between the Dam and Dam-Oct4 samples which indicate that global adjustment
methods are inappropriate for normalisation.
To confirm these observations a statistical test called Quantro used to detect signifi-
cantly global differences in the read count distributions between the Dam and Dam-
Oct4 samples (see Figure 4.23). The test measures whether the median of the distri-
butions are different across groups, then permutes the data to assess how likely by
chance this difference would have occurred (Hicks and Irizarry, 2015). The test statis-
tics were significant using 1,000 permutations which indicated that there were statisti-
cally significant global differences in the distribution of read counts between the Dam
and Dam-Oct4 samples, therefore global adjustment methods should be avoided. This
result was also repeated using the Sox2 NSC DamID-seq data 4.24.
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FIGURE 4.23. Quantro test statistics for Oct4 ESC DamID-seq data.
The test statistic Quantro was used to test for global differences between and within the distri-
butions of Dam and Dam-Oct4 read counts. Each graph contains a histogram of the null test
statistics from sample permutations (B = 1,000). The red line is the observed test statistic.
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FIGURE 4.24. Quantro test statistics for Sox2 NSC DamID-seq data.
The test statistic Quantro was used to test for global differences between and within the distri-
butions of Dam and Dam-Sox2 read counts. Each graph contains a histogram of the null test
statistics from sample permutations (B = 1,000). The red line is the observed test statistic.
A recently proposed method called smooth quantile normalisation – a generalization
of quantile normalisation - was specifically developed to address this type of scenario
(Hicks et al., 2018). It normalises the data so that samples within a condition have the
same distribution, but the distribution between conditions can still globally differ. To
examine the effect of this normalisation on the DamID-seq data, the distribution of
the normalised read counts were examined (see Figure 4.25). As expected the global
differences between the Dam and Dam-Oct4 samples were retained and in some cases
became more pronounced. At moderate to higher levels of methylation, the read count
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distributions from the Dam and Dam-Oct4 samples were perfectly overlapping within
each condition, which suggested all technical variation had been removed. The read
counts at the lower levels of methylation however became more variable, but this
was of less concern because low counts are already variable due to random sampling
(Anders and Huber, 2010). Again, the same effects were observed in the Sox2 NSC
DamID-seq data (see Figure 4.26). The impact of normalisation was then visualised
on a genome-wide scale by plotting raw and processed coverage tracks at restriction
fragment resolution (see Figures 4.27 and 4.28). The raw coverage tracks (normalised
using reads per million to account for sequencing depth) show large variation be-
tween fragments due to differences in length and GC content. However, the processed
coverage tracks (using conditional quantile modelling to remove fragment biases and
smooth quantile normalisation to retain global differences in methylation) exhibit a
flatter distribution showing that this variation is greatly reduced. This reduction al-
lows any downstream peak regions to be correctly ranked because their coverage is no
longer associated with factors unrelated to the location of the DNA-binding site of the
Dam-fusion protein. Additionally, the processed coverage tracks show less variation
between replicate samples allowing previously highly variable restriction fragments
to be identified as significantly differentially methylated regions.
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Oct4 ESC DamID-seq (Smooth Quantile)
FIGURE 4.25. Distribution of smooth quantile normalised read counts from Oct4 ESC
DamID-seq data.
The graphs show the distribution of restriction fragment read counts for Dam and Dam-Oct4
samples from multiple DamID-seq experiments using a range of cell numbers. The read counts
were normalised using smooth quantile normalisation. The distributions show that technical
variation between replicates is removed, but global differences between the Dam and Dam-
Oct4 samples are retained.
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Sox2 NSC DamID-seq (Smooth quantile)
FIGURE 4.26. Distribution of smooth quantile normalised read counts from Sox2 NSC
DamID-seq data.
The graphs show the distribution of restriction fragment read counts for Dam and Dam-Sox2
samples from multiple DamID-seq experiments using a range of cell numbers. The read counts
were normalised using smooth quantile normalisation. The distributions show that technical
variation between replicates is removed, but global differences between the Dam and Dam-
Sox2 samples are retained.
4.4. Results 159
Dam ESC 106 Rep1
Dam ESC 106 Rep2
Oct4 ESC 106 Rep1
Oct4 ESC 106 Rep2
Dam ESC 104 Rep1
Dam ESC 104 Rep2
Oct4 ESC 104 Rep1
Oct4 ESC 104 Rep2
Dam ESC 103 Rep1
Dam ESC 103 Rep2
Oct4 ESC 103 Rep1
Oct4 ESC 103 Rep2
Dam ESC 102 Rep1
Dam ESC 102 Rep2
Oct4 ESC 102 Rep1
Oct4 ESC 102 Rep2
FIGURE 4.27. Genomic snapshot of Oct4 ESC DamID-seq data before and after normalisa-
tion.
Genome browser tracks show Oct4 ESC DamID-seq data before and after normalisation: The
’before’ tracks (coloured in black) were transformed using a simple reads per million normali-
sation (RPM) to account for differences in library size. The ’after’ tracks were first transformed
using conditional quantile modelling (CQ) to remove fragment length and GC content biases,
and then transformed using smooth quantile normalisation (SQ) to retain differences in the
global methylation patterns between the Dam-Oct4 (coloured in green) and Dam (coloured in
red) samples.
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FIGURE 4.28. Genomic snapshot of Sox2 NSC DamID-seq data before and after normalisa-
tion.
Genome browser tracks show Sox2 NSC DamID-seq data before and after normalisation: The
’before’ tracks (coloured in black) are transformed using a simple reads per million normali-
sation (RPM) to account for differences in library size. The ’after’ tracks are first transformed
using conditional quantile modelling (CQ) to remove fragment length and GC content biases,
and then transformed using smooth quantile normalisation (SQ) to retain differences in the
global methylation patterns between the Dam-Sox2 (coloured in green) and Dam (coloured in
red) samples.
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Having established a suitable normalisation strategy, differential methylation analy-
sis between the Dam and Dam-fusion samples using linear modelling and empirical
Bayes methods from the limma package was performed (Ritchie et al., 2015). An im-
portant feature of these methods are that they share information between features in
order to better model the mean-variance trend in the sequence count data. The vari-
ance across all samples is typically used to estimate this trend because it is assumed
that dispersion is similar between conditions. To check whether this assumption holds
for DamID-seq data the similarity between Dam and Dam-fusion replicates in both
Oct4 ESC and Sox2 NSC DamID-seq data was examined (see Figures 4.29 and 4.30).
Multidimensional scaling plots revealed that the Dam-fusion samples were consis-
tently more variable than the Dam samples, which indicated that dispersion should
be modelled for each group independently. This was achieved by proving group infor-
mation to the array weights function in the limma package. After differential methy-
lation analysis, restriction fragments within 1 kb of each other were then stitched to-
gether and a Fisher’s combined P value and multiple testing corrected P value were
calculated (Lun and Smyth, 2016). Only regions with a significant positive fold change
above zero (i.e. higher in the Dam-fusion samples) were retained.
The observation that Dam and Dam-fusion proteins exhibit significantly different methy-
lation distributions reflects the fact that Dam methylation is observed across the en-
tirety of the genome whilst Dam-fusion methylation is primarily at the DNA-binding
sites of the target protein. These differences are in agreement with the theory behind
the methodology of the DamID technology, whereby we expect the Dam-fusion pro-
tein to be localised to the target sites and less often at non-target sites where Dam is
regularly situated. It is therefore very important that any normalisation procedure
used retains this key biological feature of the sequencing data to ensure peak calling
accuracy. Surprisingly, the DamID-seq analysis pipeline produced by Marshall and
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colleagues (introduced in Subsection 2.2.7) attempts to normalise away this inher-
ent biological difference by transforming the data so that the log2 methylation ratio
(Dam-fusion/Dam) across the majority of restriction fragments in the genome is ex-
actly zero (i.e. the level of methylation across non-target sites is forced to be exactly
the same in both the Dam and Dam-fusion proteins). Specifically, they calculate the
kernel density distribution of log2 methylation ratios across the 40% to 90% deciles
(the first free deciles are removed because they generate inconsistent normalisation
factors and the last decile is removed because it is thought to contain genuine bind-
ing) and then calculate a numerical constant to transform the data such that the point
of maximum kernel density of the log2 methylation ratios (Dam-fusion/Dam) is ex-
actly zero. Theoretically, this procedure is unsuitable for DamID-seq data for a few
reasons: First, it is likely to normalise away binding which does not occur in the high-
est decile by methylation. This is also problematic because a hard threshold does not
accommodate proteins with different DNA-binding dynamics, such as lamin-binding
and transcription factors, which markedly differ in their size and distribution along
the genome. Second, by over-estimating the level of background noise (i.e. assuming
everything below the last decile does not contain binding) the normalization factors
will exaggerate the Dam-fusion signal which occurs in the last decile by methylation.
While this may produce a cleaner visualization over genuine DNA-binding sites, it
also will create peaks over non-target sites which are highly methylated in both the
Dam and Dam-fusion proteins. Third, it is unclear how such a normalization proce-
dure would accurately take into account information from multiple replicates given
the ratios are calculated based on a pair of single replicate samples and not multiple
replicate samples. The result of this single replicate normalization factor would be that
the coverage values would not be comparable between multiple replicates processed
separately by the pipeline, instead all of sequencing data would have to be merged
first which removes any advantage of performing replicate experiments to measure
4.4. Results 163
variability. Additionally, as both technical and biological variability increases with
fewer cells it becomes more important to normalise and model the replicates together
























































































FIGURE 4.29. Multidimensional scaling analysis of Oct4 ESC DamID-seq data.
Multidimensional scaling was used to evaluate the distance between and within Dam and
Dam-Oct4 sample groups. The plots show that the Dam-Oct4 samples are much more variable
then the Dam samples, even at lower cell numbers. This difference is accounted for in the
linear modelling strategy by providing group information to the array weights function in the
limma package (Ritchie et al., 2015).





































































FIGURE 4.30. Multidimensional scaling analysis of Sox2 NSC DamID-seq data.
Multidimensional scaling was used to evaluate the distance between and within Dam and
Dam-Sox2 sample groups. The plots show that the Dam-Oct4 samples are much more variable
then the Dam samples, even at lower cell numbers. This difference is accounted for in the
linear modelling strategy by providing group information to the array weights function in the
limma package (Ritchie et al., 2015).
4.4.3 Comparison of binding sites from DamID-seq and ChIP-seq data
In order to evaluate the DamID-seq peak calling strategy, a comparison of Oct4 ESC
binding sites identified from DamID-seq data and the previously analysed ChIP-seq
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data was performed. The DamID-seq data was generated using 106, 104, and 103 cells
whilst the public ChIP-seq data was generated using a minimum of 107 cells. Three
ChIP-seq experiments with the highest numbers of peaks were used for visual and
quantitative comparison with the DamID-seq data. For easier comprehension, differ-
ent groups of overlapping and unique peaks were enumerated: Set 1 refers to peaks
in DamID-seq and both the filtered and unfiltered ChIP-seq; Set 2 refers to peaks in
DamID-seq and the unfiltered ChIP-seq; Set 3 refers to peaks in the filtered ChIP-seq
only; Set 4 refers to peaks in DamID-seq only; and Set 5 refers to peaks in the unfiltered
ChIP-seq only.
Genome browser images showed that DamID-seq and ChIP-seq reads accumulated at
similar positions and the pileup of DamID-seq reads at predicted binding sites was
reassuringly higher in the Dam-Oct4 library compared to the control Dam library (see
Figure 4.31). The location of the DamID-seq and ChIP-seq peak calls was also compa-
rable despite being called using different algorithms, this suggested that the DamID-
seq peak calling strategy was suitable and that further investigation of the binding
sites was justified. One noticeable difference however was that DamID-seq peak calls
were much larger (ranging from 103 to 104 bp) than the ChIP-seq peak calls (ranging
from 102 to 103 bp) which unfortunately lowers the resolution (see Figure 4.32). This
is because DamID-seq peaks are limited by the size of the restriction fragments, un-
like ChIP-seq which typically uses small overlapping windows to identify enrichment
(Zhang et al., 2008).
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FIGURE 4.31. Genomic snapshot of Oct4 ESC DamID-seq and ChIP-seq peak calls.
Genome browser tracks show good agreement between Oct4 ESC DamID-seq and ChIP-seq
read coverage and peak calls. As expected, the signal from the Dam-Oct4 samples are higher














FIGURE 4.32. Distribution of peak sizes from Oct4 ESC DamID-seq and ChIP-seq data.
The distribution of peak sizes indicate that DamID-seq is a lower resolution assay than ChIP-
seq. This is because DamID-seq peaks are called using restriction fragments, rather than small
overlapping windows typically used in ChIP-seq algorithms (Zhang et al., 2008).
Approximately 72% of the DamID-seq peaks called using 106 cells overlapped with
23% of the unfiltered ChIP-seq peaks (Sets 1 and 2) identified from the published ex-
periments analysed previously (see Figure 4.33). However, the latter percentage in-
creased to 40% when the filtered set of ChIP-seq peaks (Set 1) was compared, which
demonstrated that DamID-seq was able to identify a substantial proportion of repro-
ducible binding sites despite using a tenth of the cells. The pileup of aligned reads also
demonstrated that many of the overlapping peaks (Set 1) were strongly bound in both
the DamID-seq and ChIP-seq experiments (see Figure 4.34). Nonetheless, there was a
unique set of strongly bound ChIP-seq peaks (Set 3) which were not bound at all in
the DamID-seq experiments that indicated a significant difference between the two as-
says. Histone modification and chromatin accessibility data revealed that DamID-seq
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peaks which overlapped with the filtered set of ChIP-seq peaks (Set 1) were in highly
accessible chromatin containing H3K4me1, H3K4me2, and H3K27ac modifications,
indicative of enhancer and transcription factor binding regions (see Figure 4.35). In-
terestingly, peaks which were unique to ChIP-seq (Set 3) were also in highly accessible
chromatin but contained H3K4me2, H3K4me3, and H3K9ac modifications. This com-
bination of epigenetic marks suggested that DamID-seq was less able to detect binding
sites within the promoters of actively transcribed genes. The annotation of peaks to ge-
nomic features additionally demonstrated that 35% of the ChIP-seq specific peaks (Set
1) were located within promoters, compared to less than 5% of the DamID-seq specific
peaks (Set 4) (see Figure 4.37). One explanation for this deficiency is that Dam may
be unable to methylate chromatin which is highly occupied by other DNA-binding
proteins, particularly the RNA polymerase II complex. However, both ChIP-seq and
DamID-seq are able to detect binding in enhancers, which are also highly occupied
and often bound by RNA polymerase II complex. It has been shown in Drosophila that
the frequency of GATC sites within promoter regions is decreased compared to the
surrounding genomic regions, therefore it follows that methylation will be absent or
reduced (Aughey et al., 2018). This depletion of GATC sites in promoter regions is also
observed in the mouse genome (see Figure 4.36) and may explain why fewer binding
sites were detected at promoters using DamID-seq data. Following peak annotation to
the nearest TSS (using annotatePeaks from Homer), gene ontology and pathway anal-
yses demonstrated that DamID-seq and ChIP-seq peaks were largely enriched for the
same categories, including regulation of pluripotency, embryonic development, and



















FIGURE 4.33. Comparison of Oct4 ESC peaks between DamID-seq and ChIP-seq data.
The Euler diagram represents the overlap between Oct4 ESC peaks from DamID-seq and ChIP-
seq data. The filtered ChIP-seq peaks were derived from the overlap between multiple pub-
lished experiments, as described previously. For easier comprehension, different groups of
overlapping and unique peaks were enumerated: Set 1 refers to peaks in DamID-seq and both
the filtered and unfiltered ChIP-seq; Set 2 refers to peaks in DamID-seq and the unfiltered
ChIP-seq; Set 3 refers to peaks in the filtered ChIP-seq only; Set 4 refers to peaks in DamID-seq
only; and Set 5 refers to peaks in the unfiltered ChIP-seq only.
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FIGURE 4.34. Read coverage at Oct4 ESC peaks from DamID-seq and ChIP-seq data.
The heatmap shows the pileup of aligned reads at overlapping and unique Oct4 ESC peaks
identified from DamID-seq and ChIP-seq data. Each set of peaks relates to the sets found in



























































FIGURE 4.35. Chromatin accessibility and histone modification at Oct4 ESC peaks from
DamID-seq and ChIP-seq data.
The heatmap shows the chromatin accessibility and histone modifications present overlapping
and unique Oct4 ESC peaks from DamID-seq and ChIP-seq data. Each set of peaks relates to
the sets found in the corresponding Euler diagram (see Figure 4.33).
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FIGURE 4.36. Fold enrichment of GATC sites at promoter regions.
Fold enrichment of GATC sites around transcriptional start sites (TSS). For each position
around the TSS, fold enrichment is calculated as the number of GATC sites divided by the
number of transcripts measured. Promoter regions have a depletion of GATC sequences.
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FIGURE 4.37. Annotation of overlapping and unique Oct4 ESC DamID-seq and ChIP-seq
peaks.
Genomic annotation of overlapping and unique Oct4 ESC DamID-seq and ChIP-seq peaks
as promoter, downstream of gene end, 5’ untranslated region, 3’ untranslated region, exon,
intron, or intergenic. Each set of peaks relates to the sets found in the corresponding Euler
diagram (see Figure 4.33).
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KEGG Pathway Enrichment Analysis
FIGURE 4.38. Ontology and pathway analysis of Oct4 ESC ChIP-seq and DamID-seq bind-
ing sites.
Gene ontology analysis of overlapping and unique Oct4 ESC ChIP-seq and DamID-seq peaks.
The colour of the points in the graph reflect the enrichment significance of each category. The
size of the points in the graph reflect the number of peak genes which were assigned to the
relevant category.
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One of the advantages of DamID-seq is the ability to generate a sufficient DNA yield
from much lower cell numbers than conventional ChIP-seq experiments. Approxi-
mately 7,190 Oct4 ESC binding sites could still be detected using only 103 cells, which
is remarkable given this number is ten thousandths that of a conventional ChIP-seq
experiment (see Figure 4.39). Importantly, the peaks called using lower cell numbers
formed almost an entire subset of those called using higher cell numbers and many
of them contained a high number of reads which indicated that at lower cell numbers
only the strongest binding sites were detected. Overall these results indicated that the
DamID-seq peak calling strategy was effective and allowed the identification of bind-
ing sites from fewer cell numbers. Additionally, differences between DamID-seq and
ChIP-seq peaks indicated that DamID-seq is less sensitive at promoter regions.
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FIGURE 4.39. Comparison of Oct4 ESC peaks from low cell number DamID-seq experi-
ments.
The Euler diagram on the left hand side represents the overlap between DamID-seq peaks
from ESC experiments performed using 106, 104, and 103 cells. The heatmap on the right hand
side displays DamID-seq read coverage at the corresponding set of peaks.
To confirm the observations about DamID-seq data and further evaluate the peak call-
ing strategy, a comparison of Sox2 NSC binding sites identified from DamID-seq and
three public ChIP-seq data sets was also performed. Importantly, this comparison
used a different transcription factor and cell line so observations common to both
DamID-seq analyses were reinforced. The DamID-seq data was again generated using
106, 104, and 103 cells whilst the public ChIP-seq data was generated using a minimum
of 107 cells. Approximately 12,417 binding sites from a total of 46,027 sites were de-
tected in all three ChIP-seq experiments (see Figure 4.40). Additionally, overlapping
peaks were highly covered by reads which demonstrated that these sites were strongly
bound and hence reproducible. Genome browser images showed a similar pileup of
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DamID-seq and ChIP-seq reads at predicted binding sites, and the DamID-seq peak
calls were located appropriately under regions methylated higher in the Dam-Sox2
library than the control Dam library (see Figure 4.41). Approximately 55% of DamID-
seq peaks called using 106 cells overlapped with 28% of the ChIP-seq peaks identi-
fied from the three public experiments analysed (see Figure 4.42). This latter percent-
age increased to over 42% when the overlapping ChIP-seq peaks were compared, this
number was very similar to the corresponding percentage from the Oct4 ESC analy-
ses which suggested that around 60% of ChIP-seq peaks may never be detected using
DamID-seq due to an unknown technical difference between the assays. One such ex-
planation may be the existence of high-occupancy target regions in the genome which
have recently been shown to generate reproducible but meaningless enrichment of
proteins at highly expressed genes in ChIP-seq experiments (Wreczycka et al., 2017).
Nonetheless, DamID-seq peaks which overlapped with ChIP-seq peaks exhibited high
read coverage which indicated that reproducible and strong binding sites can be iden-
tified by increasing the peak calling threshold. The annotation of peaks to genomic
features demonstrated that over 20% of ChIP-seq specific peaks were located at pro-
moters, almost double the number of DamID-seq specific peaks. Additionally, both
DamID-seq and ChIP-seq peaks were enriched for neuronal gene ontology categories
and pathways including axon development, gliogenesis, and forebrain development
(see Figure 4.45). Lastly, 2,387 binding sites could be detected using only 103 cells and
these DamID-seq peaks also contained a high number of reads which again indicated
that at lower cell numbers only the strongest bindings sites were detected. Having
confirmed that the peak calling strategy was suitable and that the observations about
DamID-seq and ChIP-seq peaks were reproducible across two different transcription
factors and cell lines, a software package to enable the accurate and reproducible anal-
ysis of DamID-seq data was then developed.
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FIGURE 4.40. Comparison of Sox2 NSC peaks from published ChIP-seq experiments.
The Euler diagram on the left hand side represents the overlap between Sox2 NSC peaks from
three published ChIP-seq experiments. The heatmap on the right hand side displays read
coverage at the peaks from the same ChIP-seq data.
4.4. Results 179
Sox2 NSC 106 (DamID)
Dam NSC 106 (DamID)
Sox2 NSC 104 (DamID)
Dam NSC 104 (DamID)
Sox2 NSC 103 (DamID)

















FIGURE 4.41. Genomic snapshot of Sox2 NSC DamID-seq and ChIP-seq peak calls.
Genome browser tracks show good agreement between Sox2 NSC DamID-seq and ChIP-seq
read coverage and peak calls. As expected, the signal from the Dam-Oct4 libraries are higher
than the Dam libraries at predicted transcription-factor binding sites.


















FIGURE 4.42. Comparison of Sox2 NSC peaks between DamID-seq and ChIP-seq data.
The Euler diagram represents the overlap between Sox2 NSC peaks from DamID-seq and
ChIP-seq data. The filtered ChIP-seq peaks were derived from the overlap between multiple
published experiments, as described previously.
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FIGURE 4.43. Read coverage at Sox2 NSC peaks from DamID-seq and ChIP-seq data.
The heatmap shows the pileup of aligned reads at overlapping and unique Sox2 NSC peaks
identified from DamID-seq and ChIP-seq data. Each set of peaks relates to the sets found in
the corresponding Euler diagram (see Figure 4.42)
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FIGURE 4.44. Annotation of overlapping and unique Sox2 NSC peaks from DamID-seq
and ChIP-seq experiments.
Genomic annotation of Sox2 NSC DamID-seq and ChIP-seq peaks as promoter, downstream
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KEGG Pathway Enrichment Analysis
FIGURE 4.45. Ontology and pathway analysis of Sox2 NSC ChIP-seq and DamID-seq bind-
ing sites.
Gene ontology analysis of the genes assigned to the top 1,000 overlapping and unique Sox2
NSC ChIP-seq and DamID-seq peaks. The colour of the points in the graph reflect the enrich-
ment significance of each category. The size of the points in the graph reflect the number of
peak genes which were assigned to the relevant category.
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FIGURE 4.46. Comparison of Sox2 NSC peaks from low cell number DamID-seq experi-
ments.
The Euler diagram on the left hand side represents the overlap between DamID-seq peaks
from ESC experiments performed using 106, 104, and 103 cells. The heatmap on the right hand
side displays read coverage at the peaks from the same DamID-seq data.
4.4.4 The Daim package for analysis of DamID-seq data
In order to analyse DamID-seq experiments in a reproducible and convenient man-
ner, an R/Bioconductor package which handles quantification, pre-processing, and
peak calling of the sequencing data was developed (see Figure 4.47). The Daim pack-
age offers a workflow to identify chromatin accessibility (discussed in Chapter 5) and
transcription-factor binding sites from replicated DamID-seq data which has been
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aligned to the genome. The package is based around the RangedSummarizedExper-
iment object and all functions are capable of interacting with different slots of the
object, so no additional extraction of the data by the user is required. The package re-
lies on multiple Bioconductor packages, most important of these is the limma package
which provides the core functionality for differential testing using linear modelling
and Bayes methods (Ritchie et al., 2015). In reference to the name of the package. Al-
though it is spelled "Daim", it is actually pronounced "Dime", named after the choco-
late brand. At the time of writing, there is no Bioconductor or CRAN package called
Daim, however there is a ChIP-seq package called DIME (Taslim, Huang, and Lin,
2011). Given that packages should ideally have unique spelling names, I felt it was
better to use an alternative yet unique spelling for the Daim package.
































FIGURE 4.47. Overview of the Daim workflow for analysis of DamID-seq data.
The Daim package provides functions for the analysis, interpretation, and visualisation of
DamID-seq data. It is primarily used to identify transcription-factor binding and chromatin
accessibility sites from DamID-seq experiments.
The workflow begins with the fragmentCounts function which quantifies the level of
Dam and Dam-fusion methylation by counting the number of reads aligned to DpnI
restriction fragments. Notably, restriction fragments can be generated using either a
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custom sequence file in FASTA format or one of the many BSgenome packages al-
ready available from the Bioconductor consortium. After the reads are counted, qual-
ity control plots and genome browser tracks can be immediately generated to decide
whether the experiment was successful (see Figure 4.48). The plotComplexity function
displays the number of restriction fragments which have been sequenced at different
library sizes to decide whether more sequencing is required. The plotPCA and plot-
MDS functions can also be used to perform principal component analysis and multi-
dimensional scaling on the read counts to measure the similarity between biological
replicates. Additionally, the writeCoverage and writeDirection functions allow the
user to generate genome browser files of the restriction fragment read counts and the
average fold change between Dam and Dam-fusion libraries, respectively.
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FIGURE 4.48. Quality control plots and genome browser tracks generated using the Daim
package.
The Daim package can be used to generate various quality control plots and genome browser
tracks to assess whether the DamID-seq experiments were successful. Specifically, Daim can
generate genome browser files of the normalised restriction fragment read counts and the
average fold change between Dam and Dam-fusion libraries (e.g. Oct4/Dam).
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After thorough inspection of the raw data, the prepareBackground and normaliseC-
ounts functions can be used depending on the type of analysis required. The prepare-
Background function generates simulated libraries intended to measure background
methylation so that a differential methylation analysis between the Dam and simu-
lated libraries can be performed to identify chromatin accessibility sites. For each Dam
sample, a simulated library representing random background methylation across the
genome is generated by calculating the average number of reads aligned to neigh-
bouring restriction fragments within a range of window sizes (e.g. 5 kb, 10 kb). After
this process each restriction fragment will have a read count from each Dam sample
and their associated simulated library. These counts can then be used in a conventional
two group differential methylation analysis to detect restriction fragments which have
been significantly methylated more in the Dam sample over the simulated library (see
Subsection 5.4.3 for detailed information regarding the peak calling strategy for chro-
matin accessibility sites). The normaliseCounts function is more straightforward and
is provided to remove technical biases via smooth quantile normalisation between the
Dam and Dam-fusion libraries so that a differential methylation analysis can be per-
formed to identify transcription-factor binding sites. The effect of normalisation can
be checked using the plotDensity function which generates density plots of the nor-
malised methylation values. The sequencing data is now ready for differential methy-
lation analysis using the callPeaks function to identify either chromatin accessibility
or transcription-factor binding sites depending upon which pre-processing function
was used previously. The called peaks are returned as GRanges objects which can
then be exported in broadPeak format to import into an external genome browser, or
additional functional and sequences analyses can be performed. The annotatePeaks
function will assign each peak to the nearest gene and genomic feature, including mea-
suring the distance to the closest TSS to investigate the distribution of binding. Lastly,
the scanMotif function can be used to search the peak sequences for the occurrence
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of a given motif and its associated probability using any PWM file to filter for peaks
with a high likelihood of binding or to increase the resolution of the peak regions. The
package is freely available to download (https://github.com/jma1991/daim) and is
released under an open-source MIT license to encourage adoption and further devel-
opment from the research community.
The release status of Daim is currently at version 1.0 and can be treated as the first
official release. The intention is to release the package within the Bioconductor frame-
work, allowing users to download the package from the official Bioconductor reposi-
tory using the BiocManager package. In order to submit Daim, all of its dependencies
must be available to download on either the Bioconductor or CRAN repository. At
present, the qsmooth package which Daim uses as part of the normalization strategy
is only available through GitHub (Hicks et al., 2018). I have contacted the author and
they have kindly submitted the qsmooth package to Bioconductor and it is currently
being reviewed. In order to promote and elicit feedback on Daim I am also in the pro-
cess of asking groups who have employed DamID-seq in their research to review and
test the package on their experiments.
4.5 Discussion
These results show that DamID-seq data can be used to identify multiple transcription
factor binding sites (Oct4 and Sox2) from different cell types (ESC and NSC) with min-
imal numbers of cells (106, 104, and 103). Approximately 40% of binding sites detected
using ChIP-seq were also identified using DamID-seq – the majority of which exhib-
ited the strongest binding and functionally relevant gene ontology. This percentage
was comparable to UV ChIP-seq which ranged anywhere between 4% to 41% repro-
ducibility with formaldehyde ChIP-seq (Steube et al., 2017). Whether this reflects an
interesting aspect of the biological function of Oct4 is currently unclear. Peaks which
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are identified by multiple technologies and experiments might represent the core net-
work of a DNA-binding protein and this may reflect its core function within the ma-
jority of cells within a population. However, those peaks which exhibit variability or
appear in a small number of experiments could occur for a number of reasons, both bi-
ological and technical. For example, scRNA-seq allows one to identify highly variable
genes in order to profile different cell states or rare cell types within a population. Be-
fore this technology, it was very difficult to prove that variable expression of a partic-
ular gene was a genuine biological phenomenon caused by variable cell states. Whilst
the development of single-cell epigenomic profiling technology (e.g. uliCUT&RUN
and calling cards) will help in this endeavour, it will still be difficult to target partic-
ular cell states in future experiments because profiling will not allow the researcher
to identify a marker to use for cell sorting. Data from both scRNA-seq and single-cell
epigenome profiling within the same cell would have to be generated in order to find
markers and determine whether the highly variable peaks correlate with highly vari-
able genes. Furthermore, it is tempting to attribute distinct functions to binding sites
which have been identified by both DamID-seq and either the filtered or unfiltered
ChIP-seq peaks. However, the binding sites which are identified by DamID-seq and
the filtered ChIP-seq peaks (see Set 1 in Figures 4.33 and 4.42) are those which by defi-
nition are less variable across ChIP-seq experiments given the peaks were pre-filtered
based upon their presence in multiple experiments (see Figure 4.15). By comparison,
the sites detected by DamID-seq and the unfiltered ChIP-seq peaks (see Set 2 in 4.33
and 4.42) are peaks which are present in less than six experiments, which is a very
small number to attribute significance (see 4.15). It is also important to remember that
the sites detected by DamID-seq only (see Set 4 in 4.33 and 4.42) are not seen in any
of the ChIP-seq datasets (see the unfiltered category in 4.33 and 4.42). It is therefore
not possible to calculate the presence of peaks, and it is not of interest to calculate
how variable the read coverage of these regions is because they are not significantly
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enriched above the input read coverage, so any variability would be due to techni-
cal variation rather than biological variation. Importantly, the binding sites detected
using DamID-seq with 103 cells were also the strongest bound in ChIP-seq which in-
dicated that only the most functionally relevant sites were maintained. This validates
the DamID-seq approach and ensures that the molecular function of the DNA-binding
protein will be captured using minimal numbers of cells.
In order to achieve this level of reproducibility, appropriate normalisation and mod-
elling of the sequencing data was required. Global adjustment methods were found
to be imprecise for differential methylation analysis because Dam and Dam-fusion
libraries often exhibited global differences which were biologically rather than tech-
nically generated. Smooth quantile normalisation was therefore applied to remove
any technical variation within groups whilst retaining biological variation between
groups. Additionally, the usual assumptions of variance modelling were not suit-
able for differential methylation analysis because the Dam-fusion libraries were much
more variable, so a group-specific variance model was instead employed. These two
modifications to the analysis of the sequence count data were essential to achieving
an accurate and sensitive peak calling method.
A stand-out result from this work was the apparently large variation in binding sites
detected from published Oct4 ESC ChIP-seq experiments. Importantly, this could not
be explained by routine quality control metrics or experimental variables. Although
this data was only used to identify a subset of highly reproducible sites for comparison
with DamID-seq, a deeper investigation of causative differences is recommended. The
results from ChIP-seq are routinely interpreted based on the number and distribution
of binding sites detected, and usually a biological explanation based on these obser-
vations is formulated. If such sites vary this drastically between experiments there is a
concern that inaccurate conclusions about the molecular function of the DNA-binding
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protein will be attributed.
Lastly, the development of Daim ensures that researchers without the appropriate
training in computational biology will be able to comprehensively analyse their own
DamID-seq data. It provides functions for quantification, pre-processing and peak
calling of the sequencing data and includes downstream functions for visualising cov-
erage, genomic annotation and sequence scanning. Together these functions provide a
complete workflow for going from aligned sequencing reads to annotated peak calls.
The package is implemented in R and is available under an open-source MIT license





accessibility from DamID-seq data
5.1 Introduction
Chromatin accessibility is defined as the extent to which chromatinized nuclear DNA
can be physically reached or entered by a macromolecule (Klemm, Shipony, and Green-
leaf, 2019). Ease of access is determined by a number of biological and structural
mechanisms: the occupancy and organization of nucleosomes, the presence of his-
tone variants, the combination of post-translational modifications on histone tails, and
the action of transcription factor and chromatin remodelling proteins (Tsompana and
Buck, 2014). First, the occupancy and organization of nucleosomes not only govern
the higher-order structure of the chromatin but also reshape the availability of bind-
ing sites to transcription factors. Interactions between nucleosomes on the same and
different chromatin fibres influence the folding of the chromatin which can obstruct
macromolecules binding. Additionally, nucleosomes positioned at binding sites phys-
ically block transcription factors from interacting with regulatory elements required
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for gene expression. Second, the presence of histone variants changes the global struc-
ture of the nucleosome allowing the DNA to “breath” or “constrict” around the hi-
stone proteins. Multiple variants exist for each core histone protein exhibiting dis-
tinct functions within the genome. For example, the variants H2A.Z and H3.3 are
enriched within actively transcribed genes and help maintain an accessible state for
transcriptional activity during development (Henikoff and Smith, 2015). By compar-
ison, the variant macroH2A is enriched within transcriptionally silent domains such
as the inactivated X chromosome (Chadwick and Willard, 2001). Third, the combi-
nation of post-translational modifications on histone tails change the affinity of DNA
wrapped around the nucleosome (Bannister and Kouzarides, 2011). For example, the
acetylation of particular lysines on multiple histones (notably H3K9, H3K14, H3K18,
H4K5, H4K8, and H4K12) by histone acetyltransferases (HATs) neutralise its posi-
tive charge weakening the interaction between histones and the DNA molecule. This
modification can also be removed by histone deacetylases (HDACs) to strengthen the
interaction and decrease chromatin accessibility (Görisch et al., 2005). Similarly, the
phosphorylation of a variety of amino acids (serines, threonines, and tyrosines) on
different histones (H3 and H4) by kinases introduce a highly negative charge to the
histone which loosens the chromatin. Phosphatases though carry out the opposite
modification, removing phosphate groups which reduces the negative charge includ-
ing chromatin accessibility (Schick et al., 2015). Finally, the action of transcription
factors in response to external stimuli provide sequence-specific changes in accessi-
bility to the chromatin. Given the wide variety of transcription factors, a number of
models have been discovered which facilitate chromatin remodelling: the factor can
passively compete for binding sites with dynamic nucleosomes which turnover reg-
ularly, the factor and active chromatin remodellers bind to non-nucleosomal DNA to
displace nucleosomes in cis stabilized by a secondary transcription factor, the factor
binds to accessible regulatory elements which recruit active chromatin remodellers to
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displaced nucleosomes in trans stabilised by a secondary transcription factor, or the
factor binds directly to the DNA and displaces the nucleosome with or without help
from chromatin remodelling proteins (Klemm, Shipony, and Greenleaf, 2019). Over-
all, the interplay between these biological and structural mechanisms generates a dy-
namic chromatin accessibility landscape which is often cell-type specific and reflects
their requirement for particular genes to be expressed through regulatory elements
such as promoters and enhancers.
Chromatin accessibility assays (including ATAC-seq, DNase-seq, and FAIRE-seq) al-
low researchers to determine which regions of the genome are open and therefore
implicated in genomic regulation (see Section 1.2 for a description of each method).
Genomic features such as promoters and enhancers are typically exposed and bound
by multiple DNA-binding proteins in order to drive transcription and other epigenetic
modifications. The wide application of these assays has already provided insights into
the mechanisms of iPSC reprogramming and embryo development, highlighting the
importance of studying chromatin biology (Li et al., 2017; Gao et al., 2018). Whilst
these assays continue to be used with great success, they are limited in a number of
ways: DNase-seq and FAIRE-seq require at least 1 x 106 cells in order to generate
a sufficient DNA yield, consequently they are impractical for use on rare cell types
(Song and Crawford, 2010; Simon et al., 2012). FAIRE-seq further suffers from a low
signal-to-noise ratio, therefore capturing only the most accessible regions and making
biological interpretation challenging (Tsompana and Buck, 2014). DNase-seq addi-
tionally exhibits DNase I cleavage bias, resulting in favouritism between sites which
must be normalised (Yardımcı et al., 2014). The recent development of ATAC-seq has
largely usurped these two other assays because the experimental protocol is relatively
quick and simple, but impressively can be performed using single cells (Buenrostro
et al., 2013). There is however still one drawback, none of these assays can measure
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chromatin accessibility from individual cell types without isolation. A laborious pro-
cess which not only lends itself to human error, but also to undesirable alteration of
the chromatin landscape through chemical handling (Tsompana and Buck, 2014).
Having determined in previous chapters that Dam preferentially binds to regions
of the genome generally considered open (enriched for H3K4me1, H3K4me2, and
H3K27ac histone modifications) it is conceivable that Dam may be used independently
to measure chromatin accessibility. This re-purposing of the sequencing data would
double the application of a single DamID-seq experiment and give more context to
the DNA-binding sites which have already been identified. Encouragingly, one or
two research groups have already begun to exploit this phenomenon and have used
transgene-driven Dam expression to profile in vivo chromatin accessibility from indi-
vidual cell types (Sha et al., 2010; Aughey et al., 2018). This solves the aforementioned
complications associated with isolation and culture of rare cell types.
Whilst these studies provide a first proof of concept, many of these experiments were
performed with large amounts of starting material from organisms with compara-
tively small genomes (e.g. C. elegans and D. melanogaster). Consequently, there is no
direct evidence that this approach is usable for large mammalian genomes in situa-
tions where cell number is limited. Comparative analyses between DamID-seq and
other chromatin accessibility assays are also currently limited, leading one to worry
about its efficacy and potential wide adoption. For example, whilst Aughey and col-
leagues do show that DamID-seq yields comparable results to ATAC-seq and FAIRE-
seq, their study does not include a comparison with DNase-seq and there is no attempt
at reproducing the results using data from different studies (Aughey et al., 2018). By
using data from more than one study, the accuracy and reproducibility of DamID-seq
could be better evaluated given the expected levels of variability between and within
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replicates from different assays. These arguments therefore warrant the need for fur-
ther investigation of the chromatin accessibility sites identified from DamID-seq data
in order to establish whether or not this is a convincingly forthcoming and perhaps
superior method.
5.2 Aims
The aims of this chapter are to determine whether Dam methylation can be used to
measure chromatin accessibility, how accurate this measurement is in comparison to
previously established assays, and whether accessibility can be measured using lower
cell numbers. To answer these questions, DamID-seq data from mouse embryonic
stem cells (106, 104, 103, and 102 cells) and embryonic fibroblast cells (106 cells) will
be compared to publicly available ATAC-seq, DNase-seq and FAIRE-seq data. A com-
putational method to identify chromatin accessibility sites from DamID-seq data will
also be described and is implemented in the Daim software package.
5.3 Attribution
The ATAC-seq, ChIP-seq, DNase-seq, FAIRE-seq, and RNA-seq libraries presented in
this chapter were generated by the relevant research groups and the raw sequencing
data was analysed by the author, James Ashmore. The DamID-seq libraries were gen-
erated by Dr Luca Tosti, a previous PhD student in Prof Keisuke Kaji’s research group.
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5.4 Results
5.4.1 Evaluation of Dam methylation and chromatin accessibility
In order to determine whether Dam methylation can be used to measure chromatin
accessibility, the agreement between DamID-seq and other chromatin accessibility as-
says from ESCs and MEFs was investigated. Firstly, read coverage at representative
accessible regions in the genome showed that Dam methylation corresponded with
the signal from multiple independent ATAC-seq, DNase-seq, and FAIRE-seq experi-
ments (see Figures 5.1 and 5.2). These regions also contained CTCF binding and hi-
stone modifications (including H3K4me1, H3K4me3, and H3K27ac) associated with
promoters and enhancers. Interestingly, the resolution of accessibility regions mea-
sured by Dam also appeared to be higher than the resolution of transcription factor
binding measured by Dam-fusion. This observation may be explained by the fact that
the Dam-fusion protein methylates accessible GATC sites around the transcription fac-
tor binding site, where as the Dam protein directly methylates the accessible region.
The signal of Dam methylation also appeared to be much higher than all other as-
says displayed. This was apparent given the scaling required for the genome browser
tracks for each assay, whereby the maximum value for the DamID-seq samples was
nearly three times higher than the maximum value for the other assays. Next, read
coverage at promoters showed that Dam methylation was localised around the TSS
and decreased with RNA-seq expression and RNA PolII occupancy (see Figure 5.3).
Read coverage at enhancers also showed Dam methylation was present and decreased
with p300, H3K4me1, and H3K27ac occupancy (see Figure 5.4). Importantly, these
patterns were consistent with those from other chromatin accessibility assays.
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FIGURE 5.1. Genomic snapshot of Dam methylation in ESCs at the Nanog locus.
Comparison of DamID-seq with ATAC-seq, DNase-seq and FAIRE-seq data. Active promoters
and enhancers are highlighted using CTCF, H3K4me1, H3K4me3, and H3K27ac ChIP-seq data.
The vertical grey bars highlight regions of agreement between assays.
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FIGURE 5.2. Genomic snapshot of Dam methylation in MEFs at the Thy1 locus.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. Active promot-
ers and enhancers are highlighted using CTCF, H3K4me1, H3K4me3, and H3K27ac ChIP-seq






































































































Chromatin accessibility assays (MEF)
FIGURE 5.3. Heatmap of Dam methylation in ESCs and MEFs at promoter regions.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. The promoter
regions are ranked by decreasing RNA-seq expression. Active promoters are highlighted using
RNA PolII ChIP-seq data.


















































































































Chromatin accessibility assays (MEF)
FIGURE 5.4. Heatmap of Dam methylation in ESCs and MEFs at enhancer regions.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. The enhancer
regions are ranked by decreasing RNA-seq expression. Active enhancers are highlighted using
p300, H3K4me1, and H3K27ac ChIP-seq data.
To ensure Dam methylation was not generically deposited, differentially accessible
regions between ESCs and MEFs were examined. To begin with, read coverage at
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representative promoters and enhancers showed that Dam methylation corresponded
with cell-type specific gene expression and enhancer activity (see Figures 5.5, 5.6, 5.7,
and 5.8). The promoters and enhancers of pluripotency and fibroblast related genes
were only accessible in the relevant cell-types, as seen from the multiple independent
ATAC-seq, DNase-seq, and FAIRE-seq experiments. Genome-wide expression pro-
filing was then used to identify differentially expressed genes from public RNA-seq
data (Milagre et al., 2017). Principal component analysis demonstrated that the ESC
and MEF replicates were more similar within groups than between groups, and that
there were substantial differences between their gene expression profiles (see Figure
5.9). A volcano plot of gene expression changes demonstrated that a large number of
genes were significantly differentially expressed (see Figure 5.10). Moreover, the dif-
ferentially expressed genes were involved in processes indicative of each cell-type’s
function and origin (see Figures 5.11 and 5.12). Surprisingly, read coverage at the pro-
moters of these genes showed very little difference in accessibility and methylation in
the ESC experiments (see Figure 5.13). A possible explanation for this is that many
promoters in ESCs reside in a bivalent state (contain both active and repressive chro-
matin modifications) meaning that although the promoter is accessible the gene may
not be transcribed (Harikumar and Meshorer, 2015). By comparison, read coverage
in the MEF experiments showed a substantial difference in accessibility and methyla-
tion as one would have expected. In order to identify differentially active enhancers,
overlapping and unique enhancer regions were located by intersecting peak calls from
ChIP-seq data of p300, H3K4me1, and H3K27ac enhancer-associated chromatin mod-
ifications (see Figure 5.14). Reassuringly, read coverage at these enhancers showed
substantial differences in accessibility and methylation corresponding to cell-type spe-
cific enhancer activity (see Figure 5.4). Together, these results strongly indicated that
Dam methylation was correlated with accessibility, and that sequencing data from
Dam libraries could be used to profile the chromatin landscape.
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FIGURE 5.5. Genomic snapshot of Dam methylation in ESCs and MEFs at the Esrrb locus.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. Differentially
expressed genes are highlighted using RNA-seq and RNA PolII ChIP-seq data. The vertical
grey bars highlight regions of agreement and disagreement between assays and cell types,
respectively.
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FIGURE 5.6. Genomic snapshot of Dam methylation in ESCs and MEFs at the Cdh2 locus.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. Differentially
expressed genes are highlighted using RNA-seq and RNA PolII ChIP-seq data. The vertical
grey bars highlight regions of agreement and disagreement between assays and cell types,
respectively.
208 Chapter 5. Identification of chromatin accessibility from DamID-seq data
Dam 106 ESC (Replicate 1)














FIGURE 5.7. Genomic snapshot of Dam methylation in ESCs and MEFs at the Nanog locus.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. Differentially
expressed enhancers are highlighted using p300, H3K4me1, and H3K27ac ChIP-seq data. The
vertical grey bars highlight regions of agreement and disagreement between assays and cell
types, respectively.
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FIGURE 5.8. Genomic snapshot of Dam methylation in ESCs and MEFs at the Cola12 locus.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. Differentially
expressed enhancers are highlighted using p300, H3K4me1, and H3K27ac ChIP-seq data. The
vertical grey bars highlight regions of agreement and disagreement between assays and cell
types, respectively.






















FIGURE 5.9. Principal component analysis of ESC and MEF gene expression.
Principal component analysis of ESC and MEF RNA-seq data. The X axis measures the first
principal component (PC1) which accounts for 98% of the variance. The Y axis measures the
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FIGURE 5.10. Volcano plot of ESC and MEF gene expression changes.
Volcano plot of ESC and MEF RNA-seq data. There are 2,164 and 2,194 significantly differen-
tially expressed genes (FDR < 0.05) between ESCs and MEFs, respectively. The X axis measures
the gene expression fold change and the Y axis measures the adjusted P value from differential
expression analysis. Significantly differentially expressed genes are coloured red and the top
10 differentially expressed genes are labelled.
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FIGURE 5.11. Gene ontology analysis of differentially expressed ESC genes.
Gene ontology analysis of differentially expressed ESC genes for biological process, cellular
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FIGURE 5.12. Gene ontology analysis of differentially expressed MEF genes.
Gene ontology analysis of differentially expressed MEF genes for biological process, cellular
component, and molecular function categories.








































































































Chromatin accessibility assays (MEF)
FIGURE 5.13. Heatmap of Dam methylation in ESCs and MEFs at DEG promoter regions.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. The DEG pro-
moter regions are ranked by decreasing RNA-seq expression. Active promoters are high-












FIGURE 5.14. Euler diagram of ESC and MEF enhancer regions.
Diagram representing the overlap between ESC and MEF enhancer regions.








































































































































































Chromatin accessibility assays (MEF)
FIGURE 5.15. Heatmap of Dam methylation in ESCs and MEFs at DB enhancer regions.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq data. The DB enhancer
regions are ranked by enhancer expression. Active enhancers are highlighted using p300,
H3K4me1, and H3K27ac ChIP-seq data
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5.4.2 Comparison of accessibility sites between and within assays
In order to evaluate the accuracy and sensitivity of DamID-seq data, a reliable set of
chromatin accessibility sites from already established assays was first required. Peaks
were called using publicly available ATAC-seq, DNase-seq, and FAIRE-seq data from
three independent ESC and MEF experiments. The level of variability between and
within assays was measured by comparing the number of overlapping and unique
peaks identified from the different experiments. For easier comprehension, different
groups of overlapping and unique peaks were enumerated: Set 1 refers to peaks in all
three experiments; Sets 2 to 4 refer to peaks in two out of three experiments; and Sets
5 to 7 refer to peaks in only one experiment. First, there were 82,357 and 77,340 ATAC-
seq peaks which overlapped all three ESC and MEF experiments, respectively (see
Figure 5.16). Read coverage at peaks in Set 1 was higher than in all other sets, indicat-
ing that these sites were highly accessible and reproducible between experiments. By
comparison, read coverage at peaks in Sets 2 to 7 was visibly reduced indicating that
these sites were only partially accessible and in some experiments completely closed.
There were also slightly more peaks in Sets 5 to 7 than in Set1 which demonstrated
that there were more unique than overlapping peaks between experiments. In gen-
eral, the ATAC-seq data generated a large number of both highly reproducible and
distinct chromatin accessibility sites. Next, there were 6,223 and 50,629 DNase-seq
peaks which overlapped all three ESC and MEF experiments, respectively (see Fig-
ure 5.17). One possible reason for the disparity in numbers, is that peak calling in
the ESC experiments was not optimal, evidenced by the fact that peaks in Sets 5 to
7 display read coverage in the experiments where a peak had for some reason not
been called. Unexpectedly, peaks from two of the ESC experiments formed nearly a
complete subset of the third experiment. Apart from unknown laboratory variation,
the only variable which may account for this result is library size. However, the total
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number of reads was comparable (~30 M per experiment) and small differences were
unlikely to have had such a profound effect on peak calling. Similar to the ATAC-seq
data, peaks in Set 1 were highly accessible and reproducible compared to peaks in Sets
2 to 7 which were more closed. Given such discrepancy between the ESC and MEF ex-
periments it was more difficult to conclude anything from the DNase-seq data, apart
from that the total number of peaks was slightly fewer than the ATAC-seq data. Lastly,
there were 1,965 and 481 FAIRE-seq peaks which overlapped all three ESC and MEF
experiments, respectively (see Figure 5.18). Worryingly, the total number of peaks for
each experiment was drastically different and hardly any peaks overlapped between
experiments. This result could not be attributed to imprecise peak calling as read cov-
erage over peaks in Sets 5 to 7 was only visible from the experiment where the peak
had been called. Additionally, read coverage over peaks in Sets 5 to 7 was remarkably
high which indicated that these sites were apparently highly accessible but irrepro-
ducible. The large discrepancy between experiments could also not be attributed to
library size because experiments with the largest number of reads sometimes had the
fewest number of peaks. Obviously, the FAIRE-seq data was highly irreproducible

































































FIGURE 5.16. Comparison of ATAC-seq peaks from ESC and MEF experiments.
Euler diagrams on the left hand side represent the overlap between ATAC-seq peaks from ESC
and MEF experiments. Heatmaps on the right hand side display chromatin accessibility from
ATAC-seq data.






























































FIGURE 5.17. Comparison of DNase-seq peaks from ESC and MEF experiments.
Euler diagrams on the left hand side represent the overlap between DNase-seq peaks from




























































FIGURE 5.18. Comparison of FAIRE-seq peaks from ESC and MEF experiments.
Euler diagrams on the left hand side represent the overlap between FAIRE-seq peaks from
ESC and MEF experiments. Heatmaps on the right hand side display chromatin accessibility
from DNase-seq data.
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Having investigated the level of variability within assays, the number of overlapping
and unique peaks between assays was then considered. Peaks for each assay were
generated from Sets 1 to 4 (peaks in more than two experiments) because in some
cases the third outlier experiment still exhibited moderate read coverage even if a
peak had for some reason not been called. As described previously, groups of over-
lapping and unique peaks were enumerated: Set 1 refers to peaks in all three assays;
Sets 2 to 4 refer to peaks in two out of three assays; and Sets 5 to 7 refer to peaks in
only one assay. Approximately 7,543 and 14,001 peaks overlapped all three assays
from ESC and MEF experiments, respectively (see Figure 5.19). This relatively small
number was due to very few overlapping peaks between FAIRE-seq experiments, and
consequently a much larger number of peaks overlapped between the ATAC-seq and
DNase-seq assays. The majority of DNase-seq and FAIRE-seq peaks also formed a
subset of the ATAC-seq peaks, which suggested that ATAC-seq is either more sensi-
tive or less accurate than the other assays. To determine whether the relatively large
number of unique ATAC-seq peaks was caused by the peak generation strategy, the
number of overlapping and unique peaks between assays was calculated using peaks
generated from Sets 1 to 7 (peaks in at least one experiment) (see Figure 5.20). The
large number of unique ATAC-seq peaks did not decrease dramatically, but rather
the number of unique peaks for all assays increased. To identify hallmark differences
between the peaks from each assay, read coverage and histone modification of over-
lapping and unique peaks was examined (see Figures 5.21 and 5.22). As expected,
the read coverage of peaks from Set 1 was higher than all others which indicated that
these sites were highly accessible and reproducible between assays. This set of peaks
also contained H3K4me1, H3K4me2, H3K4me3, H3K9ac, and H3K27ac modifications
which together mark accessible regulatory regions such as transcription factor bind-
ing sites, transcribed genes, active promoters, and active enhancers (Wang, Li, and
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Hu, 2014; Liu et al., 2016; Karmodiya et al., 2012; Creyghton et al., 2010). Genomic an-
notation of the peaks likewise showed that reproducible peaks between assays were
mostly located at promoters and within gene bodies, where as peaks from other sets
were predominantly found within introns and intergenic regions (see Figure 5.23). En-
couragingly, there was substantial read coverage from DamID-seq at peaks from Sets
1 to 5 which provided further evidence that Dam can measure chromatin accessibil-
ity. Unlike FAIRE-seq, both ATAC-seq and DNase-seq specific peaks exhibited partial
read coverage and H3K4me1, H3K4me2, and H3K27ac modifications which suggests
that these two assays are more sensitive than FAIRE-seq and on average capture a
larger number of partially open chromatin regions. Together, these results demon-
strated that there are substantial differences in the number of peaks called between
assays, and that truly reproducible chromatin accessibility sites are a minority which
exhibit high read coverage and relevant histone modifications. Importantly, it is up to
the researcher to determine whether or not they are interested in partially open sites
which would be irreproducible between multiple experiments. Whilst it is difficult to
fully determine causative differences between assays from public sequencing data, it
is clear that FAIRE-seq is not as accurate or reproducible as ATAC-seq or DNase-seq
and will no longer considered.




















ATAC, DNase, and FAIRE peaks (ESC)





















ATAC, DNase, and FAIRE peaks (MEF)
Using sets 1 to 4 from three independent experiments
FIGURE 5.19. Overlap between ATAC-seq, DNase-seq and FAIRE-seq peaks in ESCs and
MEFs using peaks in more than one experiment.
Euler diagrams represent the overlap between ATAC-seq, DNase-seq, and FAIRE-seq peaks
from ESC and MEF experiments. Assay-specific peaks were generated using peaks in more






















ATAC, DNase, and FAIRE peaks (ESC)




















ATAC, DNase, and FAIRE peaks (MEF)
Using sets 1 to 7 from three independent experiments
FIGURE 5.20. Overlap between ATAC-seq, DNase-seq and FAIRE-seq peaks in ESCs and
MEFs using peaks in one or more experiments.
Euler diagrams represent the overlap between ATAC-seq, DNase-seq, and FAIRE-seq peaks
from ESC and MEF assays. Assay-specific peaks were generated using peaks present in one or
more experiments (Sets 1 to 7).







































































































































































FIGURE 5.21. Chromatin accessibility and histone modifications in ESCs at overlapping
ATAC-seq, DNase-seq, and FAIRE-seq peaks.
The top panel contains a heatmap illustrating DamID-seq, ATAC-seq, DNase-seq, and FAIRE-
seq signal at overlapping and unique ATAC-seq, DNase-seq, and FAIRE-seq peaks. The bot-









































































































































































FIGURE 5.22. Chromatin accessibility and histone modifications in MEFs at overlapping
ATAC-seq, DNase-seq, and FAIRE-seq peaks.
The top panel contains a heatmap illustrating DamID-seq, ATAC-seq, DNase-seq, and FAIRE-
seq signal at overlapping and unique ATAC-seq, DNase-seq, and FAIRE-seq peaks. The bot-
tom panel contains a heatmap illustrating histone modification ChIP-seq signal at the same
peak regions.
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ATAC, DNase, and FAIRE peaks (ESC)
Using sets 1 to 7 from three independent experiments
Set 5 Set 6 Set 7

























ATAC, DNase, and FAIRE peaks (MEF)
Using sets 1 to 7 from three independent experiments
FIGURE 5.23. Annotation of overlapping ATAC-seq, DNase-seq, and FAIRE-seq peaks from
ESC and MEF experiments.
Genomic annotation of chromatin accessibility peaks as promoter, downstream of gene end, 5’
untranslated region, 3’ untranslated region, exon, intron, or intergenic.
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5.4.3 Identification of accessibility sites from DamID-seq data
Having generated a reliable set of chromatin accessibility sites and investigated the ex-
pected level of variability between already established assays, a method to call peaks
from DamID-seq data was now required. First, a differential methylation analysis be-
tween the Dam libraries and simulated libraries representing the background level of
methylation was performed (see Figure 5.24). To generate the simulated libraries, re-
striction fragment read counts were calculated by measuring the average number of
reads aligned to neighbouring restriction fragments within a range of window sizes
(e.g. 5 kb, 10 kb) from the Dam libraries. This technique is commonly used in single-
sample peak calling algorithms (e.g. MACS2) because it protects against local fluctu-
ations in read coverage due to chromatin structure, PCR amplification, and genome
copy number variation (Zhang et al., 2008). To identify significantly methylated re-
striction fragments, differential methylation analysis using linear modelling and em-
pirical Bayes methods was performed (Ritchie et al., 2015). Importantly, the relation-
ship between the Dam libraries and the simulated libraries was explicitly included in
the linear modelling strategy (see Table 5.1). This approach is conceptually similar
to Reduced Representation Bisulfite Sequencing (RRBS) data where methylated and
unmethylated counts generated from the same sample are modelled with the same
dispersion but different means (Chen et al., 2017). Restriction fragments within 1 kb
of each other were then stitched together and a Fisher’s combined P value and mul-
tiple testing corrected P value were calculated (Lun and Smyth, 2016). The method
described here was implemented in the Daim software package and can be tested by
following the online manual and using the example data provided.














FIGURE 5.24. Snapshot of Dam and simulated libraries in ESCs at the Esrrb locus.
For each Dam library, a simulated library representing the background level of methylation
was generated. Differential methylation analysis between the Dam and simulated libraries
was performed.
Rep1 Rep2 Rep3 Dam
1 0 0 1
1 0 0 0
0 1 0 1
0 1 0 0
0 0 1 1
0 0 1 0
TABLE 5.1. Design matrix for assessing differential methylation between Dam and simu-
lated libraries.
The table represents a design matrix used with linear modelling to assess differential methy-
lation between the Dam and simulated libraries. The first three coefficients are used to model
the total number of reads (Dam or simulated) for three replicates. The fourth coefficient is
used to to estimate the log ratio of Dam methylation to simulated background methylation.
In order to evaluate the peak calling strategy, a comparison of sites identified from
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DamID-seq and other chromatin accessibility assays from ESC and MEF experiments
was performed. Approximately 120,597 and 91,306 significant peaks (FDR < 0.1) were
called using Daim for the ESC and MEF DamID-seq data generated with 106 cells,
respectively (see Table 5.2). These numbers were comparable to the number of signifi-
cant peaks (FDR < 0.1) called using MACS2 for the ATAC-seq, DNase-seq, and FAIRE-
seq experiments (see Table 5.3). Genome browser tracks showed that the DamID-seq
peak calls were appropriately located under the areas of Dam methylation and were
in similar positions to the ATAC-seq, DNase-seq, and FAIRE-seq peak calls (see Fig-
ures 5.25 and 5.26). One noticeable difference was that the DamID-seq peak calls were
much larger (100 bp to 10,000 bp) than those from the other chromatin accessibility
assays (100 bp to 1,000 bp) (see Figure 5.27). The most likely explanation for this is
that DamID-seq peaks were called from restriction fragments, where as peaks from
the other assays were called using MACS2, which divides the genome into short over-
lapping windows (Zhang et al., 2008). The approach by MACS2 would not be suitable
for DamID-seq data because the assay is performed by digesting the DNA library with
methylation-sensitive enzymes which cut at GATC restriction sites, it does not methy-
late each individual nucleotide along the genome. Although the genome browser fig-
ures appear to show very similar size peaks between the different technologies, it is
clear from the distributions that DamID-seq peaks are generally much larger. These
larger peaks also tend to be evenly distributed across the genome, and not in particular
regions (see Figure 5.28).







TABLE 5.2. Number of peaks called from DamID-seq data.
This table contains the number of significant peaks (FDR < 0.1) called from DamID-seq data
using the Daim software package.
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Reference Assay Cell Peaks
Chronis 2017 ATAC-seq ESC 117,389
Maza 2015 ATAC-seq ESC 150,262
Simon 2017 ATAC-seq ESC 249,172
Chronis 2017 ATAC-seq MEF 124,682
Li 2017 ATAC-seq MEF 168,047
Maza 2015 ATAC-seq MEF 123,578
Beer 2014 DNase-seq ESC 15,172
Domcke 2015 DNase-seq ESC 62,500
Sherwood 2014 DNase-seq ESC 9,682
Beer 2014 DNase-seq MEF 128,892
Deng 2015 DNase-seq MEF 151,681
Herdman 2017 DNase-seq MEF 82,375
Buecker 2014 FAIRE-seq ESC 36,019
Dieuleveult 2016 FAIRE-seq ESC 7,357
Murtha 2015 FAIRE-seq ESC 300,457
Murtha 2015 FAIRE-seq MEF 31,883
Tiwari 2015 FAIRE-seq MEF 39,047
Wapinski 2013 FAIRE-seq MEF 65,588
TABLE 5.3. Number of peaks called from ATAC-seq, DNase-seq, and FAIRE-seq data.
This table contains the number of significant peaks (FDR < 0.1) called from ATAC-seq, DNase-
seq and FAIRE-seq data using MACS2. The reference column contains the author and year of
the sequencing experiment (see Chapter 2 for a full list of accession numbers).













FIGURE 5.25. Genomic snapshot of peaks from ESC chromatin accessibility data.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq peaks. The DamID-
seq peaks were called using Daim (FDR < 0.1) and the ATAC-seq, DNase-seq, and FAIRE-seq













FIGURE 5.26. Genomic snapshot of peaks from MEF chromatin accessibility data.
Comparison of DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq peaks. The DamID-
seq peaks were called using Daim (FDR < 0.1) and the ATAC-seq, DNase-seq, and FAIRE-seq
peaks were called using MACS2 (FDR < 0.1).
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FIGURE 5.27. Distribution of peak sizes from chromatin accessibility assays.
Graphs display the distribution of peak sizes from ESC and MEF ATAC-seq, DamID-seq,
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FIGURE 5.28. Distribution of DamID-seq peak sizes by genomic feature.
Boxplots display the distribution of peak sizes by genomic feature from ESC and MEF DamID-
seq data. The vertical red line indicates the average peak size.
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To assess the similarity between DamID-seq and other chromatin accessibility assays,
the number of overlapping and unique peaks was calculated using peaks from Sets
1 to 4 between experiments (see Figure 5.29). Approximately 68,191 (50.31%) and
56,054 (54.23%) DamID-seq peaks overlapped with at least one other assay in the ESC
and MEF experiments, respectively. These proportions were similar to the ATAC-seq
peaks (56.03% and 71.94%) but were much lower than DNase-seq peaks (99.59% and
86.46%). Interestingly, very few peaks uniquely overlapped between DamID-seq and
DNase-seq in both the ESC and MEF experiments which suggests that chromatin ac-
cessibility sites identified by ATAC-seq and DNase-seq are more related. In addition,
the number of unique ATAC-seq and DamID-seq peaks were similar in both the ESC
(58,705 and 67,356) and MEF (34,612 and 47,313) experiments. To verify that the rather
large number of unique DamID-seq peaks were genuine, the proportion of overlap-
ping and unique peaks was calculated using peaks from Sets 1 to 7 between experi-
ments (see Figure 5.30). However, the number of unique DamID-seq peaks decreased
only slightly in both the ESC (67,356 to 49,141) and MEF (47,313 to 34,687) experiments.
In order to identify hallmark differences in the overlapping and unique DamID-seq
peaks, read coverage and histone modification data was examined (see Figure 5.31).
The read coverage data showed that peaks found in all assays were highly accessible,
which indicated that the strongest peaks were also the most reproducible. Interest-
ingly, peaks which were found in either DamID-seq and ATAC-seq only (Set 2) or
DamID-seq and DNase-seq only (Set 3) were measured as highly accessible in the
DamID-seq assay but only marginally accessible in the ATAC-seq and DNase-seq as-
says. Likewise, peaks found in ATAC-seq and DNase-seq only were as accessible as
the peaks found in all three assays. The histone modification data showed that peaks
found in all three assays were highly enriched for H3K4me1, H3K4me2, H3K4me3,
H3K9ac, and H3K27ac which are commonly associated with transcribed genes, active
promoters, and active enhancers (see Figure 5.32). Interestingly, peaks which were
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unique to DamID-seq lacked any histone modifications and peaks which were shared
between DamID-seq and just one other assay had a reduced H3K4me3 and H3K9ac
level. Lastly, the distribution of overlapping and unique DamID-seq peaks within ge-
nomic features was examined (see Figure 5.33). Generally, the genome annotations
showed that all sets of peaks were predominantly found in intergenic and intron re-
gions, but that peaks common to all assays were also to a large extent located within
promoter regions. Worryingly, peaks which were unique to ATAC-seq and DNase-
seq were also found at promoter regions which suggests that DamID-seq is unable
to detect chromatin accessibility sites at certain promoters. However, as discussed
previous (see Subsection 4.4.3) this difference could be explained by the depletion of
GATC sites in promoter regions in the mouse genome (see Figure 4.36) which may ex-
plain why fewer accessibility sites were detected at promoters using DamID-seq data.
Together these results indicate that high coverage DamID-seq peaks predominantly
overlap with high coverage peaks from other chromatin accessibility assays, however
unlike ATAC-seq and DNase-seq, unique DamID-seq peaks are not enriched for hi-
stone modifications associated with accessible genomic features. Whether these are
true accessibility sites or are simply a technical artefact remains to be understood.



















DamID, ATAC, and DNase peaks (ESC)





















DamID, ATAC, and DNase peaks (MEF)
Using sets 1 to 4 from three independent experiments
FIGURE 5.29. Overlap between DamID-seq, ATAC-seq, and DNase-seq peaks in ESCs and
MEFs using peaks in more than one experiment.
Euler diagrams represent the overlap between DamID-seq, ATAC-seq, and DNase-seq peaks
from ESC and MEF experiments. The ATAC-seq and DNase-seq peaks were generated using



















DamID, ATAC, and DNase peaks (ESC)





















DamID, ATAC, and DNase peaks (MEF)
Using sets 1 to 7 from three independent experiments
FIGURE 5.30. Overlap between DamID-seq, ATAC-seq, and DNase-seq peaks in ESCs and
MEFs using peaks in one or more experiments.
Euler diagrams represent the overlap between DamID-seq, ATAC-seq, and DNase-seq peaks
from ESC and MEF experiments. The ATAC-seq and DNase-seq peaks were generated using
peaks in one or more experiments (Sets 1 to 7).









































































































































































FIGURE 5.31. Chromatin accessibility and histone modifications in ESCs at overlapping
DamID-seq, ATAC-seq, and DNase-seq peaks.
The top panel contains a heatmap illustrating DamID-seq, ATAC-seq, DNase-seq, and FAIRE-
seq signal at overlapping and unique DamID-seq, ATAC-seq, and FAIRE-seq peaks. The bot-











































































































































































FIGURE 5.32. Chromatin accessibility and histone modifications in MEFs at overlapping
DamID-seq, ATAC-seq, and DNase-seq peaks.
The top panel contains a heatmap illustrating DamID-seq, ATAC-seq, DNase-seq, and FAIRE-
seq signal at overlapping and unique DamID-seq, ATAC-seq, and FAIRE-seq peaks. The bot-
tom panel contains a heatmap illustrating histone modification ChIP-seq signal at the same
peak regions.
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DamID, ATAC, and DNase peaks (ESC)
Using sets 1 to 7 from three independent experiments
Set 5 Set 6 Set 7






















DamID, ATAC, and DNase peaks (MEF)
Using sets 1 to 7 from three independent experiments
FIGURE 5.33. Annotation of overlapping DamID-seq, ATAC-seq, and DNase-seq peaks
from ESC and MEF experiments.
Genomic annotation of chromatin accessibility peaks as promoter, downstream of gene end, 5’
untranslated region, 3’ untranslated region, exon, intron, or intergenic.
5.4. Results 245
Having demonstrated that chromatin accessibility sites can be detected from DamID-
seq data generated with 106 cells, the sensitivity of DamID-seq at lower cell numbers
was then examined. Peaks were called from ESC DamID-seq data generated with 104,
103, and 102 cells using the method implemented in the Daim software package (see
Figure 5.34). A similar number of peaks were called using 106 (N=120,597) and 104
(N=138,919) cells, but this dropped by over half using 103 (N=65,401) cells and no
significant peaks were detected using 102 cells (see Table 5.2). To determine why no
significant peaks were detected using 102 cells, correlation plots of the restriction frag-
ment read counts between biological replicates were generated (see Figure 5.36). The
correlation plots showed that Spearman’s rank correlation coefficient decreased as the
number of cells decreased (ranging from 0.80 to 0.29) and that past 103 cells the cor-
relation between biological replicates was extremely low, hence the variation was too
high to achieve a significant probability level (FDR < 0.1). Another possible explana-
tion for the drop in the number of peaks was that as the number of cells decreased the
complexity of the libraries also decreased (see Figure 5.35). Reassuringly, the major-
ity of peaks called at lower cell numbers formed a subset of those called from higher
cell numbers (see Figure 5.37). Read coverage of the overlapping and unique peaks
also demonstrated that the peaks called using lower cell numbers were the strongest
accessible peaks called using higher cell numbers, which are also reproducible across
assays. Lastly, the distribution of peaks within genomic features was similar between
different cell numbers which indicated that peak calling at specific genomic features
was not biased by cell number (see Figure 5.38). These results indicated that a large
number of chromatin accessibility sites can be detected using a minimum of 103 cells,
and that the method implemented in the Daim software package is accurate at lower
cell numbers.












FIGURE 5.34. Genomic snapshot of low cell number DamID-seq peak calls in ESCs at the
Nanog locus.
Comparison of low cell number DamID-seq with ATAC-seq, DNase-seq, and FAIRE-seq peaks.
The DamID-seq peaks were called using Daim (FDR < 0.1). The ATAC-seq, DNase-seq, and




















































FIGURE 5.35. Library complexity of low cell number ESC DamID-seq data.
The top graph measures the sequencing read complexity at different library sizes. The bottom
graph measures the number of restriction fragments occupied at different library sizes.
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FIGURE 5.36. Spearman correlation between low cell number ESC DamID-seq replicates.
Graphs of Spearman correlations between low cell number DamID-seq biological replicates
calculated using the normalised number of counts for each restriction fragment. The correla-







































FIGURE 5.37. Comparison of low cell number DamID-seq peaks from ESC experiments.
Euler diagrams on the left hand side represent the overlap between low cell number DamID-
seq peaks from ESC experiments. Heatmaps on the right hand side display chromatin acces-
sibility from DamID-seq data.
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Using 106, 104, and 103 cells
FIGURE 5.38. Annotation of overlapping low cell number DamID-seq peaks ESC experi-
ments.
Genomic annotation of chromatin accessibility peaks as promoter, downstream of gene
end,5’untranslated region, 3’ untranslated region, exon, intron, or intergenic.
5.5 Discussion
These results show that DamID-seq can be used to measure chromatin accessibil-
ity with minimal numbers of cells (106, 104, 103) from a large mammalian genome.
This finding complements previous research by providing further evidence that Dam
methylates accessible chromatin in a manner similar to already established assays. It
also provides the first proof that a large number of reproducible chromatin accessi-
bility sites can be identified from DamID-seq data prepared with 103 cells at a min-
imum. This is especially significant when combined with transgene-drive Dam ex-
pression, because it provides researchers limited by starting material with an accurate
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and sensitive in vivo profiling method. This work also demonstrates that truly repro-
ducible chromatin accessibility sites, based upon comparative analyses across exper-
iments and assays, are in a minority and it is not clear whether they are relevant or
important to the biology under investigation. Most of the reproducible sites are lo-
cated near regulatory genomic features such as promoters and enhancers, whilst the
rather large number of unique sites appear to be randomly distributed within inter-
genic regions. This suggests that many chromatin accessibility sites identified using
these assays are not functionally important and instead represent a heterogenous land-
scape caused either by tissue heterogeneity or chemical handling. In reality, multiple
biological and technical factors collude in this regard, and that comparative analysis
of public sequencing data is insufficient to thoroughly understand this phenomenon.
Despite these complications, it is clear that ATAC-seq outperformed all of the other
assays and only in the particular situation where isolation of rare cell types is too
challenging should DamID-seq be specifically applied. The resolution of DamID-seq
peaks is also very low compared to ATAC-seq, and whilst this is problematic, it is
difficult to envisage how an analysis of chromatin accessibility would be particularly
biased. Most analyses of this type of data do not rely on nucleotide-level resolution,
primarily because chromatin accessibility usually spans multiple kilobases along the
genome. Perhaps more concerning, is that FAIRE-seq data is extremely irreproducible
and past research relying on this technology should be either carefully interpreted
or performed again with a different assay. Lastly, the development of a peak calling
method for DamID-seq and its implementation in an open-source software package
will allow researchers to readily analyse their own sequencing data, which hopefully
will create an impetus for the wide adoption of the technology and allow for future






6.1 Summary of research
The results presented in this thesis show that DamID-seq is capable of identifying tran-
scription factor binding sites and chromatin accessibility sites using a minimum of 103
cells. In order to reach this conclusion a comprehensive investigation of biases in the
experimental procedure, differential methylation analysis of the sequence count data,
and similarity between DamID-seq and already established assays was conducted.
First, it was demonstrated that technical variables such as polymerase usage and Dp-
nII digestion were important in generating sufficient enrichment of methylated chro-
matin and that identification of differentially methylated restriction fragments was
influenced by sequence composition. Second, the statistical properties of the sequence
count data revealed that global adjustment methods were not appropriate for normali-
sation and that the variance between replicate experiments should be modelled within
groups independently. Third, comparative analyses with already established genome-
wide methods verified that the target sites identified using DamID-seq were genuine
and that with fewer cells only the strongest sites were detected. These findings cul-
minated in the development of Daim – an R/Bioconductor software package for the
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analysis, interpretation, and visualisation of DamID-seq data. The availability of this
software should help streamline reproducible analyses and alleviate the concerns of
researchers looking to perform DamID-seq experiments who lack the relevant training
in computational biology.
6.2 Contributions of research
This work contributes significantly to the understanding of DamID-seq data and lays
the appropriate theoretical groundwork for development of new tools and interpreta-
tion of results:
First, a systematic evaluation of potential biases in the sequencing data revealed that
the lower resolution of DamID-seq was limited to multiple kilobases. By comparison
the strand-specific nature of ChIP-seq can be used to achieve near base pair resolution.
The removal of PCR duplicates was not detrimental to the signal at transcription factor
binding sites, and in some cases increased relative to the background. The binding of
Dam was not biased by the local nucleotide composition of GATC sites, unlike the Tn5
transposase used in ATAC-seq experiments. The GC content and length of restriction
fragments influenced the ability to detect differential methylation, which indicated
that downstream corrective measures were required. Lastly, a chromatin state model
of Dam binding demonstrated that the protein binds principally at genomic regions
associated with chromatin accessibility, such as enhancers and promoters.
Second, the evaluation of distributional properties of the restriction fragment read
counts showed that global adjustment methods were not appropriate and instead
smooth quantile normalisation was suitable to retain genuine differences between the
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Dam and Dam-fusion libraries. Additionally, it was shown that the Dam-fusion li-
braries were much more variable than the Dam libraries which indicated that the vari-
ance of the restriction fragment read counts should be modelled independently for
each group when performing differential methylation analysis. Together, these obser-
vations informed the development of a peak-calling strategy which was able to iden-
tify binding sites from multiple transcription factors and cell lines using a minimum
of 103 cells.
Third, having observed that Dam preferentially binds genomic regions generally con-
sidered to be accessible the opportunity to repurpose the sequencing data to iden-
tify chromatin accessibility sites was examined. Through comparison with ATAC-
seq, DNase-seq, and FAIRE-seq data it was shown that Dam can be used to mea-
sure chromatin accessibility. Given this result, a method to identify accessibility sites
from DamID-seq data was described and evaluated through comparative analyses
with multiple independent ATAC-seq, DNase-seq, and FAIRE-seq experiments.
6.3 Comparison with previous research
Whilst the results presented in this thesis largely complement and extend research by
previous groups, a number of small points of disagreement were discovered:
First, the removal of the DpnII digestion step as advocated by recently published
DamID-seq protocols caused a significant reduction in the methylation signal from
Dam and Dam-fusion binding. The original role of DpnII was to remove restriction
fragments caused by non-specific methylation to help decrease the background in the
sequencing data and make peak-calling more accurate and sensitive. However, the
conjecture from newer publications is that the occurrence of non-specific methylation
is so low that DpnII digestion is redundant and that only DpnI digestion is required.
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While this observation may have been true for these publications, it is interesting to
note that many of them were investigating nuclear lamin structure and assembly. The
interaction of lamin with DNA spans hundreds of kilobases and the analysis of such
data typically involves aggregating read counts from large windows so individual re-
ductions in binding may not have been compelling or even noticed. The footprint of
transcription factors on the other hand is localised to less than a hundred base pairs
and hence DpnII appears to be essential for proper enrichment and removal of the
non-specific background.
Second, the use of the Clontech Advantage polymerase used in the original and a
number of subsequent DamID-seq protocols was inefficient at amplifying certain re-
striction fragments and reduced the library complexity. This was particularly im-
portant because restriction fragments containing DNA-binding sites were no longer
represented in the sequencing library making the assay overall less sensitive. The
extent of this problem however is probably dependent on the experimental organ-
ism as smaller genomes will on average lose fewer restriction fragments than larger
genomes, especially if the average GC content and size of the restriction fragments is
suited to the polymerase. In the case of transcription factors and other small footprint
DNA-binding proteins, it is essential that as many methylated restriction fragments
as possible are amplified in the sequencing library. Each of these restriction fragments
may contain a single DNA-binding site, and for each one which has failed to am-
plify the number of peak calls is reduced. This issue is less concerning however for
large scale interactions such as nuclear lamin, where the absence of a few restriction
fragments within kilobase pair regions can be tolerated. Future DamID-seq experi-
ments of small footprint DNA-binding proteins should therefore probably substitute
the Clontech Advantage polymerase for a more processive one, such as the Kapa HiFi
polymerase which was examined.
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Third, routine quality control metrics proposed by the ENCODE consortia and the
CISTROME project were surprisingly ineffective at predicting the success of a ChIP-
seq experiment. Large-scale comparative analysis of published Oct4 ESC ChIP-seq
data demonstrated a high level of variability in the number of peaks called between
experiments which could not be explained by sequence quality, mapping quality, li-
brary complexity, or ChIP enrichment. Whilst many of these metrics in theory are rea-
sonable, they do not consider variation at the experimental level which can be argued
is more important to consider. However, cross-referencing of the peaks with known
experimental variables such as cell culture media and antibody selection also did not
provide any explanation. Instead, it might be suggested that the combination of tech-
nical and biological factors is irretrievably mixed such that any single metric is hardly
predicative. Given the inherent variation in experimental procedures it would be quite
difficult to design an experiment to measure the power of each quality metric in rela-
tion to the number of peaks called. Perhaps a bigger question would be whether or
not the variability between replicate experiments reflects the genuine binding which
occurred in the biological sample, in which case post-hoc filtering which is commonly
performed on ChIP-seq peaks to retain only the reproducible sites may not be justified.
This could be tested using a number of different experiments: Highly multiplexed
single-cell ChIP-qPCR could be used to target highly variable peaks (HVP) to check
whether Oct4 binding can be measured in any cells from a population (VanInsberghe
et al., 2018). This approach could be extended using single-cell CUT&RUN and more
recently single-cell calling cards (ssCC) to increase the chances of detecting HPVs by
assaying a larger sample of the population (Hainer et al., 2018b; Moudgil et al., 2019).
Such HPVs could also be distinguished by applying the CRISPR/Cas9 system to mu-
tate or completely remove a subset of highly variable ChIP-seq peak regions in Oct4
knock-out cells (King and Klose, 2017). After performing a combination of ChIP-seq
experiments in mutated versus wildtype and knock-out versus wildtype cells, certain
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HVPs could first be identified as genuine Oct4 binding sites (i.e. peaks present only in
the wildtype versus knock-out cells) and then this could be cross-referenced against
HVPs which are still present even in the absence of the binding site (i.e. peaks origi-
nating from non-specific DNA sliding versus specific DNA binding).
The fact that most published studies analysed in this thesis did not perform replicate
experiments and are therefore difficult to reproduce is not entirely surprising. Ioan-
nidis and colleagues argue that the reward system in science, described as the pur-
chasing of academic “goods” (e.g. promotion and other powers) with “currency” (e.g.
publications and grants) can unintentionally select for “prolifically mediocre and/or
irreproducible research” (Ioannidis, 2014). They exemplify the problem by measur-
ing the repeatability of 18 published microarray gene expression analyses, concluding
that only two in principle and six partially were reproducible compared to ten that
could not be reproduced. The reasons for this were mainly unavailability of data,
and discrepancies in data annotation and analysis protocols (Ioannidis et al., 2009).
When considering why few experiments are replicated, a number of reasons have
been suggested: Large-scale studies are particularly expensive and performing a min-
imum of three replicates is prohibitively expensive. Some biological samples are diffi-
cult to obtain, such as in clinical research, and there is simply not enough material to
spread across multiple experiments. Resources can be better spent on assaying sam-
ples once via different technologies (e.g. ChIP-seq, RNA-seq, and ATAC-seq) than
multiple times with only one technology. Replication is not incorporated up front in
designing the research agenda in a given field, this is particularly prominent in ChIP-
seq experiments where the most popular peak calling algorithms (e.g. GEM, MACS,
and MUSIC) do not model variability between replicates and simply average or sum
the biological signal across datasets (Thomas et al., 2017). This is in sharp contrast
to RNA-seq experiments where the most popular tools model the data in such a way
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that a minimum of two replicates is required to even run the analysis software (e.g.
DESeq2, edgeR, and limma) (Conesa et al., 2016). Overall, Ioannidis and colleagues
suggest a number of ways to mediate the problem including “the adoption of large-
scale collaborative research; replication culture; registration; sharing; reproducibility
practices; better statistical methods; standardization of definitions and analyses; more
appropriate (usually more stringent) statistical thresholds; and improvement in study
design standards, peer review, reporting and dissemination of research, and training
of the scientific workforce.” (Ioannidis, 2014). Although not all of these interventions
are practical, it is clear that the current system does not reward replication and that
the adoption of some of these practices is necessary.
6.4 Scientific and engineering implications
The development of the Daim software package for the analysis of DamID-seq data
will help facilitate research in conditions where the number of cells are limited or
an effective antibody for the protein of interest has not been produced. Using the
peak calling strategy described, transcription factor binding and chromatin accessi-
bility sites were detected using a minimum of 103 cells. This represents a significant
decrease from the 107 cells required for conventional ChIP-seq experiments, which
should allow unprecedented interrogation of DNA-binding and chromatin accessibil-
ity within rare cell types and in vivo organisms. In fact, Daim has already been used
successfully within our research group to measure for the first time Oct4 binding in the
gastrulating mouse embryo (Tosti et al., 2018). The implementation of a single method
to detect binding and accessibility from the same sequencing data also allows for a
deeper understanding of the epigenetic environment in which the transcription fac-
tor is binding. In iPSC cells and reprogramming a number of so-called pioneer factors
bind specifically to closed chromatin to recruit nucleosome remodelling proteins – this
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characteristic could readily be captured in a single DamID-seq experiment. Whilst the
development of new functional genomic technologies is nearly always welcome, it is
important to be conscious of the fact that DamID-seq fills a particular niche and that it
is not competing in same space as already established assays. For example, chromatin
accessibility can already be measured from 50 to 50,000 cells using ATAC-seq and has
recently been upgraded for use in single cell experiments. This technology has largely
usurped all previous chromatin accessibility assays including DNase-seq and FAIRE-
seq because of its simple and quick experimental protocol. However, DamID-seq is
the only one of these assays which can be combined with tissue-specific promoter ex-
pression to measure in vivo chromatin accessibility across different cell types (Southall
et al., 2013). For detection of DNA binding sites, the advantage of DamID-seq over
conventional ChIP-seq is the ability to use far fewer cells and no reliance on having
an effective antibody for the protein of interest. However, recently a technique called
CUT&RUN which is based on antibody-targeted cleavage of the protein bound DNA
has been shown to map transcription factor binding sites with high resolution from
103 cells (Skene and Henikoff, 2017). Whilst this is a significant improvement, it still
relies on having an efficient antibody and cannot be used to profile in vivo binding
across different cell types.
6.5 Limitations of the research
Despite showing that DamID-seq can be used to identify transcription factor binding
and chromatin accessibility sites from a minimum of 103 cells, there were a number of
factors that limited the scope of this work:
First, all of the DamID-seq data analysed in this work was generated within our re-
search group so the level of variability between independent experiments could not
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be measured. As seen from the comparative ChIP-seq analyses, a multitude of un-
known technical and biological factors contribute to the accuracy and sensitivity of a
sequencing experiment. This could therefore change the interpretation of the results
described in this work depending on how drastically the number of peaks changed.
The lack of comparable sequencing data is mainly due to the fact that only in the last
year did our research group describe an optimised DamID-seq protocol which would
allow the identification of transcription factor binding sites from minimal numbers of
cells (Tosti et al., 2018). It is hoped that in the coming years the adoption of DamID-
seq by different research groups will generate a large supply of sequencing data so
that technical artefacts may be identified and methods to accommodate or remove
their influence on the results can be developed. Two notable examples include the
identification of so-called blacklist regions and high-occupancy target (HOT) regions
in a number of functional genomic assays (Landt et al., 2012; Li et al., 2016). The
blacklist regions were discovered by ENCODE through comparative analysis of hun-
dreds of sequencing experiments, which allowed them to identify what they describe
as regions of the genome that show artificially high read mapping independent of the
experimental condition. Sequencing data is now routinely filtered to remove these
anomalously mapped reads in order not to impact the calculation of quality control
metrics and call peaks within these regions (Carroll et al., 2014). The HOT regions
were originally defined based on an unusually high number of transcription factor
binding sites located at specific genes, and at first appeared to be relevant to the de-
velopmental processes of the cell. However, through comparative analyses of knock-
out transcription factor ChIP-seq data these regions were later found to be artefac-
tual and instead were caused by specific sequence characteristics and enrichment of
DNA tertiary structures (Wreczycka et al., 2017). Given the infancy of mammalian
DamID-seq it is not inconceivable that technical artefacts in the data are waiting to be
discovered and may currently be misinterpreted as DamID-seq specific peaks. In the
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absence of a large amount of published sequencing data, it may be prudent to design
functional experiments which target DamID-seq specific peaks to check their binding.
One possible approach would be to design a qPCR experiment to measure the ratio of
Dam and Dam-fusion methylation which would independently confirm that binding
had occurred. Another would be to compare peaks called using Dam-fusion proteins
containing either a functioning or non-functioning transcription factor. Those peaks
which are present in the non-functioning assay would allow one to identify charac-
teristics of DamID-seq artefactual regions which could then be used in future experi-
ments to remove peaks within these regions.
Second, the peak calling strategy implemented in the Daim software package relies
upon replicated DamID-seq data in order to identify transcription factor binding and
chromatin accessibility sites. This is a departure from many conventional peak-calling
algorithms which do not model the variability between replicate experiments (Pepke,
Wold, and Mortazavi, 2009). Instead, peaks are called using merged data from multi-
ple experiments or separately which then requires post-hoc analyses to identify repro-
ducible peaks across experiments. The sophistication of these post-hoc analyses varies
from simply looking at overlapping peaks to modelling the irreproducible discovery
rate (IDR) to identify at what significance threshold peaks from two experiments stop
being reproduced (Landt et al., 2012). The former method has clear limitations because
a user-defined definition for what amount of overlap and in how many replicates con-
stitutes a reproducible peak is required. The latter method is much more independent
in that only a pre-defined value for the IDR significance threshold - usually 0.05 in
the biological sciences - is required. The method implemented in the Daim software
package however is to directly model the significance of each peak by looking at the
variation in read counts between experiments. If a read count is highly variable it is
unlikely to be assigned a P value small enough to cross the pre-defined value for the
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false discovery rate (FDR) significance threshold. This disparity in measuring repro-
ducible peaks therefore creates an artificial difference between assays which may be
misinterpreted or attributed to factors unrelated. For example, a peak which exhibits
a high average read count but also high variance between experiments is less likely to
be called by the Daim method because the level of variability reduces the likelihood
of achieving a P value smaller than the pre-defined FDR significance threshold. This
variability however may be an intractable feature of the sequencing data and enrich-
ment should instead be modelled using simpler non-parametric assumptions. This
is perhaps the main advantage of conventional peak-calling algorithms because any
difference in the signal-to-noise ratio between replicate experiments is not explicitly
measured. With particularly noisy sequencing data, this allows the researcher to be
more flexible in their definition of a genuine peak based on prior biological under-
standing of the system, at the inevitable cost of increasing the false-positive rate. In
the specific context of DamID-seq, it may be advantageous to investigate potential
non-parametric peak-calling alternatives especially at lower cell numbers where the
variance between experiments is increased. There is currently only one published non-
parametric algorithm, however it has not been made readily available and has only
been demonstrated using sequencing data from the much smaller Drosophila genome
(Li, Hempel, and Jiang, 2015). Peaks are defined based upon re-sampling of the data to
generate a distribution of average fold changes which is then used to identify restric-
tion fragments which achieve a fold change greater than the 95th percentile. Whilst
this approach reportedly generated a comparable number of peaks to ChIP-seq data,
without access to the original algorithm or reimplementation from details in the pub-
lication it is difficult to evaluate this particular method.
Third, the peak calling strategy implemented in the Daim software package was only
tested on mammalian transcription factor binding. These proteins often have a small
264 Chapter 6. Discussion
footprint, hence there is no evidence that Daim can be used to detect large interac-
tions such as nuclear lamin binding. In theory, this should not be problematic because
peak calls are made by combining neighbouring restriction fragments – increasing this
distance should allow chaining of restriction fragments into much larger regions rep-
resentative of the actual binding. To promote the use of Daim it is important to show
that DamID-seq data from other organisms can also be analysed. The technology itself
was originally developed for Drosophila and is where the application of DamID-seq is
currently most popular. However, no problems are currently anticipated because the
peak calling strategy is agnostic and only requires the reference genome sequence
to generate the restriction fragment annotation used for read counting. In fact, the
DamID-seq signal-to-noise ratio in Drosophila is reported to be much higher than in
mammalian cells due to technical differences related to the optimum expression of
Dam, which suggests that peak calling should be more effective.
6.6 Future work
Although the results presented in this thesis demonstrate that Daim can be used to
analyse DamID-seq data from minimal numbers of cells, there are several follow-up
experiments which are required:
First, a comparative analysis of other DamID-seq peak callers would help establish
which algorithmic features are best suited to this type of sequencing data. There are
currently four different published analysis pipelines for DamID-seq data, all of which
implement novel approaches but none of which have been benchmarked (see Table 6.1
and Subsection 2.2.7 for details about each pipeline). The current advantage of Daim
is that it incorporates methods for identifying both transcription factor binding and
chromatin accessibility sites, whereas the other four only detect binding. However,
most analyses of DamID-seq data in the literature use ad-hoc analyses catered to the
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Author Pubmed ID Availability
Li et al 25785608 Available upon request from author
Marshall et al 26112292 https://owenjm.github.io/damidseq_pipeline
Gutierrez-Triana et al 27707796 https://bitbucket.org/juanlmateo/idear
Maksimov et al 27766446 https://github.com/Vift/DamID-Seq
TABLE 6.1. Publicly available DamID-seq analysis pipelines.
This table contains a list of all publicly available DamID-seq analysis pipelines at the time this
work was published (see Subsection X for an extensive description of each pipeline).
experiment and are rarely released as a fully functioning software package. It would
take a great deal of development time to reimplement these described methods so a
comparison of officially published analysis pipelines would be better suited. The main
difference between these four peak callers and Daim is that they do not account for
replicate variability in the estimation of peak significance. This approach is much more
similar to conventional ChIP-seq peak callers and it would not be surprising if a larger
number of peaks overlapped. Whether this represented more accurate peak calling or
simply increased false positive rates on par with current ChIP-seq algorithms would
be an interesting avenue of investigation.
Second, a number of computational methods have been developed for Hi-C data
which theoretically could be adapted to DamID-seq data. In a typical Hi-C exper-
iment, chromatin is crosslinked with formaldehyde, digested using restriction en-
zymes, and interacting restriction fragments are ligated together and sequenced. The
aligned reads are then counted into restriction fragments and this measurement is
used to quantify interacting regions of the genome. The quantification of restriction
fragments is what makes DamID-seq and Hi-C analytically similar, and a number of
approaches to removing sequence composition biases and detecting enriched restric-
tion fragments have already been developed. Most notably, the use of hidden Markov
models (HMM) to detect the edges of topologically-associated domains (TAD) could
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directly be adapted to identify differentially methylated regions. A measurement
called the directionality index (DI) is used to quantify the extent of upstream and
downstream bias in the sequencing data, this produces a fold change value for each
restriction fragment along the genome. The fold change values are then used with
the HMM to assign upstream and downstream bias calls to each restriction fragment.
If the DI values were replaced with the fold change values from the Dam and Dam-
fusion binding this approach would theoretically be usable, however its accuracy and
sensitivity would have to be determined.
Third, an implementation of a non-parametric or single replicate peak-calling algo-
rithm for DamID-seq data would be advantageous at lower cell numbers. Obser-
vations of the sequencing data indicated that library complexity decreased with cell
number and this produced stark differences between the replicates which was diffi-
cult to overcome with normalisation. A restriction fragment in one replicate would
have a read count of zero compared to a second replicate with a high read count – the
difference between these two replicates was presumably the chance amplification of
the restriction fragment in one replicate from the minimal number of cells. Genuine
binding sites detected using ChIP-seq and larger cell number DamID-seq experiments
were missed at lower cell numbers due precisely to this read count variation. Impu-
tation methods for single cell RNA-seq which try to replace the missing value would
not be helpful in this scenario because they require a large number of independent
replicates to accurately model the drop-out rate. By calling peaks from multiple repli-
cates independently, a flexible rule may instead be applied to retain peaks which are
in a certain number of experiments. The likely increase in false positive and true posi-
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